HDAC1 ||| S:0 E:5 ||| NNP
.  ||| S:5 E:7 ||| .
Introduction  ||| S:7 E:20 ||| UH
Preimplantation  ||| S:20 E:36 ||| JJ
embryo  ||| S:36 E:43 ||| NN
development  ||| S:43 E:55 ||| NN
includes  ||| S:55 E:64 ||| VBZ
fertilization ||| S:64 E:77 ||| VBN
,  ||| S:77 E:79 ||| ,
cell  ||| S:79 E:84 ||| NN
cleavage ||| S:84 E:92 ||| NN
,  ||| S:92 E:94 ||| ,
morula  ||| S:94 E:101 ||| NN
and  ||| S:101 E:105 ||| CC
blastocyst  ||| S:105 E:116 ||| JJ
formation ||| S:116 E:125 ||| NN
.  ||| S:125 E:127 ||| .
The  ||| S:127 E:131 ||| DT
formation  ||| S:131 E:141 ||| NN
of  ||| S:141 E:144 ||| IN
a  ||| S:144 E:146 ||| DT
h ||| S:146 E:147 ||| JJ
ealthy  ||| S:147 E:154 ||| JJ
blastocyst  ||| S:154 E:165 ||| NN
is  ||| S:165 E:168 ||| VBZ
critical  ||| S:168 E:177 ||| JJ
for  ||| S:177 E:181 ||| IN
subsequent  ||| S:181 E:192 ||| JJ
implantation ||| S:192 E:204 ||| NN
,  ||| S:204 E:206 ||| ,
pregnancy  ||| S:206 E:216 ||| NN
and  ||| S:216 E:220 ||| CC
fetal  ||| S:220 E:226 ||| JJ
development  ||| S:226 E:238 ||| NN
( ||| S:238 E:239 ||| -LRB-
Watson  ||| S:239 E:246 ||| NNP
&  ||| S:246 E:248 ||| CC
Barcroft ||| S:248 E:256 ||| NNP
,  ||| S:256 E:258 ||| ,
2001 ||| S:258 E:262 ||| CD
) ||| S:262 E:263 ||| -RRB-
.  ||| S:263 E:265 ||| .
The  ||| S:265 E:269 ||| DT
preimplantation  ||| S:269 E:285 ||| JJ
embryo  ||| S:285 E:292 ||| NN
exhibits  ||| S:292 E:301 ||| VBZ
an  ||| S:301 E:304 ||| DT
autonomous  ||| S:304 E:315 ||| JJ
development  ||| S:315 E:327 ||| NN
capability  ||| S:327 E:338 ||| NN
influenced  ||| S:338 E:349 ||| VBN
by  ||| S:349 E:352 ||| IN
various  ||| S:352 E:360 ||| JJ
factors  ||| S:360 E:368 ||| NNS
within  ||| S:368 E:375 ||| IN
the  ||| S:375 E:379 ||| DT
maternal  ||| S:379 E:388 ||| NN
and  ||| S:388 E:392 ||| CC
embryonic  ||| S:392 E:402 ||| JJ
environment  ||| S:402 E:414 ||| NN
( ||| S:414 E:415 ||| -LRB-
Schultz ||| S:415 E:422 ||| NNP
,  ||| S:422 E:424 ||| ,
2005 ||| S:424 E:428 ||| CD
) ||| S:428 E:429 ||| -RRB-
.  ||| S:429 E:431 ||| .
Similarly ||| S:431 E:440 ||| RB
,  ||| S:440 E:442 ||| ,
in  ||| S:442 E:445 ||| IN
vitro  ||| S:445 E:451 ||| JJ
culture  ||| S:451 E:459 ||| NN
conditions  ||| S:459 E:470 ||| NNS
also  ||| S:470 E:475 ||| RB
exert  ||| S:475 E:481 ||| JJ
crucial  ||| S:481 E:489 ||| JJ
effects  ||| S:489 E:497 ||| NNS
on  ||| S:497 E:500 ||| IN
embryo  ||| S:500 E:507 ||| NN
developmental  ||| S:507 E:521 ||| NN
potential  ||| S:521 E:531 ||| NN
( ||| S:531 E:532 ||| -LRB-
Niemann  ||| S:532 E:540 ||| NNP
&  ||| S:540 E:542 ||| CC
Wrenzycki ||| S:542 E:551 ||| NNP
,  ||| S:551 E:553 ||| ,
2000 ||| S:553 E:557 ||| CD
;  ||| S:557 E:559 ||| :
Schultz  ||| S:559 E:567 ||| NNP
&  ||| S:567 E:569 ||| CC
Williams ||| S:569 E:577 ||| NNP
,  ||| S:577 E:579 ||| ,
2002 ||| S:579 E:583 ||| CD
;  ||| S:583 E:585 ||| :
Ecker  ||| S:585 E:591 ||| FW
et  ||| S:591 E:594 ||| FW
al. ||| S:594 E:597 ||| FW
,  ||| S:597 E:599 ||| ,
2004 ||| S:599 E:603 ||| CD
) ||| S:603 E:604 ||| -RRB-
.  ||| S:604 E:606 ||| .
In  ||| S:606 E:609 ||| IN
clinical  ||| S:609 E:618 ||| JJ
assisted  ||| S:618 E:627 ||| JJ
reproductive  ||| S:627 E:640 ||| JJ
technology ||| S:640 E:650 ||| NN
,  ||| S:650 E:652 ||| ,
embryos  ||| S:652 E:660 ||| NNS
are  ||| S:660 E:664 ||| VBP
selected  ||| S:664 E:673 ||| VBN
for  ||| S:673 E:677 ||| IN
transfer  ||| S:677 E:686 ||| NN
based  ||| S:686 E:692 ||| VBN
mainly  ||| S:692 E:699 ||| RB
on  ||| S:699 E:702 ||| IN
morphological  ||| S:702 E:716 ||| JJ
criteria ||| S:716 E:724 ||| NNS
,  ||| S:724 E:726 ||| ,
which  ||| S:726 E:732 ||| WDT
to  ||| S:732 E:735 ||| TO
some  ||| S:735 E:740 ||| DT
extent  ||| S:740 E:747 ||| NN
reflect  ||| S:747 E:755 ||| VBP
their  ||| S:755 E:761 ||| PRP$
developmental  ||| S:761 E:775 ||| JJ
potential ||| S:775 E:784 ||| NN
.  ||| S:784 E:786 ||| .
In  ||| S:786 E:789 ||| IN
most  ||| S:789 E:794 ||| JJS
cases ||| S:794 E:799 ||| NNS
,  ||| S:799 E:801 ||| ,
day-2  ||| S:801 E:807 ||| NNP
or  ||| S:807 E:810 ||| CC
day-3  ||| S:810 E:816 ||| CD
cleavage-stage  ||| S:816 E:831 ||| JJ
embryos  ||| S:831 E:839 ||| NNS
are  ||| S:839 E:843 ||| VBP
usually  ||| S:843 E:851 ||| RB
transferred ||| S:851 E:862 ||| VBN
.  ||| S:862 E:864 ||| .
Human  ||| S:864 E:870 ||| NNP
embryonic  ||| S:870 E:880 ||| FW
genome  ||| S:880 E:887 ||| FW
activation  ||| S:887 E:898 ||| FW
( ||| S:898 E:899 ||| -LRB-
EGA ||| S:899 E:902 ||| NNP
)  ||| S:902 E:904 ||| -RRB-
occurs  ||| S:904 E:911 ||| VBZ
from  ||| S:911 E:916 ||| IN
the  ||| S:916 E:920 ||| DT
4  ||| S:920 E:922 ||| CD
8-cell  ||| S:922 E:929 ||| CD
stage  ||| S:929 E:935 ||| NN
( ||| S:935 E:936 ||| -LRB-
Braude  ||| S:936 E:943 ||| FW
et  ||| S:943 E:946 ||| FW
al. ||| S:946 E:949 ||| FW
,  ||| S:949 E:951 ||| ,
1988 ||| S:951 E:955 ||| CD
) ||| S:955 E:956 ||| -RRB-
,  ||| S:956 E:958 ||| ,
which  ||| S:958 E:964 ||| WDT
makes  ||| S:964 E:970 ||| VBZ
embryo  ||| S:970 E:977 ||| JJ
selection  ||| S:977 E:987 ||| NN
at  ||| S:987 E:990 ||| IN
earlier  ||| S:990 E:998 ||| RBR
developmental  ||| S:998 E:1012 ||| JJ
stages  ||| S:1012 E:1019 ||| NNS
less  ||| S:1019 E:1024 ||| RBR
reliable ||| S:1024 E:1032 ||| JJ
.  ||| S:1032 E:1034 ||| .
In  ||| S:1034 E:1037 ||| IN
reality ||| S:1037 E:1044 ||| NN
,  ||| S:1044 E:1046 ||| ,
prolonged  ||| S:1046 E:1056 ||| JJ
culture  ||| S:1056 E:1064 ||| NN
is  ||| S:1064 E:1067 ||| VBZ
not  ||| S:1067 E:1071 ||| RB
always  ||| S:1071 E:1078 ||| RB
utilized  ||| S:1078 E:1087 ||| VBN
as  ||| S:1087 E:1090 ||| IN
a  ||| S:1090 E:1092 ||| DT
selection  ||| S:1092 E:1102 ||| NN
tool  ||| S:1102 E:1107 ||| NN
because  ||| S:1107 E:1115 ||| IN
aneuploidies  ||| S:1115 E:1128 ||| NN
or  ||| S:1128 E:1131 ||| CC
aberrant  ||| S:1131 E:1140 ||| JJ
gene  ||| S:1140 E:1145 ||| NN
expression  ||| S:1145 E:1156 ||| NN
prevent  ||| S:1156 E:1164 ||| VB
development  ||| S:1164 E:1176 ||| NN
to  ||| S:1176 E:1179 ||| TO
the  ||| S:1179 E:1183 ||| DT
blastocyst  ||| S:1183 E:1194 ||| JJ
stage  ||| S:1194 E:1200 ||| NN
in  ||| S:1200 E:1203 ||| IN
a  ||| S:1203 E:1205 ||| DT
large  ||| S:1205 E:1211 ||| JJ
proportion  ||| S:1211 E:1222 ||| NN
of  ||| S:1222 E:1225 ||| IN
embryos  ||| S:1225 E:1233 ||| NNS
( ||| S:1233 E:1234 ||| -LRB-
Gardner  ||| S:1234 E:1242 ||| NNP
et  ||| S:1242 E:1245 ||| NNP
al. ||| S:1245 E:1248 ||| NNP
,  ||| S:1248 E:1250 ||| ,
1998 ||| S:1250 E:1254 ||| CD
;  ||| S:1254 E:1256 ||| :
Dal  ||| S:1256 E:1260 ||| NNP
Canto  ||| S:1260 E:1266 ||| NNP
et  ||| S:1266 E:1269 ||| NNP
al. ||| S:1269 E:1272 ||| NNP
,  ||| S:1272 E:1274 ||| ,
2012 ||| S:1274 E:1278 ||| CD
) ||| S:1278 E:1279 ||| -RRB-
.  ||| S:1279 E:1281 ||| .
Hence ||| S:1281 E:1286 ||| RB
,  ||| S:1286 E:1288 ||| ,
it  ||| S:1288 E:1291 ||| PRP
is  ||| S:1291 E:1294 ||| VBZ
imperative  ||| S:1294 E:1305 ||| VBN
to  ||| S:1305 E:1308 ||| TO
characterize  ||| S:1308 E:1321 ||| VB
the  ||| S:1321 E:1325 ||| DT
mechanisms  ||| S:1325 E:1336 ||| NNS
controlling  ||| S:1336 E:1348 ||| VBG
preimplantation  ||| S:1348 E:1364 ||| JJ
development ||| S:1364 E:1375 ||| NN
,  ||| S:1375 E:1377 ||| ,
to  ||| S:1377 E:1380 ||| TO
further  ||| S:1380 E:1388 ||| VB
our  ||| S:1388 E:1392 ||| PRP$
understanding  ||| S:1392 E:1406 ||| NN
of  ||| S:1406 E:1409 ||| IN
basic  ||| S:1409 E:1415 ||| JJ
reproductive  ||| S:1415 E:1428 ||| JJ
biology ||| S:1428 E:1435 ||| NN
,  ||| S:1435 E:1437 ||| ,
as  ||| S:1437 E:1440 ||| RB
well  ||| S:1440 E:1445 ||| RB
as  ||| S:1445 E:1448 ||| RB
advance  ||| S:1448 E:1456 ||| VB
practical  ||| S:1456 E:1466 ||| JJ
applications  ||| S:1466 E:1479 ||| NNS
in  ||| S:1479 E:1482 ||| IN
the  ||| S:1482 E:1486 ||| DT
clinic ||| S:1486 E:1492 ||| NN
.  ||| S:1492 E:1494 ||| .
Preimplantation  ||| S:1494 E:1510 ||| JJ
embryonic  ||| S:1510 E:1520 ||| JJ
development  ||| S:1520 E:1532 ||| NN
is  ||| S:1532 E:1535 ||| VBZ
regulated  ||| S:1535 E:1545 ||| VBN
both  ||| S:1545 E:1550 ||| DT
genetically  ||| S:1550 E:1562 ||| NN
and  ||| S:1562 E:1566 ||| CC
epigenetically ||| S:1566 E:1580 ||| NN
.  ||| S:1580 E:1582 ||| .
The  ||| S:1582 E:1586 ||| DT
global  ||| S:1586 E:1593 ||| JJ
gene  ||| S:1593 E:1598 ||| NN
expression  ||| S:1598 E:1609 ||| NN
profile  ||| S:1609 E:1617 ||| NN
is  ||| S:1617 E:1620 ||| VBZ
dynamic  ||| S:1620 E:1628 ||| JJ
and  ||| S:1628 E:1632 ||| CC
displays  ||| S:1632 E:1641 ||| NNS
stage-specific  ||| S:1641 E:1656 ||| JJ
characteristics  ||| S:1656 E:1672 ||| NNS
at  ||| S:1672 E:1675 ||| IN
different  ||| S:1675 E:1685 ||| JJ
developmental  ||| S:1685 E:1699 ||| JJ
stages  ||| S:1699 E:1706 ||| NNS
of  ||| S:1706 E:1709 ||| IN
the  ||| S:1709 E:1713 ||| DT
preimplantation  ||| S:1713 E:1729 ||| JJ
embryo ||| S:1729 E:1735 ||| NN
.  ||| S:1735 E:1737 ||| .
For  ||| S:1737 E:1741 ||| IN
example ||| S:1741 E:1748 ||| NN
,  ||| S:1748 E:1750 ||| ,
Oct4 ||| S:1750 E:1754 ||| NNP
,  ||| S:1754 E:1756 ||| ,
Nanog ||| S:1756 E:1761 ||| NNP
,  ||| S:1761 E:1763 ||| ,
Gata3  ||| S:1763 E:1769 ||| NNP
and  ||| S:1769 E:1773 ||| CC
Bmp8b  ||| S:1773 E:1779 ||| NNP
are  ||| S:1779 E:1783 ||| VBP
activated  ||| S:1783 E:1793 ||| VBN
between  ||| S:1793 E:1801 ||| IN
the  ||| S:1801 E:1805 ||| DT
4  ||| S:1805 E:1807 ||| CD
8-cell  ||| S:1807 E:1814 ||| CD
embryonic  ||| S:1814 E:1824 ||| JJ
stage  ||| S:1824 E:1830 ||| NN
( ||| S:1830 E:1831 ||| -LRB-
Hamatani  ||| S:1831 E:1840 ||| FW
et  ||| S:1840 E:1843 ||| FW
al. ||| S:1843 E:1846 ||| FW
,  ||| S:1846 E:1848 ||| ,
2004 ||| S:1848 E:1852 ||| CD
) ||| S:1852 E:1853 ||| -RRB-
.  ||| S:1853 E:1855 ||| .
These  ||| S:1855 E:1861 ||| DT
genes  ||| S:1861 E:1867 ||| NNS
are  ||| S:1867 E:1871 ||| VBP
key  ||| S:1871 E:1875 ||| JJ
regulators  ||| S:1875 E:1886 ||| NNS
of  ||| S:1886 E:1889 ||| IN
differentiation  ||| S:1889 E:1905 ||| NN
into  ||| S:1905 E:1910 ||| IN
the  ||| S:1910 E:1914 ||| DT
inner  ||| S:1914 E:1920 ||| JJ
cell  ||| S:1920 E:1925 ||| NN
mass  ||| S:1925 E:1930 ||| NN
( ||| S:1930 E:1931 ||| -LRB-
ICM ||| S:1931 E:1934 ||| NNP
)  ||| S:1934 E:1936 ||| -RRB-
and  ||| S:1936 E:1940 ||| CC
trophectoderm  ||| S:1940 E:1954 ||| NNS
( ||| S:1954 E:1955 ||| -LRB-
TE ||| S:1955 E:1957 ||| NNP
) ||| S:1957 E:1958 ||| -RRB-
,  ||| S:1958 E:1960 ||| ,
which  ||| S:1960 E:1966 ||| WDT
is  ||| S:1966 E:1969 ||| VBZ
the  ||| S:1969 E:1973 ||| DT
very  ||| S:1973 E:1978 ||| RB
first  ||| S:1978 E:1984 ||| JJ
cell  ||| S:1984 E:1989 ||| NN
lineage  ||| S:1989 E:1997 ||| NN
specification  ||| S:1997 E:2011 ||| NN
in  ||| S:2011 E:2014 ||| IN
mouse  ||| S:2014 E:2020 ||| JJ
embryonic  ||| S:2020 E:2030 ||| JJ
development  ||| S:2030 E:2042 ||| NN
( ||| S:2042 E:2043 ||| -LRB-
Yamanaka  ||| S:2043 E:2052 ||| FW
et  ||| S:2052 E:2055 ||| FW
al. ||| S:2055 E:2058 ||| FW
,  ||| S:2058 E:2060 ||| ,
2006 ||| S:2060 E:2064 ||| CD
) ||| S:2064 E:2065 ||| -RRB-
.  ||| S:2065 E:2067 ||| .
Many  ||| S:2067 E:2072 ||| JJ
studies  ||| S:2072 E:2080 ||| NNS
have  ||| S:2080 E:2085 ||| VBP
suggested  ||| S:2085 E:2095 ||| VBN
that  ||| S:2095 E:2100 ||| IN
DNA  ||| S:2100 E:2104 ||| NNP
methylation  ||| S:2104 E:2116 ||| NN
and  ||| S:2116 E:2120 ||| CC
the  ||| S:2120 E:2124 ||| DT
regulation  ||| S:2124 E:2135 ||| NN
of  ||| S:2135 E:2138 ||| IN
histone  ||| S:2138 E:2146 ||| JJ
modifications  ||| S:2146 E:2160 ||| NNS
have  ||| S:2160 E:2165 ||| VBP
profound  ||| S:2165 E:2174 ||| JJ
effects  ||| S:2174 E:2182 ||| NNS
on  ||| S:2182 E:2185 ||| IN
preimplantation  ||| S:2185 E:2201 ||| JJ
embryonic  ||| S:2201 E:2211 ||| JJ
development  ||| S:2211 E:2223 ||| NN
( ||| S:2223 E:2224 ||| -LRB-
Monk  ||| S:2224 E:2229 ||| FW
et  ||| S:2229 E:2232 ||| FW
al. ||| S:2232 E:2235 ||| FW
,  ||| S:2235 E:2237 ||| ,
1987 ||| S:2237 E:2241 ||| CD
;  ||| S:2241 E:2243 ||| :
Santos  ||| S:2243 E:2250 ||| FW
et  ||| S:2250 E:2253 ||| FW
al. ||| S:2253 E:2256 ||| FW
,  ||| S:2256 E:2258 ||| ,
2005 ||| S:2258 E:2262 ||| CD
;  ||| S:2262 E:2264 ||| :
Yeo  ||| S:2264 E:2268 ||| FW
et  ||| S:2268 E:2271 ||| FW
al. ||| S:2271 E:2274 ||| FW
,  ||| S:2274 E:2276 ||| ,
2005 ||| S:2276 E:2280 ||| CD
;  ||| S:2280 E:2282 ||| :
Torres-Padilla  ||| S:2282 E:2297 ||| FW
et  ||| S:2297 E:2300 ||| FW
al. ||| S:2300 E:2303 ||| FW
,  ||| S:2303 E:2305 ||| ,
2006 ||| S:2305 E:2309 ||| CD
) ||| S:2309 E:2310 ||| -RRB-
.  ||| S:2310 E:2312 ||| .
Two  ||| S:2312 E:2316 ||| CD
major  ||| S:2316 E:2322 ||| JJ
histone  ||| S:2322 E:2330 ||| JJ
deacetylase  ||| S:2330 E:2342 ||| NNS
( ||| S:2342 E:2343 ||| -LRB-
HDAC ||| S:2343 E:2347 ||| NNP
)  ||| S:2347 E:2349 ||| -RRB-
complexes  ||| S:2349 E:2359 ||| NNS
( ||| S:2359 E:2360 ||| -LRB-
NuRD  ||| S:2360 E:2365 ||| NNP
and  ||| S:2365 E:2369 ||| CC
SIN3 ||| S:2369 E:2373 ||| CD
)  ||| S:2373 E:2375 ||| -RRB-
have  ||| S:2375 E:2380 ||| VBP
specific  ||| S:2380 E:2389 ||| JJ
functions  ||| S:2389 E:2399 ||| NNS
in  ||| S:2399 E:2402 ||| IN
embryonic  ||| S:2402 E:2412 ||| JJ
development  ||| S:2412 E:2424 ||| NN
( ||| S:2424 E:2425 ||| -LRB-
Ahringer ||| S:2425 E:2433 ||| NNP
,  ||| S:2433 E:2435 ||| ,
2000 ||| S:2435 E:2439 ||| CD
) ||| S:2439 E:2440 ||| -RRB-
.  ||| S:2440 E:2442 ||| .
HDAC1  ||| S:2442 E:2448 ||| NNP
is  ||| S:2448 E:2451 ||| VBZ
a  ||| S:2451 E:2453 ||| DT
major  ||| S:2453 E:2459 ||| JJ
deacetylase  ||| S:2459 E:2471 ||| NN
in  ||| S:2471 E:2474 ||| IN
preimplantation  ||| S:2474 E:2490 ||| JJ
embryos  ||| S:2490 E:2498 ||| NN
and  ||| S:2498 E:2502 ||| CC
its  ||| S:2502 E:2506 ||| PRP$
expression  ||| S:2506 E:2517 ||| NN
negatively  ||| S:2517 E:2528 ||| RB
regulates  ||| S:2528 E:2538 ||| VBZ
the  ||| S:2538 E:2542 ||| DT
acetylation  ||| S:2542 E:2554 ||| JJ
state  ||| S:2554 E:2560 ||| NN
of  ||| S:2560 E:2563 ||| IN
histone  ||| S:2563 E:2571 ||| JJ
H4K5  ||| S:2571 E:2576 ||| NN
during  ||| S:2576 E:2583 ||| IN
preimplantation  ||| S:2583 E:2599 ||| JJ
embryonic  ||| S:2599 E:2609 ||| JJ
development  ||| S:2609 E:2621 ||| NN
( ||| S:2621 E:2622 ||| -LRB-
Ma  ||| S:2622 E:2625 ||| NNP
&  ||| S:2625 E:2627 ||| CC
Schultz ||| S:2627 E:2634 ||| NNP
,  ||| S:2634 E:2636 ||| ,
2008 ||| S:2636 E:2640 ||| CD
) ||| S:2640 E:2641 ||| -RRB-
.  ||| S:2641 E:2643 ||| .
Although  ||| S:2643 E:2652 ||| IN
knowledge  ||| S:2652 E:2662 ||| NN
of  ||| S:2662 E:2665 ||| IN
the  ||| S:2665 E:2669 ||| DT
mechanisms  ||| S:2669 E:2680 ||| NNS
of  ||| S:2680 E:2683 ||| IN
preimplantation  ||| S:2683 E:2699 ||| JJ
development  ||| S:2699 E:2711 ||| NN
has  ||| S:2711 E:2715 ||| VBZ
increased  ||| S:2715 E:2725 ||| VBN
gradually  ||| S:2725 E:2735 ||| RB
over  ||| S:2735 E:2740 ||| IN
the  ||| S:2740 E:2744 ||| DT
past  ||| S:2744 E:2749 ||| JJ
decade ||| S:2749 E:2755 ||| NN
,  ||| S:2755 E:2757 ||| ,
the  ||| S:2757 E:2761 ||| DT
key  ||| S:2761 E:2765 ||| JJ
transcription  ||| S:2765 E:2779 ||| JJ
factors  ||| S:2779 E:2787 ||| NNS
that  ||| S:2787 E:2792 ||| WDT
are  ||| S:2792 E:2796 ||| VBP
essential  ||| S:2796 E:2806 ||| JJ
for  ||| S:2806 E:2810 ||| IN
blastocyst  ||| S:2810 E:2821 ||| JJ
formation  ||| S:2821 E:2831 ||| NN
and  ||| S:2831 E:2835 ||| CC
how  ||| S:2835 E:2839 ||| WRB
they  ||| S:2839 E:2844 ||| PRP
interact  ||| S:2844 E:2853 ||| VBD
with  ||| S:2853 E:2858 ||| IN
epigenetic  ||| S:2858 E:2869 ||| JJ
regulators  ||| S:2869 E:2880 ||| NNS
have  ||| S:2880 E:2885 ||| VBP
yet  ||| S:2885 E:2889 ||| RB
to  ||| S:2889 E:2892 ||| TO
be  ||| S:2892 E:2895 ||| VB
characterized ||| S:2895 E:2908 ||| VBN
.  ||| S:2908 E:2910 ||| .
ING2  ||| S:2910 E:2915 ||| NNP
participates  ||| S:2915 E:2928 ||| VBZ
in  ||| S:2928 E:2931 ||| IN
diverse  ||| S:2931 E:2939 ||| JJ
cellular  ||| S:2939 E:2948 ||| JJ
processes  ||| S:2948 E:2958 ||| NNS
involving  ||| S:2958 E:2968 ||| VBG
tumor  ||| S:2968 E:2974 ||| NN
suppression ||| S:2974 E:2985 ||| NN
,  ||| S:2985 E:2987 ||| ,
DNA  ||| S:2987 E:2991 ||| NNP
repair ||| S:2991 E:2997 ||| NN
,  ||| S:2997 E:2999 ||| ,
cell  ||| S:2999 E:3004 ||| NN
cycle  ||| S:3004 E:3010 ||| NN
regulation ||| S:3010 E:3020 ||| NN
,  ||| S:3020 E:3022 ||| ,
and  ||| S:3022 E:3026 ||| CC
cellular  ||| S:3026 E:3035 ||| JJ
senescence ||| S:3035 E:3045 ||| NN
,  ||| S:3045 E:3047 ||| ,
all  ||| S:3047 E:3051 ||| DT
of  ||| S:3051 E:3054 ||| IN
which  ||| S:3054 E:3060 ||| WDT
are  ||| S:3060 E:3064 ||| VBP
functionally  ||| S:3064 E:3077 ||| VBN
linked  ||| S:3077 E:3084 ||| VBN
to  ||| S:3084 E:3087 ||| TO
the  ||| S:3087 E:3091 ||| DT
p53  ||| S:3091 E:3095 ||| NN
tumor  ||| S:3095 E:3101 ||| NN
suppressor  ||| S:3101 E:3112 ||| NN
protein  ||| S:3112 E:3120 ||| NN
( ||| S:3120 E:3121 ||| -LRB-
Unoki  ||| S:3121 E:3127 ||| FW
et  ||| S:3127 E:3130 ||| FW
al. ||| S:3130 E:3133 ||| FW
,  ||| S:3133 E:3135 ||| ,
2008 ||| S:3135 E:3139 ||| CD
;  ||| S:3139 E:3141 ||| :
Zhang  ||| S:3141 E:3147 ||| FW
et  ||| S:3147 E:3150 ||| FW
al. ||| S:3150 E:3153 ||| FW
,  ||| S:3153 E:3155 ||| ,
2008 ||| S:3155 E:3159 ||| CD
;  ||| S:3159 E:3161 ||| :
Larrieu  ||| S:3161 E:3169 ||| FW
et  ||| S:3169 E:3172 ||| FW
al. ||| S:3172 E:3175 ||| FW
,  ||| S:3175 E:3177 ||| ,
2009 ||| S:3177 E:3181 ||| CD
) ||| S:3181 E:3182 ||| -RRB-
.  ||| S:3182 E:3184 ||| .
Additionally ||| S:3184 E:3196 ||| RB
,  ||| S:3196 E:3198 ||| ,
ING2  ||| S:3198 E:3203 ||| NNP
has  ||| S:3203 E:3207 ||| VBZ
biological  ||| S:3207 E:3218 ||| JJ
functions  ||| S:3218 E:3228 ||| NNS
that  ||| S:3228 E:3233 ||| WDT
are  ||| S:3233 E:3237 ||| VBP
independent  ||| S:3237 E:3249 ||| JJ
of  ||| S:3249 E:3252 ||| IN
the  ||| S:3252 E:3256 ||| DT
p53  ||| S:3256 E:3260 ||| NN
pathway ||| S:3260 E:3267 ||| NN
.  ||| S:3267 E:3269 ||| .
As  ||| S:3269 E:3272 ||| IN
a  ||| S:3272 E:3274 ||| DT
basic  ||| S:3274 E:3280 ||| JJ
subunit  ||| S:3280 E:3288 ||| NN
of  ||| S:3288 E:3291 ||| IN
the  ||| S:3291 E:3295 ||| DT
histone  ||| S:3295 E:3303 ||| JJ
deacetylase  ||| S:3303 E:3315 ||| NN
Sin3  ||| S:3315 E:3320 ||| CD
complex ||| S:3320 E:3327 ||| NN
,  ||| S:3327 E:3329 ||| ,
ING2  ||| S:3329 E:3334 ||| NNP
mediates  ||| S:3334 E:3343 ||| VBD
the  ||| S:3343 E:3347 ||| DT
binding  ||| S:3347 E:3355 ||| NN
of  ||| S:3355 E:3358 ||| IN
the  ||| S:3358 E:3362 ||| DT
Sin3  ||| S:3362 E:3367 ||| JJ
complex  ||| S:3367 E:3375 ||| NN
to  ||| S:3375 E:3378 ||| TO
some  ||| S:3378 E:3383 ||| DT
promoters  ||| S:3383 E:3393 ||| NNS
where  ||| S:3393 E:3399 ||| WRB
di- ||| S:3399 E:3402 ||| JJ
/ ||| S:3402 E:3403 ||| FW
tri-methylated  ||| S:3403 E:3418 ||| FW
H3K4  ||| S:3418 E:3423 ||| FW
regulates  ||| S:3423 E:3433 ||| FW
gene  ||| S:3433 E:3438 ||| FW
repression  ||| S:3438 E:3449 ||| FW
( ||| S:3449 E:3450 ||| -LRB-
Smith  ||| S:3450 E:3456 ||| NNP
et  ||| S:3456 E:3459 ||| NNP
al. ||| S:3459 E:3462 ||| NNP
,  ||| S:3462 E:3464 ||| ,
2010 ||| S:3464 E:3468 ||| CD
) ||| S:3468 E:3469 ||| -RRB-
.  ||| S:3469 E:3471 ||| .
ING2  ||| S:3471 E:3476 ||| NNP
can  ||| S:3476 E:3480 ||| MD
also  ||| S:3480 E:3485 ||| RB
play  ||| S:3485 E:3490 ||| VB
a  ||| S:3490 E:3492 ||| DT
role  ||| S:3492 E:3497 ||| NN
in  ||| S:3497 E:3500 ||| IN
modulating  ||| S:3500 E:3511 ||| FW
histone  ||| S:3511 E:3519 ||| FW
methyltransferase  ||| S:3519 E:3537 ||| FW
( ||| S:3537 E:3538 ||| -LRB-
HMT ||| S:3538 E:3541 ||| NNP
)  ||| S:3541 E:3543 ||| -RRB-
activity  ||| S:3543 E:3552 ||| NN
associated  ||| S:3552 E:3563 ||| VBN
with  ||| S:3563 E:3568 ||| IN
silencing  ||| S:3568 E:3578 ||| JJ
function ||| S:3578 E:3586 ||| NN
,  ||| S:3586 E:3588 ||| ,
which  ||| S:3588 E:3594 ||| WDT
involves  ||| S:3594 E:3603 ||| VBZ
a  ||| S:3603 E:3605 ||| DT
non-HDAC  ||| S:3605 E:3614 ||| JJ
class  ||| S:3614 E:3620 ||| NN
I  ||| S:3620 E:3622 ||| PRP
or  ||| S:3622 E:3625 ||| CC
II  ||| S:3625 E:3628 ||| NNP
pathway  ||| S:3628 E:3636 ||| NNS
( ||| S:3636 E:3637 ||| -LRB-
Goeman  ||| S:3637 E:3644 ||| FW
et  ||| S:3644 E:3647 ||| FW
al. ||| S:3647 E:3650 ||| FW
,  ||| S:3650 E:3652 ||| ,
2008 ||| S:3652 E:3656 ||| CD
) ||| S:3656 E:3657 ||| -RRB-
.  ||| S:3657 E:3659 ||| .
As  ||| S:3659 E:3662 ||| IN
ING2  ||| S:3662 E:3667 ||| NNP
modulates  ||| S:3667 E:3677 ||| VBD
both  ||| S:3677 E:3682 ||| DT
gene  ||| S:3682 E:3687 ||| NN
expression  ||| S:3687 E:3698 ||| NN
and  ||| S:3698 E:3702 ||| CC
chromatin  ||| S:3702 E:3712 ||| JJ
modification ||| S:3712 E:3724 ||| NN
,  ||| S:3724 E:3726 ||| ,
this  ||| S:3726 E:3731 ||| DT
study  ||| S:3731 E:3737 ||| NN
attempted  ||| S:3737 E:3747 ||| VBD
to  ||| S:3747 E:3750 ||| TO
examine  ||| S:3750 E:3758 ||| VB
the  ||| S:3758 E:3762 ||| DT
role  ||| S:3762 E:3767 ||| NN
of  ||| S:3767 E:3770 ||| IN
ING2  ||| S:3770 E:3775 ||| CD
in  ||| S:3775 E:3778 ||| IN
mouse  ||| S:3778 E:3784 ||| JJ
preimplantation  ||| S:3784 E:3800 ||| JJ
embryonic  ||| S:3800 E:3810 ||| JJ
development ||| S:3810 E:3821 ||| NN
.  ||| S:3821 E:3823 ||| .
Materials  ||| S:3823 E:3833 ||| NNS
and  ||| S:3833 E:3837 ||| CC
methods  ||| S:3837 E:3845 ||| NNS
All  ||| S:3845 E:3849 ||| DT
chemicals  ||| S:3849 E:3859 ||| NNS
and  ||| S:3859 E:3863 ||| CC
culture  ||| S:3863 E:3871 ||| NN
media  ||| S:3871 E:3877 ||| NNS
were  ||| S:3877 E:3882 ||| VBD
purchased  ||| S:3882 E:3892 ||| VBN
from  ||| S:3892 E:3897 ||| IN
Sigma-Aldrich  ||| S:3897 E:3911 ||| NNP
Inc ||| S:3911 E:3914 ||| NNP
.  ||| S:3914 E:3916 ||| .
( ||| S:3916 E:3917 ||| -LRB-
St.  ||| S:3917 E:3921 ||| NNP
Louis ||| S:3921 E:3926 ||| NNP
,  ||| S:3926 E:3928 ||| ,
MO ||| S:3928 E:3930 ||| NNP
,  ||| S:3930 E:3932 ||| ,
USA ||| S:3932 E:3935 ||| NNP
) ||| S:3935 E:3936 ||| -RRB-
,  ||| S:3936 E:3938 ||| ,
unless  ||| S:3938 E:3945 ||| IN
stated  ||| S:3945 E:3952 ||| VBN
otherwise ||| S:3952 E:3961 ||| RB
.  ||| S:3961 E:3964 ||| .
Embryo  ||| S:3964 E:3971 ||| NN
collection  ||| S:3971 E:3982 ||| NN
and  ||| S:3982 E:3986 ||| CC
culture  ||| S:3986 E:3995 ||| NN
The  ||| S:3995 E:3999 ||| DT
ICR  ||| S:3999 E:4003 ||| NNP
mice  ||| S:4003 E:4008 ||| NNS
were  ||| S:4008 E:4013 ||| VBD
fed  ||| S:4013 E:4017 ||| VBN
ad  ||| S:4017 E:4020 ||| NN
libitum  ||| S:4020 E:4028 ||| NN
with  ||| S:4028 E:4033 ||| IN
a  ||| S:4033 E:4035 ||| DT
standard  ||| S:4035 E:4044 ||| JJ
diet  ||| S:4044 E:4049 ||| NN
and  ||| S:4049 E:4053 ||| CC
were  ||| S:4053 E:4058 ||| VBD
housed  ||| S:4058 E:4065 ||| VBN
in  ||| S:4065 E:4068 ||| IN
a  ||| S:4068 E:4070 ||| DT
room  ||| S:4070 E:4075 ||| NN
with  ||| S:4075 E:4080 ||| IN
controlled  ||| S:4080 E:4091 ||| JJ
temperature  ||| S:4091 E:4103 ||| NN
and  ||| S:4103 E:4107 ||| CC
lighting  ||| S:4107 E:4116 ||| NN
( ||| S:4116 E:4117 ||| -LRB-
20  ||| S:4117 E:4120 ||| CD
22  ||| S:4120 E:4123 ||| CD
C ||| S:4123 E:4124 ||| NNP
,  ||| S:4124 E:4126 ||| ,
12  ||| S:4126 E:4129 ||| CD
h ||| S:4129 E:4130 ||| CD
/ ||| S:4130 E:4131 ||| CD
12  ||| S:4131 E:4134 ||| CD
h  ||| S:4134 E:4136 ||| JJ
light ||| S:4136 E:4141 ||| NN
/ ||| S:4141 E:4142 ||| CD
dark  ||| S:4142 E:4147 ||| JJ
cycle ||| S:4147 E:4152 ||| NN
) ||| S:4152 E:4153 ||| -RRB-
,  ||| S:4153 E:4155 ||| ,
in  ||| S:4155 E:4158 ||| IN
accordance  ||| S:4158 E:4169 ||| NN
with  ||| S:4169 E:4174 ||| IN
the  ||| S:4174 E:4178 ||| DT
Institutional  ||| S:4178 E:4192 ||| NNP
Animal  ||| S:4192 E:4199 ||| NNP
Care  ||| S:4199 E:4204 ||| NNP
and  ||| S:4204 E:4208 ||| CC
Use  ||| S:4208 E:4212 ||| NNP
Committee  ||| S:4212 E:4222 ||| NNP
( ||| S:4222 E:4223 ||| -LRB-
IACUC ||| S:4223 E:4228 ||| NNP
)  ||| S:4228 E:4230 ||| -RRB-
guidelines  ||| S:4230 E:4241 ||| NNS
of  ||| S:4241 E:4244 ||| IN
Nanjing  ||| S:4244 E:4252 ||| NNP
Medical  ||| S:4252 E:4260 ||| NNP
University ||| S:4260 E:4270 ||| NNP
.  ||| S:4270 E:4272 ||| .
For  ||| S:4272 E:4276 ||| IN
the  ||| S:4276 E:4280 ||| DT
collection  ||| S:4280 E:4291 ||| NN
of  ||| S:4291 E:4294 ||| IN
zygotes ||| S:4294 E:4301 ||| NN
,  ||| S:4301 E:4303 ||| ,
8-week-old  ||| S:4303 E:4314 ||| CD
female  ||| S:4314 E:4321 ||| JJ
ICR  ||| S:4321 E:4325 ||| NN
mice  ||| S:4325 E:4330 ||| NNS
were  ||| S:4330 E:4335 ||| VBD
injected  ||| S:4335 E:4344 ||| VBN
with  ||| S:4344 E:4349 ||| IN
human  ||| S:4349 E:4355 ||| JJ
chorionic  ||| S:4355 E:4365 ||| JJ
gonadotropin  ||| S:4365 E:4378 ||| NNS
( ||| S:4378 E:4379 ||| -LRB-
HCG ||| S:4379 E:4382 ||| NNP
)  ||| S:4382 E:4384 ||| -RRB-
and  ||| S:4384 E:4388 ||| CC
mated  ||| S:4388 E:4394 ||| VBN
with  ||| S:4394 E:4399 ||| IN
male  ||| S:4399 E:4404 ||| JJ
ICR  ||| S:4404 E:4408 ||| NN
mice  ||| S:4408 E:4413 ||| NNS
shortly  ||| S:4413 E:4421 ||| RB
after  ||| S:4421 E:4427 ||| IN
injection ||| S:4427 E:4436 ||| NN
.  ||| S:4436 E:4438 ||| .
After  ||| S:4438 E:4444 ||| IN
21  ||| S:4444 E:4447 ||| CD
h ||| S:4447 E:4448 ||| NN
,  ||| S:4448 E:4450 ||| ,
zygotes  ||| S:4450 E:4458 ||| NN
were  ||| S:4458 E:4463 ||| VBD
collected  ||| S:4463 E:4473 ||| VBN
from  ||| S:4473 E:4478 ||| IN
the  ||| S:4478 E:4482 ||| DT
oviducts  ||| S:4482 E:4491 ||| NN
of  ||| S:4491 E:4494 ||| IN
the  ||| S:4494 E:4498 ||| DT
mated  ||| S:4498 E:4504 ||| JJ
female  ||| S:4504 E:4511 ||| JJ
mice  ||| S:4511 E:4516 ||| NNS
and  ||| S:4516 E:4520 ||| CC
transferred  ||| S:4520 E:4532 ||| VBN
into  ||| S:4532 E:4537 ||| IN
4- ||| S:4537 E:4539 ||| NNP
( ||| S:4539 E:4540 ||| -LRB-
2-hydroxyethyl ||| S:4540 E:4554 ||| NNP
) ||| S:4554 E:4555 ||| -RRB-
-1-piperazineethanesulfonic  ||| S:4555 E:4583 ||| FW
acid  ||| S:4583 E:4588 ||| FW
( ||| S:4588 E:4589 ||| -LRB-
HEPES ||| S:4589 E:4594 ||| NNP
) ||| S:4594 E:4595 ||| -RRB-
-buffered  ||| S:4595 E:4605 ||| NNP
Chatot ||| S:4605 E:4611 ||| NNP
,  ||| S:4611 E:4613 ||| ,
Ziomet  ||| S:4613 E:4620 ||| NNP
and  ||| S:4620 E:4624 ||| CC
Bavister  ||| S:4624 E:4633 ||| NNP
( ||| S:4633 E:4634 ||| -LRB-
CZB ||| S:4634 E:4637 ||| NNP
)  ||| S:4637 E:4639 ||| -RRB-
medium ||| S:4639 E:4645 ||| NN
.  ||| S:4645 E:4647 ||| .
Cumulus  ||| S:4647 E:4655 ||| JJ
cells  ||| S:4655 E:4661 ||| NNS
were  ||| S:4661 E:4666 ||| VBD
dispersed  ||| S:4666 E:4676 ||| VBN
by  ||| S:4676 E:4679 ||| IN
treatment  ||| S:4679 E:4689 ||| NN
with  ||| S:4689 E:4694 ||| IN
1  ||| S:4694 E:4696 ||| CD
mg ||| S:4696 E:4698 ||| CD
/ ||| S:4698 E:4699 ||| CD
ml  ||| S:4699 E:4702 ||| JJ
hyaluronidase  ||| S:4702 E:4716 ||| NN
in  ||| S:4716 E:4719 ||| IN
HEPES-CZB ||| S:4719 E:4728 ||| JJ
.  ||| S:4728 E:4730 ||| .
Cumulus-free  ||| S:4730 E:4743 ||| JJ
zygotes  ||| S:4743 E:4751 ||| NN
were  ||| S:4751 E:4756 ||| VBD
washed  ||| S:4756 E:4763 ||| VBN
with  ||| S:4763 E:4768 ||| IN
HEPES-CZB  ||| S:4768 E:4778 ||| JJ
medium  ||| S:4778 E:4785 ||| NN
and  ||| S:4785 E:4789 ||| CC
then  ||| S:4789 E:4794 ||| RB
cultured  ||| S:4794 E:4803 ||| VBN
in  ||| S:4803 E:4806 ||| IN
CZB  ||| S:4806 E:4810 ||| NNP
medium  ||| S:4810 E:4817 ||| NN
until  ||| S:4817 E:4823 ||| IN
they  ||| S:4823 E:4828 ||| PRP
developed  ||| S:4828 E:4838 ||| VBD
to  ||| S:4838 E:4841 ||| TO
later  ||| S:4841 E:4847 ||| RBR
cleavage-stage  ||| S:4847 E:4862 ||| JJ
embryos ||| S:4862 E:4869 ||| NN
.  ||| S:4869 E:4871 ||| .
All  ||| S:4871 E:4875 ||| DT
cultures  ||| S:4875 E:4884 ||| NNS
were  ||| S:4884 E:4889 ||| VBD
carried  ||| S:4889 E:4897 ||| VBN
out  ||| S:4897 E:4901 ||| RP
within  ||| S:4901 E:4908 ||| IN
a  ||| S:4908 E:4910 ||| DT
humidified  ||| S:4910 E:4921 ||| JJ
5 ||| S:4921 E:4922 ||| CD
%  ||| S:4922 E:4924 ||| NN
CO2  ||| S:4924 E:4928 ||| CD
incubator  ||| S:4928 E:4938 ||| NN
at  ||| S:4938 E:4941 ||| IN
37  ||| S:4941 E:4944 ||| CD
C ||| S:4944 E:4945 ||| NNP
.  ||| S:4945 E:4949 ||| .
Immunofluorescence  ||| S:4949 E:4968 ||| NNP
and  ||| S:4968 E:4972 ||| CC
confocal  ||| S:4972 E:4981 ||| JJ
microscopy  ||| S:4981 E:4993 ||| NN
For  ||| S:4993 E:4997 ||| IN
immunofluorescence  ||| S:4997 E:5016 ||| JJ
staining  ||| S:5016 E:5025 ||| NN
of  ||| S:5025 E:5028 ||| IN
ING2 ||| S:5028 E:5032 ||| NNP
,  ||| S:5032 E:5034 ||| ,
the  ||| S:5034 E:5038 ||| DT
embryos  ||| S:5038 E:5046 ||| NN
were  ||| S:5046 E:5051 ||| VBD
fixed  ||| S:5051 E:5057 ||| VBN
in  ||| S:5057 E:5060 ||| IN
4 ||| S:5060 E:5061 ||| CD
%  ||| S:5061 E:5063 ||| NN
paraformaldehyde  ||| S:5063 E:5080 ||| NN
in  ||| S:5080 E:5083 ||| IN
phosphate-buffered  ||| S:5083 E:5102 ||| JJ
saline  ||| S:5102 E:5109 ||| NNS
( ||| S:5109 E:5110 ||| -LRB-
PBS ||| S:5110 E:5113 ||| NNP
;  ||| S:5113 E:5115 ||| :
pH  ||| S:5115 E:5118 ||| JJ
7.4 ||| S:5118 E:5121 ||| CD
)  ||| S:5121 E:5123 ||| -RRB-
for  ||| S:5123 E:5127 ||| IN
at  ||| S:5127 E:5130 ||| IN
least  ||| S:5130 E:5136 ||| JJS
30  ||| S:5136 E:5139 ||| CD
min  ||| S:5139 E:5143 ||| NN
at  ||| S:5143 E:5146 ||| IN
room  ||| S:5146 E:5151 ||| NN
temperature ||| S:5151 E:5162 ||| NN
.  ||| S:5162 E:5164 ||| .
After  ||| S:5164 E:5170 ||| IN
being  ||| S:5170 E:5176 ||| VBG
permeabilized  ||| S:5176 E:5190 ||| NN
with  ||| S:5190 E:5195 ||| IN
0.5 ||| S:5195 E:5198 ||| CD
%  ||| S:5198 E:5200 ||| NN
Triton  ||| S:5200 E:5207 ||| NNP
X-100  ||| S:5207 E:5213 ||| NNP
at  ||| S:5213 E:5216 ||| IN
room  ||| S:5216 E:5221 ||| NN
temperature  ||| S:5221 E:5233 ||| NN
for  ||| S:5233 E:5237 ||| IN
20  ||| S:5237 E:5240 ||| CD
min ||| S:5240 E:5243 ||| NN
,  ||| S:5243 E:5245 ||| ,
the  ||| S:5245 E:5249 ||| DT
embryos  ||| S:5249 E:5257 ||| NN
were  ||| S:5257 E:5262 ||| VBD
incubated  ||| S:5262 E:5272 ||| VBN
for  ||| S:5272 E:5276 ||| IN
1  ||| S:5276 E:5278 ||| CD
h  ||| S:5278 E:5280 ||| NN
in  ||| S:5280 E:5283 ||| IN
blocking  ||| S:5283 E:5292 ||| VBG
solution  ||| S:5292 E:5301 ||| NN
composed  ||| S:5301 E:5310 ||| VBN
of  ||| S:5310 E:5313 ||| IN
1 ||| S:5313 E:5314 ||| CD
%  ||| S:5314 E:5316 ||| NN
bovine  ||| S:5316 E:5323 ||| NNS
serum  ||| S:5323 E:5329 ||| VBP
albumin  ||| S:5329 E:5337 ||| VBN
in  ||| S:5337 E:5340 ||| IN
PBS ||| S:5340 E:5343 ||| NNP
,  ||| S:5343 E:5345 ||| ,
followed  ||| S:5345 E:5354 ||| VBN
by  ||| S:5354 E:5357 ||| IN
incubation  ||| S:5357 E:5368 ||| NN
with  ||| S:5368 E:5373 ||| IN
goat  ||| S:5373 E:5378 ||| CD
anti-ING2  ||| S:5378 E:5388 ||| CD
antibody  ||| S:5388 E:5397 ||| NN
( ||| S:5397 E:5398 ||| -LRB-
dilution ||| S:5398 E:5406 ||| NN
,  ||| S:5406 E:5408 ||| ,
1 ||| S:5408 E:5409 ||| CD
: ||| S:5409 E:5410 ||| :
100 ||| S:5410 E:5413 ||| CD
)  ||| S:5413 E:5415 ||| -RRB-
overnight  ||| S:5415 E:5425 ||| JJ
at  ||| S:5425 E:5428 ||| IN
4  ||| S:5428 E:5430 ||| CD
C.  ||| S:5430 E:5433 ||| NNP
After  ||| S:5433 E:5439 ||| IN
three  ||| S:5439 E:5445 ||| CD
washes  ||| S:5445 E:5452 ||| NN
in  ||| S:5452 E:5455 ||| IN
PBS  ||| S:5455 E:5459 ||| NNP
containing  ||| S:5459 E:5470 ||| VBG
0.1 ||| S:5470 E:5473 ||| CD
%  ||| S:5473 E:5475 ||| NN
Tween  ||| S:5475 E:5481 ||| NNP
20  ||| S:5481 E:5484 ||| CD
and  ||| S:5484 E:5488 ||| CC
0.01 ||| S:5488 E:5492 ||| CD
%  ||| S:5492 E:5494 ||| NN
Triton  ||| S:5494 E:5501 ||| NNP
X-100  ||| S:5501 E:5507 ||| NNP
for  ||| S:5507 E:5511 ||| IN
5  ||| S:5511 E:5513 ||| CD
min  ||| S:5513 E:5517 ||| CD
each ||| S:5517 E:5521 ||| DT
,  ||| S:5521 E:5523 ||| ,
the  ||| S:5523 E:5527 ||| DT
embryos  ||| S:5527 E:5535 ||| NN
were  ||| S:5535 E:5540 ||| VBD
labelled  ||| S:5540 E:5549 ||| VBN
with  ||| S:5549 E:5554 ||| IN
fluorescein  ||| S:5554 E:5566 ||| FW
isothiocyanate-conjugated  ||| S:5566 E:5592 ||| FW
rabbit  ||| S:5592 E:5599 ||| FW
anti-goat  ||| S:5599 E:5609 ||| FW
IgG  ||| S:5609 E:5613 ||| FW
( ||| S:5613 E:5614 ||| -LRB-
dilution ||| S:5614 E:5622 ||| NN
,  ||| S:5622 E:5624 ||| ,
1 ||| S:5624 E:5625 ||| CD
: ||| S:5625 E:5626 ||| :
100 ||| S:5626 E:5629 ||| CD
)  ||| S:5629 E:5631 ||| -RRB-
for  ||| S:5631 E:5635 ||| IN
1  ||| S:5635 E:5637 ||| CD
h  ||| S:5637 E:5639 ||| NN
at  ||| S:5639 E:5642 ||| IN
room  ||| S:5642 E:5647 ||| NN
temperature ||| S:5647 E:5658 ||| NN
.  ||| S:5658 E:5660 ||| .
After  ||| S:5660 E:5666 ||| IN
three  ||| S:5666 E:5672 ||| CD
washes  ||| S:5672 E:5679 ||| NN
in  ||| S:5679 E:5682 ||| IN
PBS  ||| S:5682 E:5686 ||| NNP
containing  ||| S:5686 E:5697 ||| VBG
0.1 ||| S:5697 E:5700 ||| CD
%  ||| S:5700 E:5702 ||| NN
Tween  ||| S:5702 E:5708 ||| NNP
20  ||| S:5708 E:5711 ||| CD
and  ||| S:5711 E:5715 ||| CC
0.01 ||| S:5715 E:5719 ||| CD
%  ||| S:5719 E:5721 ||| NN
Triton  ||| S:5721 E:5728 ||| NNP
X-100 ||| S:5728 E:5733 ||| NNP
,  ||| S:5733 E:5735 ||| ,
the  ||| S:5735 E:5739 ||| DT
embryos  ||| S:5739 E:5747 ||| NN
were  ||| S:5747 E:5752 ||| VBD
co-stained  ||| S:5752 E:5763 ||| JJ
with  ||| S:5763 E:5768 ||| IN
propidium  ||| S:5768 E:5778 ||| JJ
iodide  ||| S:5778 E:5785 ||| NNS
( ||| S:5785 E:5786 ||| -LRB-
10  ||| S:5786 E:5790 ||| CD
g ||| S:5790 E:5791 ||| CD
/ ||| S:5791 E:5792 ||| CD
ml  ||| S:5792 E:5795 ||| NN
in  ||| S:5795 E:5798 ||| IN
PBS ||| S:5798 E:5801 ||| NNP
) ||| S:5801 E:5802 ||| -RRB-
,  ||| S:5802 E:5804 ||| ,
prior  ||| S:5804 E:5810 ||| RB
to  ||| S:5810 E:5813 ||| TO
being  ||| S:5813 E:5819 ||| VBG
mounted  ||| S:5819 E:5827 ||| VBN
on  ||| S:5827 E:5830 ||| IN
glass  ||| S:5830 E:5836 ||| NN
slides  ||| S:5836 E:5843 ||| NNS
and  ||| S:5843 E:5847 ||| CC
examined  ||| S:5847 E:5856 ||| VBN
under  ||| S:5856 E:5862 ||| IN
a  ||| S:5862 E:5864 ||| DT
confocal  ||| S:5864 E:5873 ||| FW
laser  ||| S:5873 E:5879 ||| FW
scanning  ||| S:5879 E:5888 ||| FW
microscope  ||| S:5888 E:5899 ||| FW
( ||| S:5899 E:5900 ||| -LRB-
Zeiss  ||| S:5900 E:5906 ||| NNP
LSM  ||| S:5906 E:5910 ||| NNP
510  ||| S:5910 E:5914 ||| CD
META ||| S:5914 E:5918 ||| NNP
,  ||| S:5918 E:5920 ||| ,
Jena  ||| S:5920 E:5925 ||| NNP
Germany ||| S:5925 E:5932 ||| NNP
) ||| S:5932 E:5933 ||| -RRB-
.  ||| S:5933 E:5937 ||| .
Immunoblotting  ||| S:5937 E:5952 ||| JJ
analysis  ||| S:5952 E:5962 ||| NN
The  ||| S:5962 E:5966 ||| DT
extracted  ||| S:5966 E:5976 ||| JJ
proteins  ||| S:5976 E:5985 ||| NNS
of  ||| S:5985 E:5988 ||| IN
adult  ||| S:5988 E:5994 ||| FW
ICR  ||| S:5994 E:5998 ||| FW
mouse  ||| S:5998 E:6004 ||| FW
ovaries  ||| S:6004 E:6012 ||| FW
and  ||| S:6012 E:6016 ||| FW
morphologically  ||| S:6016 E:6032 ||| FW
normal  ||| S:6032 E:6039 ||| FW
4-cell  ||| S:6039 E:6046 ||| FW
embryos  ||| S:6046 E:6054 ||| FW
( ||| S:6054 E:6055 ||| -LRB-
150  ||| S:6055 E:6059 ||| CD
embryos ||| S:6059 E:6066 ||| CD
/ ||| S:6066 E:6067 ||| CD
sample ||| S:6067 E:6073 ||| NN
)  ||| S:6073 E:6075 ||| -RRB-
were  ||| S:6075 E:6080 ||| VBD
separated  ||| S:6080 E:6090 ||| VBN
by  ||| S:6090 E:6093 ||| IN
sodium  ||| S:6093 E:6100 ||| FW
dodecyl  ||| S:6100 E:6108 ||| FW
sulfate  ||| S:6108 E:6116 ||| FW
polyacrylamide  ||| S:6116 E:6131 ||| FW
gel  ||| S:6131 E:6135 ||| FW
electrophoresis  ||| S:6135 E:6151 ||| FW
( ||| S:6151 E:6152 ||| -LRB-
SDS-PAGE ||| S:6152 E:6160 ||| NNP
)  ||| S:6160 E:6162 ||| -RRB-
and  ||| S:6162 E:6166 ||| CC
then  ||| S:6166 E:6171 ||| RB
subsequently  ||| S:6171 E:6184 ||| RB
transferred  ||| S:6184 E:6196 ||| VBN
to  ||| S:6196 E:6199 ||| TO
polyvinylidene  ||| S:6199 E:6214 ||| VB
fluoride  ||| S:6214 E:6223 ||| JJ
membranes  ||| S:6223 E:6233 ||| NN
via  ||| S:6233 E:6237 ||| IN
electrophoresis ||| S:6237 E:6252 ||| NN
.  ||| S:6252 E:6254 ||| .
Following  ||| S:6254 E:6264 ||| VBG
the  ||| S:6264 E:6268 ||| DT
transfer ||| S:6268 E:6276 ||| NN
,  ||| S:6276 E:6278 ||| ,
the  ||| S:6278 E:6282 ||| DT
membranes  ||| S:6282 E:6292 ||| NN
were  ||| S:6292 E:6297 ||| VBD
blocked  ||| S:6297 E:6305 ||| VBN
in  ||| S:6305 E:6308 ||| IN
TBST  ||| S:6308 E:6313 ||| NNP
( ||| S:6313 E:6314 ||| -LRB-
TBS  ||| S:6314 E:6318 ||| NNP
buffer  ||| S:6318 E:6325 ||| NN
with  ||| S:6325 E:6330 ||| IN
0.1 ||| S:6330 E:6333 ||| CD
%  ||| S:6333 E:6335 ||| NN
Tween  ||| S:6335 E:6341 ||| NNP
20 ||| S:6341 E:6343 ||| CD
)  ||| S:6343 E:6345 ||| -RRB-
containing  ||| S:6345 E:6356 ||| VBG
5 ||| S:6356 E:6357 ||| CD
%  ||| S:6357 E:6359 ||| NN
skimmed  ||| S:6359 E:6367 ||| NN
milk  ||| S:6367 E:6372 ||| NN
for  ||| S:6372 E:6376 ||| IN
2  ||| S:6376 E:6378 ||| CD
h ||| S:6378 E:6379 ||| NN
,  ||| S:6379 E:6381 ||| ,
followed  ||| S:6381 E:6390 ||| VBN
by  ||| S:6390 E:6393 ||| IN
incubation  ||| S:6393 E:6404 ||| JJ
overnight  ||| S:6404 E:6414 ||| JJ
at  ||| S:6414 E:6417 ||| IN
4  ||| S:6417 E:6419 ||| CD
C  ||| S:6419 E:6421 ||| NNP
with  ||| S:6421 E:6426 ||| IN
goat  ||| S:6426 E:6431 ||| FW
polyclonal  ||| S:6431 E:6442 ||| FW
anti-ING2  ||| S:6442 E:6452 ||| FW
antibody  ||| S:6452 E:6461 ||| FW
( ||| S:6461 E:6462 ||| -LRB-
dilution ||| S:6462 E:6470 ||| NN
,  ||| S:6470 E:6472 ||| ,
1 ||| S:6472 E:6473 ||| CD
: ||| S:6473 E:6474 ||| :
500 ||| S:6474 E:6477 ||| CD
;  ||| S:6477 E:6479 ||| :
sc-67646 ||| S:6479 E:6487 ||| CD
,  ||| S:6487 E:6489 ||| ,
Santa  ||| S:6489 E:6495 ||| NNP
Cruz ||| S:6495 E:6499 ||| NNP
,  ||| S:6499 E:6501 ||| ,
Dallas ||| S:6501 E:6507 ||| NNP
,  ||| S:6507 E:6509 ||| ,
TX ||| S:6509 E:6511 ||| NNP
,  ||| S:6511 E:6513 ||| ,
USA ||| S:6513 E:6516 ||| NNP
) ||| S:6516 E:6517 ||| -RRB-
.  ||| S:6517 E:6519 ||| .
After  ||| S:6519 E:6525 ||| IN
being  ||| S:6525 E:6531 ||| VBG
washed  ||| S:6531 E:6538 ||| VBN
in  ||| S:6538 E:6541 ||| IN
TBST  ||| S:6541 E:6546 ||| NNP
three  ||| S:6546 E:6552 ||| CD
times  ||| S:6552 E:6558 ||| NNS
for  ||| S:6558 E:6562 ||| IN
10  ||| S:6562 E:6565 ||| CD
min  ||| S:6565 E:6569 ||| CD
each ||| S:6569 E:6573 ||| DT
,  ||| S:6573 E:6575 ||| ,
the  ||| S:6575 E:6579 ||| DT
membranes  ||| S:6579 E:6589 ||| NN
were  ||| S:6589 E:6594 ||| VBD
incubated  ||| S:6594 E:6604 ||| VBN
for  ||| S:6604 E:6608 ||| IN
1  ||| S:6608 E:6610 ||| CD
h  ||| S:6610 E:6612 ||| NN
at  ||| S:6612 E:6615 ||| IN
37  ||| S:6615 E:6618 ||| CD
C  ||| S:6618 E:6620 ||| NNP
with  ||| S:6620 E:6625 ||| IN
horseradish  ||| S:6625 E:6637 ||| FW
peroxidase-conjugated  ||| S:6637 E:6659 ||| FW
rabbit  ||| S:6659 E:6666 ||| FW
anti-goat  ||| S:6666 E:6676 ||| FW
IgG  ||| S:6676 E:6680 ||| FW
( ||| S:6680 E:6681 ||| -LRB-
dilution ||| S:6681 E:6689 ||| NN
,  ||| S:6689 E:6691 ||| ,
1 ||| S:6691 E:6692 ||| CD
: ||| S:6692 E:6693 ||| :
1000 ||| S:6693 E:6697 ||| CD
) ||| S:6697 E:6698 ||| -RRB-
.  ||| S:6698 E:6700 ||| .
Finally ||| S:6700 E:6707 ||| RB
,  ||| S:6707 E:6709 ||| ,
the  ||| S:6709 E:6713 ||| DT
membranes  ||| S:6713 E:6723 ||| NN
were  ||| S:6723 E:6728 ||| VBD
processed  ||| S:6728 E:6738 ||| VBN
and  ||| S:6738 E:6742 ||| CC
analyzed  ||| S:6742 E:6751 ||| VBD
using  ||| S:6751 E:6757 ||| VBG
an  ||| S:6757 E:6760 ||| DT
enhanced  ||| S:6760 E:6769 ||| JJ
chemiluminescence  ||| S:6769 E:6787 ||| JJ
detection  ||| S:6787 E:6797 ||| JJ
system  ||| S:6797 E:6804 ||| NN
( ||| S:6804 E:6805 ||| -LRB-
Amersham ||| S:6805 E:6813 ||| NNP
,  ||| S:6813 E:6815 ||| ,
Piscataway ||| S:6815 E:6825 ||| NNP
,  ||| S:6825 E:6827 ||| ,
NJ ||| S:6827 E:6829 ||| NNP
,  ||| S:6829 E:6831 ||| ,
USA ||| S:6831 E:6834 ||| NNP
) ||| S:6834 E:6835 ||| -RRB-
.  ||| S:6835 E:6839 ||| .
Reverse  ||| S:6839 E:6847 ||| RB
transcription  ||| S:6847 E:6861 ||| JJ
polymerase  ||| S:6861 E:6872 ||| JJ
chain  ||| S:6872 E:6878 ||| NN
reaction  ||| S:6878 E:6887 ||| NN
( ||| S:6887 E:6888 ||| -LRB-
RT-PCR ||| S:6888 E:6894 ||| NNP
)  ||| S:6894 E:6897 ||| -RRB-
The  ||| S:6897 E:6901 ||| DT
primer  ||| S:6901 E:6908 ||| JJ
sequences  ||| S:6908 E:6918 ||| JJ
utilized  ||| S:6918 E:6927 ||| NN
for  ||| S:6927 E:6931 ||| IN
RT-PCR  ||| S:6931 E:6938 ||| JJ
analysis  ||| S:6938 E:6947 ||| NN
of  ||| S:6947 E:6950 ||| IN
Ing2  ||| S:6950 E:6955 ||| CD
expression  ||| S:6955 E:6966 ||| NN
were  ||| S:6966 E:6971 ||| VBD
as  ||| S:6971 E:6974 ||| RB
follows ||| S:6974 E:6981 ||| VBZ
:  ||| S:6981 E:6983 ||| :
sense ||| S:6983 E:6988 ||| NN
,  ||| S:6988 E:6990 ||| ,
5  ||| S:6990 E:6992 ||| CD
-GGGAGCTGGACAACACCTACCAA-3  ||| S:6992 E:7020 ||| CD
and  ||| S:7020 E:7024 ||| CC
antisense ||| S:7024 E:7033 ||| NN
,  ||| S:7033 E:7035 ||| ,
5  ||| S:7035 E:7037 ||| CD
-TTCGAGCATCTGGGTGACAATC-3  ||| S:7037 E:7063 ||| CD
.  ||| S:7063 E:7065 ||| .
Total  ||| S:7065 E:7071 ||| JJ
RNA  ||| S:7071 E:7075 ||| NNP
extraction  ||| S:7075 E:7086 ||| NN
and  ||| S:7086 E:7090 ||| CC
RT  ||| S:7090 E:7093 ||| NNP
were  ||| S:7093 E:7098 ||| VBD
performed  ||| S:7098 E:7108 ||| VBN
using  ||| S:7108 E:7114 ||| VBG
an  ||| S:7114 E:7117 ||| DT
RNeasy  ||| S:7117 E:7124 ||| JJ
Micro  ||| S:7124 E:7130 ||| NNP
Kit  ||| S:7130 E:7134 ||| NNP
( ||| S:7134 E:7135 ||| -LRB-
Qiagen ||| S:7135 E:7141 ||| NNP
,  ||| S:7141 E:7143 ||| ,
Valencia ||| S:7143 E:7151 ||| NNP
,  ||| S:7151 E:7153 ||| ,
CA ||| S:7153 E:7155 ||| NNP
,  ||| S:7155 E:7157 ||| ,
USA ||| S:7157 E:7160 ||| NNP
) ||| S:7160 E:7161 ||| -RRB-
,  ||| S:7161 E:7163 ||| ,
according  ||| S:7163 E:7173 ||| VBG
to  ||| S:7173 E:7176 ||| TO
the  ||| S:7176 E:7180 ||| DT
manufacturer ||| S:7180 E:7192 ||| NN
's  ||| S:7192 E:7195 ||| POS
instructions ||| S:7195 E:7207 ||| NNS
;  ||| S:7207 E:7209 ||| :
with  ||| S:7209 E:7214 ||| IN
oligo-dT  ||| S:7214 E:7223 ||| JJ
being  ||| S:7223 E:7229 ||| VBG
utilized  ||| S:7229 E:7238 ||| NN
as  ||| S:7238 E:7241 ||| IN
a  ||| S:7241 E:7243 ||| DT
primer ||| S:7243 E:7249 ||| NN
.  ||| S:7249 E:7251 ||| .
Real-time  ||| S:7251 E:7261 ||| JJ
PCR  ||| S:7261 E:7265 ||| NNP
analysis  ||| S:7265 E:7274 ||| NN
was  ||| S:7274 E:7278 ||| VBD
carried  ||| S:7278 E:7286 ||| VBN
out  ||| S:7286 E:7290 ||| RP
using  ||| S:7290 E:7296 ||| VBG
a  ||| S:7296 E:7298 ||| DT
Faststart  ||| S:7298 E:7308 ||| NNP
Universal  ||| S:7308 E:7318 ||| NNP
SYBR  ||| S:7318 E:7323 ||| NNP
Green  ||| S:7323 E:7329 ||| NNP
Master  ||| S:7329 E:7336 ||| NNP
Mix  ||| S:7336 E:7340 ||| NNP
( ||| S:7340 E:7341 ||| -LRB-
no.  ||| S:7341 E:7345 ||| CD
04913914001 ||| S:7345 E:7356 ||| CD
,  ||| S:7356 E:7358 ||| ,
Roche  ||| S:7358 E:7364 ||| NNP
Inc. ||| S:7364 E:7368 ||| NNP
,  ||| S:7368 E:7370 ||| ,
Basel ||| S:7370 E:7375 ||| NNP
,  ||| S:7375 E:7377 ||| ,
Switzerland ||| S:7377 E:7388 ||| NNP
) ||| S:7388 E:7389 ||| -RRB-
,  ||| S:7389 E:7391 ||| ,
with  ||| S:7391 E:7396 ||| IN
an  ||| S:7396 E:7399 ||| DT
ABI  ||| S:7399 E:7403 ||| NNP
Prism  ||| S:7403 E:7409 ||| NNP
7500  ||| S:7409 E:7414 ||| CD
System  ||| S:7414 E:7421 ||| NNP
( ||| S:7421 E:7422 ||| -LRB-
Applied  ||| S:7422 E:7430 ||| NNP
Biosystems ||| S:7430 E:7440 ||| NNP
,  ||| S:7440 E:7442 ||| ,
Foster  ||| S:7442 E:7449 ||| NNP
City ||| S:7449 E:7453 ||| NNP
,  ||| S:7453 E:7455 ||| ,
CA ||| S:7455 E:7457 ||| NNP
,  ||| S:7457 E:7459 ||| ,
USA ||| S:7459 E:7462 ||| NNP
) ||| S:7462 E:7463 ||| -RRB-
.  ||| S:7463 E:7465 ||| .
We  ||| S:7465 E:7468 ||| PRP
processed  ||| S:7468 E:7478 ||| VBD
15  ||| S:7478 E:7481 ||| CD
30  ||| S:7481 E:7484 ||| CD
embryos  ||| S:7484 E:7492 ||| NN
at  ||| S:7492 E:7495 ||| IN
a  ||| S:7495 E:7497 ||| DT
time ||| S:7497 E:7501 ||| NN
,  ||| S:7501 E:7503 ||| ,
and  ||| S:7503 E:7507 ||| CC
the  ||| S:7507 E:7511 ||| DT
H3f3a  ||| S:7511 E:7517 ||| JJ
gene  ||| S:7517 E:7522 ||| NN
was  ||| S:7522 E:7526 ||| VBD
utilized  ||| S:7526 E:7535 ||| VBN
as  ||| S:7535 E:7538 ||| IN
an  ||| S:7538 E:7541 ||| DT
endogenous  ||| S:7541 E:7552 ||| JJ
control  ||| S:7552 E:7560 ||| NN
( ||| S:7560 E:7561 ||| -LRB-
May  ||| S:7561 E:7565 ||| NNP
et  ||| S:7565 E:7568 ||| NNP
al. ||| S:7568 E:7571 ||| NNP
,  ||| S:7571 E:7573 ||| ,
2009 ||| S:7573 E:7577 ||| CD
) ||| S:7577 E:7578 ||| -RRB-
.  ||| S:7578 E:7580 ||| .
Relative  ||| S:7580 E:7589 ||| JJ
quantitation  ||| S:7589 E:7602 ||| NN
of  ||| S:7602 E:7605 ||| IN
target  ||| S:7605 E:7612 ||| NN
gene  ||| S:7612 E:7617 ||| NN
expression  ||| S:7617 E:7628 ||| NN
was  ||| S:7628 E:7632 ||| VBD
evaluated  ||| S:7632 E:7642 ||| VBN
by  ||| S:7642 E:7645 ||| IN
the  ||| S:7645 E:7649 ||| DT
2  ||| S:7649 E:7653 ||| CD
Ct  ||| S:7653 E:7656 ||| JJ
method  ||| S:7656 E:7663 ||| NN
( ||| S:7663 E:7664 ||| -LRB-
Livak  ||| S:7664 E:7670 ||| NNP
&  ||| S:7670 E:7672 ||| CC
Schmittgen ||| S:7672 E:7682 ||| NNP
,  ||| S:7682 E:7684 ||| ,
2001 ||| S:7684 E:7688 ||| CD
)  ||| S:7688 E:7690 ||| -RRB-
and  ||| S:7690 E:7694 ||| CC
data  ||| S:7694 E:7699 ||| NNS
were  ||| S:7699 E:7704 ||| VBD
collated  ||| S:7704 E:7713 ||| VBN
from  ||| S:7713 E:7718 ||| IN
three  ||| S:7718 E:7724 ||| CD
replicate  ||| S:7724 E:7734 ||| CD
experiments  ||| S:7734 E:7746 ||| NNS
utilizing  ||| S:7746 E:7756 ||| VBP
different  ||| S:7756 E:7766 ||| JJ
sets  ||| S:7766 E:7771 ||| NNS
of  ||| S:7771 E:7774 ||| IN
embryos ||| S:7774 E:7781 ||| NN
.  ||| S:7781 E:7785 ||| .
ING2  ||| S:7785 E:7790 ||| NNP
MISSION  ||| S:7790 E:7799 ||| NNP
esiRNA  ||| S:7799 E:7806 ||| NNP
and  ||| S:7806 E:7810 ||| CC
in  ||| S:7810 E:7813 ||| IN
vitro  ||| S:7813 E:7819 ||| JJ
culture  ||| S:7819 E:7828 ||| NN
ING2  ||| S:7828 E:7833 ||| NNP
MISSION  ||| S:7833 E:7842 ||| NNP
esiRNA  ||| S:7842 E:7849 ||| NNP
( ||| S:7849 E:7850 ||| -LRB-
EMU022101 ||| S:7850 E:7859 ||| NNP
)  ||| S:7859 E:7861 ||| -RRB-
and  ||| S:7861 E:7865 ||| CC
negative  ||| S:7865 E:7874 ||| JJ
control  ||| S:7874 E:7882 ||| NN
EGFP  ||| S:7882 E:7887 ||| NNP
MISSION  ||| S:7887 E:7896 ||| NNP
esiRNA  ||| S:7896 E:7903 ||| NNP
( ||| S:7903 E:7904 ||| -LRB-
EHUEGFP ||| S:7904 E:7911 ||| NNP
)  ||| S:7911 E:7913 ||| -RRB-
were  ||| S:7913 E:7918 ||| VBD
purchased  ||| S:7918 E:7928 ||| VBN
from  ||| S:7928 E:7933 ||| IN
Sigma-Aldrich  ||| S:7933 E:7947 ||| NNP
Inc ||| S:7947 E:7950 ||| NNP
.  ||| S:7950 E:7952 ||| .
( ||| S:7952 E:7953 ||| -LRB-
St.  ||| S:7953 E:7957 ||| NNP
Louis ||| S:7957 E:7962 ||| NNP
,  ||| S:7962 E:7964 ||| ,
MO ||| S:7964 E:7966 ||| NNP
,  ||| S:7966 E:7968 ||| ,
USA ||| S:7968 E:7971 ||| NNP
) ||| S:7971 E:7972 ||| -RRB-
,  ||| S:7972 E:7974 ||| ,
which  ||| S:7974 E:7980 ||| WDT
possessed  ||| S:7980 E:7990 ||| VBD
the  ||| S:7990 E:7994 ||| DT
intellectual  ||| S:7994 E:8007 ||| JJ
property  ||| S:8007 E:8016 ||| NN
to  ||| S:8016 E:8019 ||| TO
design  ||| S:8019 E:8026 ||| VB
and  ||| S:8026 E:8030 ||| CC
prepare  ||| S:8030 E:8038 ||| VB
the  ||| S:8038 E:8042 ||| DT
MISSION  ||| S:8042 E:8050 ||| NNP
esiRNA ||| S:8050 E:8056 ||| NNP
.  ||| S:8056 E:8058 ||| .
The  ||| S:8058 E:8062 ||| DT
Ing2  ||| S:8062 E:8067 ||| JJ
cDNA  ||| S:8067 E:8072 ||| JJ
target  ||| S:8072 E:8079 ||| NN
sequence  ||| S:8079 E:8088 ||| NN
is  ||| S:8088 E:8091 ||| VBZ
as  ||| S:8091 E:8094 ||| RB
follows ||| S:8094 E:8101 ||| VBZ
:  ||| S:8101 E:8103 ||| :
5  ||| S:8103 E:8105 ||| CD
-AAACGCCTACAGCAGCATCTCCAGAGAGCGTTAATCAATAGCCAAGAATTGGGAGATGAAAAAATTCAGATTGTCACCCAGATGCTCGAATTGGTGGAGAACCGAGCGAGACAAATGGAGCTGCATTCACAGTGTTTCCAGGATCCTGCTGAAAGTGAGCGAGCCTCAGACAAGTCGAAGATGGATTCCAGTCAACCGGAAAGATCTTCTAGAAGACCTCGAAGACAGAGGACCAGTGAGAGCCGTGACTTATGTCACATGACAAACGGGATTGACGACTGTGATGATCAACCACCGAAAGAAAAGAGATCCAAGTCCGCCAAGAAGAAGAAGCGCTCCAAGGCCAAGCAGGAGAGGGAGGCATCCCCTGTCGAGTTTGCCATCGATCCCAATGAGCCCACCTACTGCTTGTGTAACCAAGTGTCCTACGGGGAGATGATAGGCTG-3  ||| S:8105 E:8555 ||| CD
.  ||| S:8555 E:8557 ||| .
MISSION  ||| S:8557 E:8565 ||| NN
esiRNA  ||| S:8565 E:8572 ||| NNS
are  ||| S:8572 E:8576 ||| VBP
a  ||| S:8576 E:8578 ||| DT
heterogeneous  ||| S:8578 E:8592 ||| JJ
mixture  ||| S:8592 E:8600 ||| NN
of  ||| S:8600 E:8603 ||| IN
siRNAs  ||| S:8603 E:8610 ||| JJ
that  ||| S:8610 E:8615 ||| IN
all  ||| S:8615 E:8619 ||| DT
target  ||| S:8619 E:8626 ||| NN
the  ||| S:8626 E:8630 ||| DT
same  ||| S:8630 E:8635 ||| JJ
mRNA  ||| S:8635 E:8640 ||| JJ
sequence ||| S:8640 E:8648 ||| NN
.  ||| S:8648 E:8650 ||| .
These  ||| S:8650 E:8656 ||| DT
multiple  ||| S:8656 E:8665 ||| JJ
silencing  ||| S:8665 E:8675 ||| JJ
triggers  ||| S:8675 E:8684 ||| NNS
lead  ||| S:8684 E:8689 ||| VBP
to  ||| S:8689 E:8692 ||| TO
lower  ||| S:8692 E:8698 ||| VB
off-target  ||| S:8698 E:8709 ||| JJ
effects  ||| S:8709 E:8717 ||| NNS
than  ||| S:8717 E:8722 ||| IN
single  ||| S:8722 E:8729 ||| JJ
or  ||| S:8729 E:8732 ||| CC
pooled  ||| S:8732 E:8739 ||| JJ
siRNAs ||| S:8739 E:8745 ||| NN
,  ||| S:8745 E:8747 ||| ,
and  ||| S:8747 E:8751 ||| CC
exert  ||| S:8751 E:8757 ||| VBP
highly  ||| S:8757 E:8764 ||| RB
specific  ||| S:8764 E:8773 ||| JJ
and  ||| S:8773 E:8777 ||| CC
effective  ||| S:8777 E:8787 ||| JJ
gene  ||| S:8787 E:8792 ||| NN
silencing ||| S:8792 E:8801 ||| NN
.  ||| S:8801 E:8803 ||| .
The  ||| S:8803 E:8807 ||| DT
concentration  ||| S:8807 E:8821 ||| NN
of  ||| S:8821 E:8824 ||| IN
ING2  ||| S:8824 E:8829 ||| NNP
MISSION  ||| S:8829 E:8837 ||| NNP
esiRNA  ||| S:8837 E:8844 ||| NNP
was  ||| S:8844 E:8848 ||| VBD
200  ||| S:8848 E:8852 ||| CD
ng ||| S:8852 E:8854 ||| CD
/  ||| S:8854 E:8856 ||| CD
l  ||| S:8856 E:8858 ||| NN
in  ||| S:8858 E:8861 ||| IN
nuclease-free  ||| S:8861 E:8875 ||| NNP
TE  ||| S:8875 E:8878 ||| NNP
buffer  ||| S:8878 E:8885 ||| NN
( ||| S:8885 E:8886 ||| -LRB-
10  ||| S:8886 E:8889 ||| CD
mM  ||| S:8889 E:8892 ||| JJ
Tris-HCl ||| S:8892 E:8900 ||| NN
,  ||| S:8900 E:8902 ||| ,
pH  ||| S:8902 E:8905 ||| NNP
8.0 ||| S:8905 E:8908 ||| NNP
,  ||| S:8908 E:8910 ||| ,
1  ||| S:8910 E:8912 ||| CD
mM  ||| S:8912 E:8915 ||| JJ
EDTA ||| S:8915 E:8919 ||| NNP
) ||| S:8919 E:8920 ||| -RRB-
.  ||| S:8920 E:8922 ||| .
Approximately  ||| S:8922 E:8936 ||| RB
10  ||| S:8936 E:8939 ||| CD
pl  ||| S:8939 E:8942 ||| NN
of  ||| S:8942 E:8945 ||| IN
individual  ||| S:8945 E:8956 ||| JJ
esiRNA  ||| S:8956 E:8963 ||| NN
was  ||| S:8963 E:8967 ||| VBD
microinjected  ||| S:8967 E:8981 ||| VBN
into  ||| S:8981 E:8986 ||| IN
the  ||| S:8986 E:8990 ||| DT
cytoplasm  ||| S:8990 E:9000 ||| NN
of  ||| S:9000 E:9003 ||| IN
the  ||| S:9003 E:9007 ||| DT
zygotes ||| S:9007 E:9014 ||| NN
,  ||| S:9014 E:9016 ||| ,
which  ||| S:9016 E:9022 ||| WDT
were  ||| S:9022 E:9027 ||| VBD
cultured  ||| S:9027 E:9036 ||| VBN
in  ||| S:9036 E:9039 ||| IN
CZB  ||| S:9039 E:9043 ||| NNP
medium  ||| S:9043 E:9050 ||| NN
and  ||| S:9050 E:9054 ||| CC
subjected  ||| S:9054 E:9064 ||| VBN
to  ||| S:9064 E:9067 ||| TO
further  ||| S:9067 E:9075 ||| JJ
observation ||| S:9075 E:9086 ||| NN
.  ||| S:9086 E:9088 ||| .
The  ||| S:9088 E:9092 ||| DT
developmental  ||| S:9092 E:9106 ||| JJ
progress  ||| S:9106 E:9115 ||| NN
of  ||| S:9115 E:9118 ||| IN
each  ||| S:9118 E:9123 ||| DT
group  ||| S:9123 E:9129 ||| NN
was  ||| S:9129 E:9133 ||| VBD
observed  ||| S:9133 E:9142 ||| VBN
and  ||| S:9142 E:9146 ||| CC
analyzed  ||| S:9146 E:9155 ||| VBD
using  ||| S:9155 E:9161 ||| VBG
a  ||| S:9161 E:9163 ||| DT
Nikon  ||| S:9163 E:9169 ||| NNP
TE2000-S  ||| S:9169 E:9178 ||| NNP
microscope ||| S:9178 E:9188 ||| NN
.  ||| S:9188 E:9192 ||| .
Statistical  ||| S:9192 E:9204 ||| JJ
analysis  ||| S:9204 E:9214 ||| NN
Each  ||| S:9214 E:9219 ||| DT
experiment  ||| S:9219 E:9230 ||| NN
was  ||| S:9230 E:9234 ||| VBD
repeated  ||| S:9234 E:9243 ||| VBN
at  ||| S:9243 E:9246 ||| IN
least  ||| S:9246 E:9252 ||| JJS
three  ||| S:9252 E:9258 ||| CD
times ||| S:9258 E:9263 ||| NNS
.  ||| S:9263 E:9265 ||| .
Before  ||| S:9265 E:9272 ||| IN
statistical  ||| S:9272 E:9284 ||| JJ
analysis ||| S:9284 E:9292 ||| NN
,  ||| S:9292 E:9294 ||| ,
all  ||| S:9294 E:9298 ||| DT
percentage  ||| S:9298 E:9309 ||| NN
data  ||| S:9309 E:9314 ||| NNS
were  ||| S:9314 E:9319 ||| VBD
subjected  ||| S:9319 E:9329 ||| VBN
to  ||| S:9329 E:9332 ||| TO
arc-sine  ||| S:9332 E:9341 ||| JJ
transformation ||| S:9341 E:9355 ||| NN
.  ||| S:9355 E:9357 ||| .
Data  ||| S:9357 E:9362 ||| NNP
were  ||| S:9362 E:9367 ||| VBD
analyzed  ||| S:9367 E:9376 ||| VBN
with  ||| S:9376 E:9381 ||| IN
one-way  ||| S:9381 E:9389 ||| JJ
analysis  ||| S:9389 E:9398 ||| NN
of  ||| S:9398 E:9401 ||| IN
variance ||| S:9401 E:9409 ||| NN
,  ||| S:9409 E:9411 ||| ,
paired  ||| S:9411 E:9418 ||| VBN
Student ||| S:9418 E:9425 ||| NNP
's  ||| S:9425 E:9428 ||| POS
t-test  ||| S:9428 E:9435 ||| JJ
and  ||| S:9435 E:9439 ||| CC
the  ||| S:9439 E:9443 ||| DT
chi-squared  ||| S:9443 E:9455 ||| JJ
test ||| S:9455 E:9459 ||| NN
,  ||| S:9459 E:9461 ||| ,
using  ||| S:9461 E:9467 ||| VBG
SPSS  ||| S:9467 E:9472 ||| NNP
software  ||| S:9472 E:9481 ||| NN
( ||| S:9481 E:9482 ||| -LRB-
SPSS  ||| S:9482 E:9487 ||| NNP
Inc. ||| S:9487 E:9491 ||| NNP
,  ||| S:9491 E:9493 ||| ,
Chicago ||| S:9493 E:9500 ||| NNP
,  ||| S:9500 E:9502 ||| ,
IL ||| S:9502 E:9504 ||| NNP
) ||| S:9504 E:9505 ||| -RRB-
.  ||| S:9505 E:9507 ||| .
Data  ||| S:9507 E:9512 ||| NNS
are  ||| S:9512 E:9516 ||| VBP
expressed  ||| S:9516 E:9526 ||| VBN
as  ||| S:9526 E:9529 ||| RB
mean  ||| S:9529 E:9536 ||| VB
standard  ||| S:9536 E:9545 ||| JJ
deviation  ||| S:9545 E:9555 ||| NN
( ||| S:9555 E:9556 ||| -LRB-
SD ||| S:9556 E:9558 ||| NNP
) ||| S:9558 E:9559 ||| -RRB-
,  ||| S:9559 E:9561 ||| ,
with  ||| S:9561 E:9566 ||| IN
a  ||| S:9566 E:9568 ||| DT
P-value  ||| S:9568 E:9578 ||| JJ
0.05  ||| S:9578 E:9583 ||| CD
being  ||| S:9583 E:9589 ||| VBG
considered  ||| S:9589 E:9600 ||| VBN
statistically  ||| S:9600 E:9614 ||| RB
significant ||| S:9614 E:9625 ||| JJ
.  ||| S:9625 E:9628 ||| .
Results  ||| S:9628 E:9637 ||| NNS
The  ||| S:9637 E:9641 ||| DT
expression  ||| S:9641 E:9652 ||| NN
of  ||| S:9652 E:9655 ||| IN
ING2  ||| S:9655 E:9660 ||| CD
during  ||| S:9660 E:9667 ||| IN
mouse  ||| S:9667 E:9673 ||| JJ
preimplantation  ||| S:9673 E:9689 ||| JJ
development  ||| S:9689 E:9702 ||| NN
We  ||| S:9702 E:9705 ||| PRP
analyzed  ||| S:9705 E:9714 ||| VBD
the  ||| S:9714 E:9718 ||| DT
expression  ||| S:9718 E:9729 ||| NN
profile  ||| S:9729 E:9737 ||| NN
of  ||| S:9737 E:9740 ||| IN
Ing2  ||| S:9740 E:9745 ||| CD
at  ||| S:9745 E:9748 ||| IN
each  ||| S:9748 E:9753 ||| DT
stage  ||| S:9753 E:9759 ||| NN
of  ||| S:9759 E:9762 ||| IN
mouse  ||| S:9762 E:9768 ||| JJ
preimplantation  ||| S:9768 E:9784 ||| JJ
embryonic  ||| S:9784 E:9794 ||| JJ
development ||| S:9794 E:9805 ||| NN
.  ||| S:9805 E:9807 ||| .
The  ||| S:9807 E:9811 ||| DT
RT-PCR  ||| S:9811 E:9818 ||| JJ
data  ||| S:9818 E:9823 ||| NNS
confirmed  ||| S:9823 E:9833 ||| VBD
expression  ||| S:9833 E:9844 ||| NN
of  ||| S:9844 E:9847 ||| IN
Ing2  ||| S:9847 E:9852 ||| CD
in  ||| S:9852 E:9855 ||| IN
mouse  ||| S:9855 E:9861 ||| FW
preimplantation  ||| S:9861 E:9877 ||| FW
embryos  ||| S:9877 E:9885 ||| FW
( ||| S:9885 E:9886 ||| -LRB-
Fig.  ||| S:9886 E:9891 ||| NNP
1A ||| S:9891 E:9893 ||| NNP
) ||| S:9893 E:9894 ||| -RRB-
,  ||| S:9894 E:9896 ||| ,
and  ||| S:9896 E:9900 ||| CC
further  ||| S:9900 E:9908 ||| JJ
analysis  ||| S:9908 E:9917 ||| NN
revealed  ||| S:9917 E:9926 ||| VBD
variation  ||| S:9926 E:9936 ||| VBN
in  ||| S:9936 E:9939 ||| IN
expression  ||| S:9939 E:9950 ||| NN
levels  ||| S:9950 E:9957 ||| NNS
of  ||| S:9957 E:9960 ||| IN
Ing2  ||| S:9960 E:9965 ||| CD
at  ||| S:9965 E:9968 ||| IN
different  ||| S:9968 E:9978 ||| JJ
embryonic  ||| S:9978 E:9988 ||| JJ
developmental  ||| S:9988 E:10002 ||| JJ
stages  ||| S:10002 E:10009 ||| NNS
( ||| S:10009 E:10010 ||| -LRB-
Fig.  ||| S:10010 E:10015 ||| NNP
1B ||| S:10015 E:10017 ||| NNP
) ||| S:10017 E:10018 ||| -RRB-
.  ||| S:10018 E:10020 ||| .
Most  ||| S:10020 E:10025 ||| RBS
notably ||| S:10025 E:10032 ||| RB
,  ||| S:10032 E:10034 ||| ,
Ing2  ||| S:10034 E:10039 ||| CD
expression  ||| S:10039 E:10050 ||| NN
rapidly  ||| S:10050 E:10058 ||| RB
increased  ||| S:10058 E:10068 ||| VBN
from  ||| S:10068 E:10073 ||| IN
the  ||| S:10073 E:10077 ||| DT
2-cell  ||| S:10077 E:10084 ||| NN
to  ||| S:10084 E:10087 ||| TO
4-cell  ||| S:10087 E:10094 ||| CD
cleavage-stage ||| S:10094 E:10108 ||| NN
.  ||| S:10108 E:10110 ||| .
This  ||| S:10110 E:10115 ||| DT
suggests  ||| S:10115 E:10124 ||| VBZ
that  ||| S:10124 E:10129 ||| IN
Ing2  ||| S:10129 E:10134 ||| NNP
may  ||| S:10134 E:10138 ||| MD
be  ||| S:10138 E:10141 ||| VB
a  ||| S:10141 E:10143 ||| DT
crucial  ||| S:10143 E:10151 ||| JJ
modulator  ||| S:10151 E:10161 ||| NN
of  ||| S:10161 E:10164 ||| IN
early  ||| S:10164 E:10170 ||| JJ
embryonic  ||| S:10170 E:10180 ||| JJ
development  ||| S:10180 E:10192 ||| NN
genes ||| S:10192 E:10197 ||| NNS
.  ||| S:10197 E:10199 ||| .
Western  ||| S:10199 E:10207 ||| JJ
blot  ||| S:10207 E:10212 ||| JJ
analysis  ||| S:10212 E:10221 ||| NN
utilizing  ||| S:10221 E:10231 ||| VBD
an  ||| S:10231 E:10234 ||| DT
anti-ING2  ||| S:10234 E:10244 ||| JJ
antibody  ||| S:10244 E:10253 ||| NN
revealed  ||| S:10253 E:10262 ||| VBD
an  ||| S:10262 E:10265 ||| DT
exclusive  ||| S:10265 E:10275 ||| JJ
band  ||| S:10275 E:10280 ||| NN
at  ||| S:10280 E:10283 ||| IN
the  ||| S:10283 E:10287 ||| DT
expected  ||| S:10287 E:10296 ||| JJ
molecular  ||| S:10296 E:10306 ||| JJ
mass  ||| S:10306 E:10311 ||| NN
of  ||| S:10311 E:10314 ||| IN
33  ||| S:10314 E:10317 ||| CD
kDa ||| S:10317 E:10320 ||| NN
,  ||| S:10320 E:10322 ||| ,
for  ||| S:10322 E:10326 ||| IN
both  ||| S:10326 E:10331 ||| PDT
the  ||| S:10331 E:10335 ||| DT
mouse  ||| S:10335 E:10341 ||| NN
ovary  ||| S:10341 E:10347 ||| NNS
and  ||| S:10347 E:10351 ||| CC
4-cell  ||| S:10351 E:10358 ||| CD
embryo  ||| S:10358 E:10365 ||| NN
( ||| S:10365 E:10366 ||| -LRB-
Fig.  ||| S:10366 E:10371 ||| NNP
2A ||| S:10371 E:10373 ||| NNP
) ||| S:10373 E:10374 ||| -RRB-
.  ||| S:10374 E:10377 ||| .
Figure  ||| S:10377 E:10384 ||| NN
1  ||| S:10384 E:10387 ||| CD
( ||| S:10387 E:10388 ||| -LRB-
A ||| S:10388 E:10389 ||| NNP
)  ||| S:10389 E:10391 ||| -RRB-
SDS-PAGE  ||| S:10391 E:10400 ||| JJ
gel  ||| S:10400 E:10404 ||| NN
of  ||| S:10404 E:10407 ||| IN
RT-PCR  ||| S:10407 E:10414 ||| JJ
amplification  ||| S:10414 E:10428 ||| NN
of  ||| S:10428 E:10431 ||| IN
Ing2  ||| S:10431 E:10436 ||| CD
mRNA  ||| S:10436 E:10441 ||| JJ
transcripts  ||| S:10441 E:10453 ||| NNS
extracted  ||| S:10453 E:10463 ||| VBN
at  ||| S:10463 E:10466 ||| IN
different  ||| S:10466 E:10476 ||| JJ
embryonic  ||| S:10476 E:10486 ||| JJ
stages ||| S:10486 E:10492 ||| NNS
.  ||| S:10492 E:10494 ||| .
H3f3a  ||| S:10494 E:10500 ||| NNP
was  ||| S:10500 E:10504 ||| VBD
utilized  ||| S:10504 E:10513 ||| VBN
as  ||| S:10513 E:10516 ||| IN
the  ||| S:10516 E:10520 ||| DT
endogenous  ||| S:10520 E:10531 ||| JJ
reference  ||| S:10531 E:10541 ||| NN
gene ||| S:10541 E:10545 ||| NN
.  ||| S:10545 E:10547 ||| .
Lanes  ||| S:10547 E:10553 ||| NNP
1 ||| S:10553 E:10554 ||| CD
,  ||| S:10554 E:10556 ||| ,
2 ||| S:10556 E:10557 ||| CD
,  ||| S:10557 E:10559 ||| ,
3 ||| S:10559 E:10560 ||| CD
,  ||| S:10560 E:10562 ||| ,
4 ||| S:10562 E:10563 ||| CD
,  ||| S:10563 E:10565 ||| ,
5  ||| S:10565 E:10567 ||| CD
corresponds  ||| S:10567 E:10579 ||| NN
to  ||| S:10579 E:10582 ||| TO
zygote ||| S:10582 E:10588 ||| VB
,  ||| S:10588 E:10590 ||| ,
2-cell  ||| S:10590 E:10597 ||| CD
embryo ||| S:10597 E:10603 ||| NN
,  ||| S:10603 E:10605 ||| ,
4-cell  ||| S:10605 E:10612 ||| CD
embryo ||| S:10612 E:10618 ||| NN
,  ||| S:10618 E:10620 ||| ,
morula-stage  ||| S:10620 E:10633 ||| JJ
embryo  ||| S:10633 E:10640 ||| NN
and  ||| S:10640 E:10644 ||| CC
blastocyst-stage  ||| S:10644 E:10661 ||| JJ
embryo  ||| S:10661 E:10668 ||| NN
respectively.  ||| S:10668 E:10682 ||| NNP
( ||| S:10682 E:10683 ||| -LRB-
B ||| S:10683 E:10684 ||| NNP
)  ||| S:10684 E:10686 ||| -RRB-
Real-time  ||| S:10686 E:10696 ||| NNP
PCR  ||| S:10696 E:10700 ||| NNP
analysis  ||| S:10700 E:10709 ||| NN
of  ||| S:10709 E:10712 ||| IN
Ing2  ||| S:10712 E:10717 ||| CD
mRNA  ||| S:10717 E:10722 ||| JJ
expression  ||| S:10722 E:10733 ||| NN
patterns  ||| S:10733 E:10742 ||| NNS
at  ||| S:10742 E:10745 ||| IN
different  ||| S:10745 E:10755 ||| JJ
embryonic  ||| S:10755 E:10765 ||| JJ
stages  ||| S:10765 E:10772 ||| NNS
during  ||| S:10772 E:10779 ||| IN
mouse  ||| S:10779 E:10785 ||| JJ
preimplantation  ||| S:10785 E:10801 ||| JJ
development ||| S:10801 E:10812 ||| NN
.  ||| S:10812 E:10814 ||| .
The  ||| S:10814 E:10818 ||| DT
expression  ||| S:10818 E:10829 ||| NN
level  ||| S:10829 E:10835 ||| NN
was  ||| S:10835 E:10839 ||| VBD
calculated  ||| S:10839 E:10850 ||| VBN
from  ||| S:10850 E:10855 ||| IN
the  ||| S:10855 E:10859 ||| DT
cycle  ||| S:10859 E:10865 ||| NN
threshold  ||| S:10865 E:10875 ||| NN
( ||| S:10875 E:10876 ||| -LRB-
Ct ||| S:10876 E:10878 ||| NNP
)  ||| S:10878 E:10880 ||| -RRB-
values  ||| S:10880 E:10887 ||| NNS
by  ||| S:10887 E:10890 ||| IN
the  ||| S:10890 E:10894 ||| DT
2  ||| S:10894 E:10898 ||| CD
Ct  ||| S:10898 E:10901 ||| JJ
method ||| S:10901 E:10907 ||| NN
.  ||| S:10907 E:10909 ||| .
The  ||| S:10909 E:10913 ||| DT
calibration  ||| S:10913 E:10925 ||| JJ
sample  ||| S:10925 E:10932 ||| NN
was  ||| S:10932 E:10936 ||| VBD
embryos  ||| S:10936 E:10944 ||| VBN
at  ||| S:10944 E:10947 ||| IN
the  ||| S:10947 E:10951 ||| DT
zygote  ||| S:10951 E:10958 ||| JJ
stage ||| S:10958 E:10963 ||| NN
.  ||| S:10963 E:10965 ||| .
Bar  ||| S:10965 E:10969 ||| NN
graphs  ||| S:10969 E:10976 ||| NNS
indicate  ||| S:10976 E:10985 ||| VBP
mean  ||| S:10985 E:10992 ||| JJ
standard  ||| S:10992 E:11001 ||| JJ
deviation  ||| S:11001 E:11011 ||| NN
( ||| S:11011 E:11012 ||| -LRB-
SD ||| S:11012 E:11014 ||| NNP
)  ||| S:11014 E:11016 ||| -RRB-
of  ||| S:11016 E:11019 ||| IN
three  ||| S:11019 E:11025 ||| CD
experimental  ||| S:11025 E:11038 ||| JJ
replicates ||| S:11038 E:11048 ||| NN
.  ||| S:11048 E:11052 ||| .
Figure  ||| S:11052 E:11059 ||| NN
2  ||| S:11059 E:11062 ||| CD
( ||| S:11062 E:11063 ||| -LRB-
A ||| S:11063 E:11064 ||| NNP
)  ||| S:11064 E:11066 ||| -RRB-
Western  ||| S:11066 E:11074 ||| JJ
blot  ||| S:11074 E:11079 ||| NN
with  ||| S:11079 E:11084 ||| IN
the  ||| S:11084 E:11088 ||| DT
anti  ||| S:11088 E:11093 ||| JJ
ING2  ||| S:11093 E:11098 ||| CD
antibody  ||| S:11098 E:11107 ||| NN
showed  ||| S:11107 E:11114 ||| VBD
only  ||| S:11114 E:11119 ||| RB
one  ||| S:11119 E:11123 ||| CD
distinct  ||| S:11123 E:11132 ||| JJ
band  ||| S:11132 E:11137 ||| NN
at  ||| S:11137 E:11140 ||| IN
the  ||| S:11140 E:11144 ||| DT
predicted  ||| S:11144 E:11154 ||| VBN
molecular  ||| S:11154 E:11164 ||| JJ
weight  ||| S:11164 E:11171 ||| NN
of  ||| S:11171 E:11174 ||| IN
ING2  ||| S:11174 E:11179 ||| CD
protein  ||| S:11179 E:11187 ||| NN
( ||| S:11187 E:11188 ||| -LRB-
33  ||| S:11188 E:11191 ||| CD
kD ||| S:11191 E:11193 ||| NN
) ||| S:11193 E:11194 ||| -RRB-
,  ||| S:11194 E:11196 ||| ,
for  ||| S:11196 E:11200 ||| IN
both  ||| S:11200 E:11205 ||| PDT
the  ||| S:11205 E:11209 ||| DT
mouse  ||| S:11209 E:11215 ||| NN
ovary  ||| S:11215 E:11221 ||| NNS
and  ||| S:11221 E:11225 ||| CC
4-cell  ||| S:11225 E:11232 ||| NNP
embryo.  ||| S:11232 E:11240 ||| NNP
( ||| S:11240 E:11241 ||| -LRB-
B ||| S:11241 E:11242 ||| NNP
)  ||| S:11242 E:11244 ||| -RRB-
Immunofluorescence  ||| S:11244 E:11263 ||| NNP
staining  ||| S:11263 E:11272 ||| NN
of  ||| S:11272 E:11275 ||| IN
ING2  ||| S:11275 E:11280 ||| NNP
and  ||| S:11280 E:11284 ||| CC
nuclear  ||| S:11284 E:11292 ||| JJ
DNA  ||| S:11292 E:11296 ||| NN
in  ||| S:11296 E:11299 ||| IN
preimplantation  ||| S:11299 E:11315 ||| JJ
embryos  ||| S:11315 E:11323 ||| NN
with  ||| S:11323 E:11328 ||| IN
specific  ||| S:11328 E:11337 ||| JJ
anti-ING2  ||| S:11337 E:11347 ||| CD
antibody  ||| S:11347 E:11356 ||| NN
( ||| S:11356 E:11357 ||| -LRB-
green ||| S:11357 E:11362 ||| JJ
,  ||| S:11362 E:11364 ||| ,
a  ||| S:11364 E:11367 ||| DT
f  ||| S:11367 E:11369 ||| NN
)  ||| S:11369 E:11371 ||| -RRB-
and  ||| S:11371 E:11375 ||| CC
propidium  ||| S:11375 E:11385 ||| JJ
iodide  ||| S:11385 E:11392 ||| NNS
( ||| S:11392 E:11393 ||| -LRB-
red ||| S:11393 E:11396 ||| JJ
,  ||| S:11396 E:11398 ||| ,
a  ||| S:11398 E:11402 ||| DT
f  ||| S:11402 E:11405 ||| NN
)  ||| S:11405 E:11407 ||| -RRB-
respectively.  ||| S:11407 E:11421 ||| CD
zygote ||| S:11421 E:11427 ||| NN
,  ||| S:11427 E:11429 ||| ,
approximately  ||| S:11429 E:11443 ||| RB
21  ||| S:11443 E:11446 ||| CD
h  ||| S:11446 E:11448 ||| NN
after  ||| S:11448 E:11454 ||| IN
human  ||| S:11454 E:11460 ||| JJ
chorionic  ||| S:11460 E:11470 ||| JJ
gonadotropin  ||| S:11470 E:11483 ||| NNS
( ||| S:11483 E:11484 ||| -LRB-
HCG ||| S:11484 E:11487 ||| NNP
)  ||| S:11487 E:11489 ||| -RRB-
injection  ||| S:11489 E:11499 ||| NN
( ||| S:11499 E:11500 ||| -LRB-
a  ||| S:11500 E:11502 ||| DT
,  ||| S:11502 E:11504 ||| ,
a  ||| S:11504 E:11507 ||| DT
) ||| S:11507 E:11508 ||| -RRB-
;  ||| S:11508 E:11510 ||| :
2-cell  ||| S:11510 E:11517 ||| CD
embryo ||| S:11517 E:11523 ||| NN
,  ||| S:11523 E:11525 ||| ,
approximately  ||| S:11525 E:11539 ||| RB
45  ||| S:11539 E:11542 ||| CD
h  ||| S:11542 E:11544 ||| NN
after  ||| S:11544 E:11550 ||| IN
HCG  ||| S:11550 E:11554 ||| NNP
injection  ||| S:11554 E:11564 ||| NN
( ||| S:11564 E:11565 ||| -LRB-
b  ||| S:11565 E:11567 ||| LS
,  ||| S:11567 E:11569 ||| ,
b  ||| S:11569 E:11572 ||| LS
) ||| S:11572 E:11573 ||| -RRB-
;  ||| S:11573 E:11575 ||| :
4-  ||| S:11575 E:11578 ||| CD
to  ||| S:11578 E:11581 ||| TO
8-cell  ||| S:11581 E:11588 ||| CD
embryo ||| S:11588 E:11594 ||| NN
,  ||| S:11594 E:11596 ||| ,
approximately  ||| S:11596 E:11610 ||| RB
58  ||| S:11610 E:11613 ||| CD
h  ||| S:11613 E:11615 ||| NN
after  ||| S:11615 E:11621 ||| IN
HCG  ||| S:11621 E:11625 ||| NNP
injection  ||| S:11625 E:11635 ||| NN
( ||| S:11635 E:11636 ||| -LRB-
c  ||| S:11636 E:11638 ||| LS
,  ||| S:11638 E:11640 ||| ,
c  ||| S:11640 E:11643 ||| LS
,  ||| S:11643 E:11645 ||| ,
d  ||| S:11645 E:11647 ||| LS
,  ||| S:11647 E:11649 ||| ,
d  ||| S:11649 E:11652 ||| LS
) ||| S:11652 E:11653 ||| -RRB-
;  ||| S:11653 E:11655 ||| :
morula ||| S:11655 E:11661 ||| CD
,  ||| S:11661 E:11663 ||| ,
approximately  ||| S:11663 E:11677 ||| RB
78  ||| S:11677 E:11680 ||| CD
h  ||| S:11680 E:11682 ||| NN
after  ||| S:11682 E:11688 ||| IN
HCG  ||| S:11688 E:11692 ||| NNP
injection  ||| S:11692 E:11702 ||| NN
( ||| S:11702 E:11703 ||| -LRB-
e ||| S:11703 E:11704 ||| LS
,  ||| S:11704 E:11707 ||| ,
e  ||| S:11707 E:11710 ||| LS
)  ||| S:11710 E:11712 ||| -RRB-
and  ||| S:11712 E:11716 ||| CC
blastocyst ||| S:11716 E:11726 ||| NN
,  ||| S:11726 E:11728 ||| ,
approximately  ||| S:11728 E:11742 ||| RB
96  ||| S:11742 E:11745 ||| CD
h  ||| S:11745 E:11747 ||| NN
after  ||| S:11747 E:11753 ||| IN
HCG  ||| S:11753 E:11757 ||| NNP
injection  ||| S:11757 E:11767 ||| NN
( ||| S:11767 E:11768 ||| -LRB-
f  ||| S:11768 E:11770 ||| LS
,  ||| S:11770 E:11772 ||| ,
f  ||| S:11772 E:11775 ||| LS
) ||| S:11775 E:11776 ||| -RRB-
.  ||| S:11776 E:11778 ||| .
Scale  ||| S:11778 E:11784 ||| NN
bar ||| S:11784 E:11787 ||| NN
:  ||| S:11787 E:11789 ||| :
2  ||| S:11789 E:11792 ||| CD
m.  ||| S:11792 E:11795 ||| CD
( ||| S:11795 E:11796 ||| -LRB-
C ||| S:11796 E:11797 ||| NNP
)  ||| S:11797 E:11799 ||| -RRB-
Unstained  ||| S:11799 E:11809 ||| NNP
2-cell  ||| S:11809 E:11816 ||| NNP
embryo  ||| S:11816 E:11823 ||| NN
was  ||| S:11823 E:11827 ||| VBD
utilized  ||| S:11827 E:11836 ||| VBN
as  ||| S:11836 E:11839 ||| IN
the  ||| S:11839 E:11843 ||| DT
negative  ||| S:11843 E:11852 ||| JJ
control ||| S:11852 E:11859 ||| NN
.  ||| S:11859 E:11861 ||| .
Scale  ||| S:11861 E:11867 ||| NN
bar ||| S:11867 E:11870 ||| NN
:  ||| S:11870 E:11872 ||| :
1  ||| S:11872 E:11875 ||| CD
m ||| S:11875 E:11876 ||| NNS
.  ||| S:11876 E:11881 ||| .
The  ||| S:11881 E:11885 ||| DT
localization  ||| S:11885 E:11898 ||| NN
of  ||| S:11898 E:11901 ||| IN
ING2  ||| S:11901 E:11906 ||| CD
during  ||| S:11906 E:11913 ||| IN
mouse  ||| S:11913 E:11919 ||| FW
preimplantation  ||| S:11919 E:11935 ||| FW
development  ||| S:11935 E:11948 ||| FW
Laser  ||| S:11948 E:11954 ||| FW
scanning  ||| S:11954 E:11963 ||| FW
confocal  ||| S:11963 E:11972 ||| FW
microscope  ||| S:11972 E:11983 ||| NN
was  ||| S:11983 E:11987 ||| VBD
used  ||| S:11987 E:11992 ||| VBN
to  ||| S:11992 E:11995 ||| TO
analyze  ||| S:11995 E:12003 ||| VB
subcellular  ||| S:12003 E:12015 ||| JJ
localization  ||| S:12015 E:12028 ||| NN
of  ||| S:12028 E:12031 ||| IN
ING2  ||| S:12031 E:12036 ||| CD
protein  ||| S:12036 E:12044 ||| NN
at  ||| S:12044 E:12047 ||| IN
different  ||| S:12047 E:12057 ||| JJ
stages  ||| S:12057 E:12064 ||| NNS
of  ||| S:12064 E:12067 ||| IN
the  ||| S:12067 E:12071 ||| DT
mouse  ||| S:12071 E:12077 ||| NN
preimplantation  ||| S:12077 E:12093 ||| NN
embryo ||| S:12093 E:12099 ||| NN
.  ||| S:12099 E:12101 ||| .
There  ||| S:12101 E:12107 ||| EX
was  ||| S:12107 E:12111 ||| VBD
increased  ||| S:12111 E:12121 ||| VBN
expression  ||| S:12121 E:12132 ||| NN
of  ||| S:12132 E:12135 ||| IN
ING2  ||| S:12135 E:12140 ||| CD
from  ||| S:12140 E:12145 ||| IN
the  ||| S:12145 E:12149 ||| DT
2-cell  ||| S:12149 E:12156 ||| JJ
embryo  ||| S:12156 E:12163 ||| NN
stage  ||| S:12163 E:12169 ||| NN
onwards  ||| S:12169 E:12177 ||| NN
with  ||| S:12177 E:12182 ||| IN
increasing  ||| S:12182 E:12193 ||| VBG
accumulation  ||| S:12193 E:12206 ||| NN
within  ||| S:12206 E:12213 ||| IN
the  ||| S:12213 E:12217 ||| DT
nucleus  ||| S:12217 E:12225 ||| JJ
beginning  ||| S:12225 E:12235 ||| NN
from  ||| S:12235 E:12240 ||| IN
the  ||| S:12240 E:12244 ||| DT
4-cell  ||| S:12244 E:12251 ||| JJ
embryo  ||| S:12251 E:12258 ||| NN
stage  ||| S:12258 E:12264 ||| NN
( ||| S:12264 E:12265 ||| -LRB-
Fig.  ||| S:12265 E:12270 ||| NNP
2B ||| S:12270 E:12272 ||| NNP
) ||| S:12272 E:12273 ||| -RRB-
.  ||| S:12273 E:12275 ||| .
Unstained  ||| S:12275 E:12285 ||| NNP
2-cell  ||| S:12285 E:12292 ||| NNP
embryos  ||| S:12292 E:12300 ||| NN
were  ||| S:12300 E:12305 ||| VBD
utilized  ||| S:12305 E:12314 ||| VBN
as  ||| S:12314 E:12317 ||| IN
the  ||| S:12317 E:12321 ||| DT
negative  ||| S:12321 E:12330 ||| JJ
controls  ||| S:12330 E:12339 ||| NNS
( ||| S:12339 E:12340 ||| -LRB-
Fig.  ||| S:12340 E:12345 ||| NNP
2C ||| S:12345 E:12347 ||| NNP
) ||| S:12347 E:12348 ||| -RRB-
.  ||| S:12348 E:12350 ||| .
The  ||| S:12350 E:12354 ||| DT
immunostaining  ||| S:12354 E:12369 ||| JJ
result  ||| S:12369 E:12376 ||| NN
is  ||| S:12376 E:12379 ||| VBZ
consistent  ||| S:12379 E:12390 ||| JJ
with  ||| S:12390 E:12395 ||| IN
the  ||| S:12395 E:12399 ||| DT
mRNA  ||| S:12399 E:12404 ||| JJ
expression  ||| S:12404 E:12415 ||| NN
patterns  ||| S:12415 E:12424 ||| NNS
revealed  ||| S:12424 E:12433 ||| VBD
by  ||| S:12433 E:12436 ||| IN
RT-PCR ||| S:12436 E:12442 ||| JJ
.  ||| S:12442 E:12444 ||| .
ING2  ||| S:12444 E:12449 ||| NNP
C-terminal  ||| S:12449 E:12460 ||| NNP
contains  ||| S:12460 E:12469 ||| VBZ
a  ||| S:12469 E:12471 ||| DT
nuclear  ||| S:12471 E:12479 ||| JJ
localization  ||| S:12479 E:12492 ||| JJ
sequence  ||| S:12492 E:12501 ||| NN
( ||| S:12501 E:12502 ||| -LRB-
NLS ||| S:12502 E:12505 ||| NNP
)  ||| S:12505 E:12507 ||| -RRB-
domain ||| S:12507 E:12513 ||| NN
,  ||| S:12513 E:12515 ||| ,
which  ||| S:12515 E:12521 ||| WDT
possesses  ||| S:12521 E:12531 ||| VBZ
three  ||| S:12531 E:12537 ||| CD
nuclear  ||| S:12537 E:12545 ||| JJ
targeting  ||| S:12545 E:12555 ||| VBG
sequences  ||| S:12555 E:12565 ||| NNS
( ||| S:12565 E:12566 ||| -LRB-
NTS ||| S:12566 E:12569 ||| NNP
)  ||| S:12569 E:12571 ||| -RRB-
that  ||| S:12571 E:12576 ||| IN
target  ||| S:12576 E:12583 ||| NN
to  ||| S:12583 E:12586 ||| TO
the  ||| S:12586 E:12590 ||| DT
nucleolus ||| S:12590 E:12599 ||| NN
.  ||| S:12599 E:12601 ||| .
Hence ||| S:12601 E:12606 ||| RB
,  ||| S:12606 E:12608 ||| ,
the  ||| S:12608 E:12612 ||| DT
nuclear  ||| S:12612 E:12620 ||| JJ
localization  ||| S:12620 E:12633 ||| NN
of  ||| S:12633 E:12636 ||| IN
ING2  ||| S:12636 E:12641 ||| NNP
thus  ||| S:12641 E:12646 ||| RB
suggests  ||| S:12646 E:12655 ||| VBZ
that  ||| S:12655 E:12660 ||| IN
ING2  ||| S:12660 E:12665 ||| NNP
may  ||| S:12665 E:12669 ||| MD
have  ||| S:12669 E:12674 ||| VB
key  ||| S:12674 E:12678 ||| JJ
functions  ||| S:12678 E:12688 ||| NNS
in  ||| S:12688 E:12691 ||| IN
regulating  ||| S:12691 E:12702 ||| VBG
gene  ||| S:12702 E:12707 ||| NN
transcription  ||| S:12707 E:12721 ||| NNS
or  ||| S:12721 E:12724 ||| CC
chromosome  ||| S:12724 E:12735 ||| NN
modification ||| S:12735 E:12747 ||| NN
.  ||| S:12747 E:12751 ||| .
Knockdown  ||| S:12751 E:12761 ||| NNP
of  ||| S:12761 E:12764 ||| IN
ING2  ||| S:12764 E:12769 ||| CD
retards  ||| S:12769 E:12777 ||| CD
embryonic  ||| S:12777 E:12787 ||| JJ
development  ||| S:12787 E:12799 ||| NN
in  ||| S:12799 E:12802 ||| IN
vitro  ||| S:12802 E:12809 ||| VBG
To  ||| S:12809 E:12812 ||| TO
investigate  ||| S:12812 E:12824 ||| VB
the  ||| S:12824 E:12828 ||| DT
role  ||| S:12828 E:12833 ||| NN
of  ||| S:12833 E:12836 ||| IN
ING2  ||| S:12836 E:12841 ||| CD
in  ||| S:12841 E:12844 ||| IN
mouse  ||| S:12844 E:12850 ||| NN
embryos ||| S:12850 E:12857 ||| NN
,  ||| S:12857 E:12859 ||| ,
zygotes  ||| S:12859 E:12867 ||| NN
were  ||| S:12867 E:12872 ||| VBD
microinjected  ||| S:12872 E:12886 ||| VBN
with  ||| S:12886 E:12891 ||| IN
sigma  ||| S:12891 E:12897 ||| JJ
MISSION  ||| S:12897 E:12905 ||| NNP
esiRNA  ||| S:12905 E:12912 ||| NNP
against  ||| S:12912 E:12920 ||| IN
ING2 ||| S:12920 E:12924 ||| CD
.  ||| S:12924 E:12926 ||| .
Zygotes  ||| S:12926 E:12934 ||| JJ
microinjected  ||| S:12934 E:12948 ||| NN
with  ||| S:12948 E:12953 ||| IN
sigma  ||| S:12953 E:12959 ||| JJ
negative  ||| S:12959 E:12968 ||| JJ
MISSION  ||| S:12968 E:12976 ||| NNP
esiRNA  ||| S:12976 E:12983 ||| NNP
served  ||| S:12983 E:12990 ||| VBD
as  ||| S:12990 E:12993 ||| IN
controls ||| S:12993 E:13001 ||| NNS
.  ||| S:13001 E:13003 ||| .
Real-time  ||| S:13003 E:13013 ||| JJ
PCR  ||| S:13013 E:13017 ||| NNP
showed  ||| S:13017 E:13024 ||| VBD
that  ||| S:13024 E:13029 ||| IN
the  ||| S:13029 E:13033 ||| DT
expression  ||| S:13033 E:13044 ||| NN
level  ||| S:13044 E:13050 ||| NN
of  ||| S:13050 E:13053 ||| IN
ING2  ||| S:13053 E:13058 ||| NNP
was  ||| S:13058 E:13062 ||| VBD
significantly  ||| S:13062 E:13076 ||| RB
reduced  ||| S:13076 E:13084 ||| VBN
( ||| S:13084 E:13085 ||| -LRB-
Fig.  ||| S:13085 E:13090 ||| NNP
3A ||| S:13090 E:13092 ||| NNP
)  ||| S:13092 E:13094 ||| -RRB-
upon  ||| S:13094 E:13099 ||| IN
microinjection  ||| S:13099 E:13114 ||| NN
with  ||| S:13114 E:13119 ||| IN
the  ||| S:13119 E:13123 ||| DT
esiRNA ||| S:13123 E:13129 ||| JJ
,  ||| S:13129 E:13131 ||| ,
and  ||| S:13131 E:13135 ||| CC
this  ||| S:13135 E:13140 ||| DT
was  ||| S:13140 E:13144 ||| VBD
further  ||| S:13144 E:13152 ||| RB
confirmed  ||| S:13152 E:13162 ||| VBN
by  ||| S:13162 E:13165 ||| IN
reduced  ||| S:13165 E:13173 ||| JJ
expression  ||| S:13173 E:13184 ||| NN
at  ||| S:13184 E:13187 ||| IN
the  ||| S:13187 E:13191 ||| DT
protein  ||| S:13191 E:13199 ||| NN
level  ||| S:13199 E:13205 ||| NN
detected  ||| S:13205 E:13214 ||| VBD
by  ||| S:13214 E:13217 ||| IN
immunostaining  ||| S:13217 E:13232 ||| NNS
( ||| S:13232 E:13233 ||| -LRB-
Fig.  ||| S:13233 E:13238 ||| NNP
3B ||| S:13238 E:13240 ||| NNP
) ||| S:13240 E:13241 ||| -RRB-
.  ||| S:13241 E:13243 ||| .
Inverted  ||| S:13243 E:13252 ||| JJ
light  ||| S:13252 E:13258 ||| JJ
microscopy  ||| S:13258 E:13269 ||| NN
was  ||| S:13269 E:13273 ||| VBD
used  ||| S:13273 E:13278 ||| VBN
to  ||| S:13278 E:13281 ||| TO
track  ||| S:13281 E:13287 ||| VB
the  ||| S:13287 E:13291 ||| DT
development  ||| S:13291 E:13303 ||| NN
of  ||| S:13303 E:13306 ||| IN
the  ||| S:13306 E:13310 ||| DT
treated  ||| S:13310 E:13318 ||| JJ
embryos  ||| S:13318 E:13326 ||| NN
that  ||| S:13326 E:13331 ||| WDT
were  ||| S:13331 E:13336 ||| VBD
cultured  ||| S:13336 E:13345 ||| VBN
up  ||| S:13345 E:13348 ||| RP
to  ||| S:13348 E:13351 ||| TO
the  ||| S:13351 E:13355 ||| DT
blastocyst  ||| S:13355 E:13366 ||| JJ
stage  ||| S:13366 E:13372 ||| NN
( ||| S:13372 E:13373 ||| -LRB-
Fig.  ||| S:13373 E:13378 ||| NNP
3C ||| S:13378 E:13380 ||| NNP
) ||| S:13380 E:13381 ||| -RRB-
.  ||| S:13381 E:13383 ||| .
Notably ||| S:13383 E:13390 ||| RB
,  ||| S:13390 E:13392 ||| ,
statistical  ||| S:13392 E:13404 ||| JJ
analysis  ||| S:13404 E:13413 ||| NN
showed  ||| S:13413 E:13420 ||| VBD
significant  ||| S:13420 E:13432 ||| JJ
differences  ||| S:13432 E:13444 ||| NNS
in  ||| S:13444 E:13447 ||| IN
the  ||| S:13447 E:13451 ||| DT
ratio  ||| S:13451 E:13457 ||| NN
of  ||| S:13457 E:13460 ||| IN
embryos  ||| S:13460 E:13468 ||| NNS
that  ||| S:13468 E:13473 ||| WDT
developed  ||| S:13473 E:13483 ||| VBD
to  ||| S:13483 E:13486 ||| TO
the  ||| S:13486 E:13490 ||| DT
4-cell ||| S:13490 E:13496 ||| NNP
,  ||| S:13496 E:13498 ||| ,
morula  ||| S:13498 E:13505 ||| NN
and  ||| S:13505 E:13509 ||| CC
blastocyst  ||| S:13509 E:13520 ||| JJ
stage  ||| S:13520 E:13526 ||| NN
between  ||| S:13526 E:13534 ||| IN
the  ||| S:13534 E:13538 ||| DT
treated  ||| S:13538 E:13546 ||| JJ
group  ||| S:13546 E:13552 ||| NN
( ||| S:13552 E:13553 ||| -LRB-
n  ||| S:13553 E:13555 ||| CD
=  ||| S:13555 E:13557 ||| SYM
150 ||| S:13557 E:13560 ||| CD
)  ||| S:13560 E:13562 ||| -RRB-
and  ||| S:13562 E:13566 ||| CC
the  ||| S:13566 E:13570 ||| DT
negative  ||| S:13570 E:13579 ||| JJ
control  ||| S:13579 E:13587 ||| NN
group  ||| S:13587 E:13593 ||| NN
( ||| S:13593 E:13594 ||| -LRB-
n  ||| S:13594 E:13596 ||| CD
=  ||| S:13596 E:13598 ||| SYM
132 ||| S:13598 E:13601 ||| CD
) ||| S:13601 E:13602 ||| -RRB-
:  ||| S:13602 E:13604 ||| :
82.7 ||| S:13604 E:13608 ||| CD
%  ||| S:13608 E:13610 ||| NN
vs.  ||| S:13610 E:13614 ||| IN
94.7 ||| S:13614 E:13618 ||| CD
%  ||| S:13618 E:13620 ||| NN
( ||| S:13620 E:13621 ||| -LRB-
P  ||| S:13621 E:13625 ||| NNP
0.05 ||| S:13625 E:13629 ||| CD
) ||| S:13629 E:13630 ||| -RRB-
,  ||| S:13630 E:13632 ||| ,
67.3 ||| S:13632 E:13636 ||| CD
%  ||| S:13636 E:13638 ||| NN
vs.  ||| S:13638 E:13642 ||| IN
89.4 ||| S:13642 E:13646 ||| CD
%  ||| S:13646 E:13648 ||| NN
( ||| S:13648 E:13649 ||| -LRB-
P  ||| S:13649 E:13653 ||| NNP
0.05 ||| S:13653 E:13657 ||| CD
) ||| S:13657 E:13658 ||| -RRB-
,  ||| S:13658 E:13660 ||| ,
48.7 ||| S:13660 E:13664 ||| CD
%  ||| S:13664 E:13666 ||| NN
vs.  ||| S:13666 E:13670 ||| IN
75.8 ||| S:13670 E:13674 ||| CD
%  ||| S:13674 E:13676 ||| NN
( ||| S:13676 E:13677 ||| -LRB-
P  ||| S:13677 E:13681 ||| NNP
0.01 ||| S:13681 E:13685 ||| CD
)  ||| S:13685 E:13687 ||| -RRB-
( ||| S:13687 E:13688 ||| -LRB-
Table  ||| S:13688 E:13694 ||| NNP
1 ||| S:13694 E:13695 ||| CD
) ||| S:13695 E:13696 ||| -RRB-
.  ||| S:13696 E:13698 ||| .
This  ||| S:13698 E:13703 ||| DT
demonstrated  ||| S:13703 E:13716 ||| VBN
that  ||| S:13716 E:13721 ||| IN
ING2  ||| S:13721 E:13726 ||| CD
expression  ||| S:13726 E:13737 ||| NN
was  ||| S:13737 E:13741 ||| VBD
essential  ||| S:13741 E:13751 ||| JJ
to  ||| S:13751 E:13754 ||| TO
mouse  ||| S:13754 E:13760 ||| VB
preimplantation  ||| S:13760 E:13776 ||| JJ
embryonic  ||| S:13776 E:13786 ||| JJ
development ||| S:13786 E:13797 ||| NN
.  ||| S:13797 E:13801 ||| .
Table  ||| S:13801 E:13807 ||| NN
1  ||| S:13807 E:13810 ||| CD
The  ||| S:13810 E:13814 ||| DT
developmental  ||| S:13814 E:13828 ||| JJ
competence  ||| S:13828 E:13839 ||| NN
of  ||| S:13839 E:13842 ||| IN
embryos  ||| S:13842 E:13850 ||| NNS
that  ||| S:13850 E:13855 ||| WDT
were  ||| S:13855 E:13860 ||| VBD
microinjected  ||| S:13860 E:13874 ||| VBN
with  ||| S:13874 E:13879 ||| IN
ING2-specific  ||| S:13879 E:13893 ||| NNP
esiRNA  ||| S:13893 E:13900 ||| NNP
or  ||| S:13900 E:13903 ||| CC
negative  ||| S:13903 E:13912 ||| JJ
esiRNA  ||| S:13912 E:13919 ||| NN
was  ||| S:13919 E:13923 ||| VBD
evaluated  ||| S:13923 E:13933 ||| VBN
by  ||| S:13933 E:13936 ||| IN
determining  ||| S:13936 E:13948 ||| VBG
the  ||| S:13948 E:13952 ||| DT
ratios  ||| S:13952 E:13959 ||| NNS
of  ||| S:13959 E:13962 ||| IN
microinjected  ||| S:13962 E:13976 ||| JJ
embryos  ||| S:13976 E:13984 ||| NNS
progressing  ||| S:13984 E:13996 ||| VBG
to  ||| S:13996 E:13999 ||| TO
various  ||| S:13999 E:14007 ||| JJ
developmental  ||| S:14007 E:14021 ||| JJ
stages  ||| S:14021 E:14030 ||| NNS
No.  ||| S:14030 E:14034 ||| NN
of  ||| S:14034 E:14037 ||| IN
embryos  ||| S:14037 E:14045 ||| NNS
( ||| S:14045 E:14046 ||| -LRB-
% ||| S:14046 E:14047 ||| NN
)  ||| S:14047 E:14050 ||| -RRB-
Treatment  ||| S:14050 E:14061 ||| NNP
Total  ||| S:14061 E:14068 ||| NNP
4-cell  ||| S:14068 E:14076 ||| NNP
Morula  ||| S:14076 E:14084 ||| NNP
Blastocyst  ||| S:14084 E:14096 ||| NNP
Ing2-esiRNA  ||| S:14096 E:14109 ||| CD
150  ||| S:14109 E:14114 ||| CD
124  ||| S:14114 E:14118 ||| CD
( ||| S:14118 E:14119 ||| -LRB-
82.7 ||| S:14119 E:14123 ||| NNP
)  ||| S:14123 E:14126 ||| -RRB-
101  ||| S:14126 E:14130 ||| CD
( ||| S:14130 E:14131 ||| -LRB-
67.3 ||| S:14131 E:14135 ||| NNP
)  ||| S:14135 E:14138 ||| -RRB-
73  ||| S:14138 E:14141 ||| CD
( ||| S:14141 E:14142 ||| -LRB-
48.7 ||| S:14142 E:14146 ||| CD
)  ||| S:14146 E:14149 ||| -RRB-
Control  ||| S:14149 E:14158 ||| NNP
132  ||| S:14158 E:14163 ||| CD
125  ||| S:14163 E:14167 ||| CD
( ||| S:14167 E:14168 ||| -LRB-
94.7 ||| S:14168 E:14172 ||| NNP
) ||| S:14172 E:14173 ||| -RRB-
**  ||| S:14173 E:14177 ||| CD
118  ||| S:14177 E:14181 ||| CD
( ||| S:14181 E:14182 ||| -LRB-
89.4 ||| S:14182 E:14186 ||| NNP
) ||| S:14186 E:14187 ||| -RRB-
**  ||| S:14187 E:14191 ||| CD
100  ||| S:14191 E:14195 ||| CD
( ||| S:14195 E:14196 ||| -LRB-
75.8 ||| S:14196 E:14200 ||| CD
) ||| S:14200 E:14201 ||| -RRB-
**  ||| S:14201 E:14208 ||| NNP
P  ||| S:14208 E:14214 ||| NNP
0.01  ||| S:14214 E:14219 ||| CD
( ||| S:14219 E:14220 ||| -LRB-
vs.  ||| S:14220 E:14224 ||| FW
control ||| S:14224 E:14231 ||| NN
) ||| S:14231 E:14232 ||| -RRB-
.  ||| S:14232 E:14236 ||| .
Figure  ||| S:14236 E:14243 ||| NN
3  ||| S:14243 E:14246 ||| CD
Zygotes  ||| S:14246 E:14254 ||| NNP
were  ||| S:14254 E:14259 ||| VBD
microinjected  ||| S:14259 E:14273 ||| VBN
with  ||| S:14273 E:14278 ||| IN
ING2  ||| S:14278 E:14283 ||| CD
specific  ||| S:14283 E:14292 ||| JJ
sigma  ||| S:14292 E:14298 ||| JJ
MISSION  ||| S:14298 E:14306 ||| NNP
esiRNA.  ||| S:14306 E:14314 ||| NNP
( ||| S:14314 E:14315 ||| -LRB-
A ||| S:14315 E:14316 ||| NNP
)  ||| S:14316 E:14318 ||| -RRB-
Real-time  ||| S:14318 E:14328 ||| NNP
PCR  ||| S:14328 E:14332 ||| NNP
detected  ||| S:14332 E:14341 ||| VBD
down-regulation  ||| S:14341 E:14357 ||| JJ
of  ||| S:14357 E:14360 ||| IN
Ing2  ||| S:14360 E:14365 ||| CD
expression ||| S:14365 E:14375 ||| NN
.  ||| S:14375 E:14377 ||| .
The  ||| S:14377 E:14381 ||| DT
control  ||| S:14381 E:14389 ||| NN
and  ||| S:14389 E:14393 ||| CC
calibration  ||| S:14393 E:14405 ||| JJ
sample  ||| S:14405 E:14412 ||| NN
was  ||| S:14412 E:14416 ||| VBD
untreated  ||| S:14416 E:14426 ||| JJ
zygotes ||| S:14426 E:14433 ||| NN
.  ||| S:14433 E:14435 ||| .
Error  ||| S:14435 E:14441 ||| NN
bars  ||| S:14441 E:14446 ||| NNS
represent  ||| S:14446 E:14456 ||| VBP
standard  ||| S:14456 E:14465 ||| JJ
deviation  ||| S:14465 E:14475 ||| NN
( ||| S:14475 E:14476 ||| -LRB-
SD ||| S:14476 E:14478 ||| NNP
)  ||| S:14478 E:14480 ||| -RRB-
( ||| S:14480 E:14481 ||| -LRB-
*P  ||| S:14481 E:14486 ||| CD
0.05 ||| S:14486 E:14490 ||| CD
) ||| S:14490 E:14491 ||| -RRB-
.  ||| S:14491 E:14493 ||| .
( ||| S:14493 E:14494 ||| -LRB-
B ||| S:14494 E:14495 ||| NNP
)  ||| S:14495 E:14497 ||| -RRB-
Immunofluorescence  ||| S:14497 E:14516 ||| FW
staining  ||| S:14516 E:14525 ||| FW
confirmed  ||| S:14525 E:14535 ||| FW
decreased  ||| S:14535 E:14545 ||| FW
ING2  ||| S:14545 E:14550 ||| FW
protein  ||| S:14550 E:14558 ||| FW
expression  ||| S:14558 E:14569 ||| FW
levels  ||| S:14569 E:14576 ||| NNS
in  ||| S:14576 E:14579 ||| IN
the  ||| S:14579 E:14583 ||| DT
microinjected  ||| S:14583 E:14597 ||| FW
mouse  ||| S:14597 E:14603 ||| FW
embryos.  ||| S:14603 E:14612 ||| FW
( ||| S:14612 E:14613 ||| -LRB-
C ||| S:14613 E:14614 ||| NNP
)  ||| S:14614 E:14616 ||| -RRB-
After  ||| S:14616 E:14622 ||| IN
zygotes  ||| S:14622 E:14630 ||| NN
were  ||| S:14630 E:14635 ||| VBD
microinjected  ||| S:14635 E:14649 ||| VBN
with  ||| S:14649 E:14654 ||| IN
ING2  ||| S:14654 E:14659 ||| CD
specific  ||| S:14659 E:14668 ||| JJ
esiRNA ||| S:14668 E:14674 ||| NN
,  ||| S:14674 E:14676 ||| ,
the  ||| S:14676 E:14680 ||| DT
ratio  ||| S:14680 E:14686 ||| NN
of  ||| S:14686 E:14689 ||| IN
embryos  ||| S:14689 E:14697 ||| NNS
that  ||| S:14697 E:14702 ||| WDT
progressed  ||| S:14702 E:14713 ||| VBD
to  ||| S:14713 E:14716 ||| TO
later  ||| S:14716 E:14722 ||| RBR
embryonic  ||| S:14722 E:14732 ||| JJ
developmental  ||| S:14732 E:14746 ||| JJ
stages  ||| S:14746 E:14753 ||| NNS
was  ||| S:14753 E:14757 ||| VBD
evaluated ||| S:14757 E:14766 ||| VBN
.  ||| S:14766 E:14768 ||| .
The  ||| S:14768 E:14772 ||| DT
depletion  ||| S:14772 E:14782 ||| NN
of  ||| S:14782 E:14785 ||| IN
ING2  ||| S:14785 E:14790 ||| NNP
led  ||| S:14790 E:14794 ||| VBD
to  ||| S:14794 E:14797 ||| TO
developmental  ||| S:14797 E:14811 ||| VB
retardation ||| S:14811 E:14822 ||| NN
.  ||| S:14822 E:14824 ||| .
The  ||| S:14824 E:14828 ||| DT
results  ||| S:14828 E:14836 ||| NNS
of  ||| S:14836 E:14839 ||| IN
five  ||| S:14839 E:14844 ||| CD
independent  ||| S:14844 E:14856 ||| JJ
experiments  ||| S:14856 E:14868 ||| NNS
were  ||| S:14868 E:14873 ||| VBD
collated  ||| S:14873 E:14882 ||| NNS
( ||| S:14882 E:14883 ||| -LRB-
*P  ||| S:14883 E:14888 ||| CD
0.05 ||| S:14888 E:14892 ||| CD
,  ||| S:14892 E:14894 ||| ,
**P  ||| S:14894 E:14900 ||| CD
0.01 ||| S:14900 E:14904 ||| CD
) ||| S:14904 E:14905 ||| -RRB-
.  ||| S:14905 E:14910 ||| .
RNAi-mediated  ||| S:14910 E:14924 ||| JJ
ablation  ||| S:14924 E:14933 ||| NN
of  ||| S:14933 E:14936 ||| IN
Ing2  ||| S:14936 E:14941 ||| CD
results  ||| S:14941 E:14949 ||| NNS
in  ||| S:14949 E:14952 ||| IN
increased  ||| S:14952 E:14962 ||| JJ
p21  ||| S:14962 E:14966 ||| NN
and  ||| S:14966 E:14970 ||| CC
decreased  ||| S:14970 E:14980 ||| VBD
HDAC1  ||| S:14980 E:14986 ||| CD
expression  ||| S:14986 E:14998 ||| NN
To  ||| S:14998 E:15001 ||| TO
gain  ||| S:15001 E:15006 ||| VB
a  ||| S:15006 E:15008 ||| DT
better  ||| S:15008 E:15015 ||| JJR
understanding  ||| S:15015 E:15029 ||| NN
of  ||| S:15029 E:15032 ||| IN
the  ||| S:15032 E:15036 ||| DT
basis  ||| S:15036 E:15042 ||| NN
for  ||| S:15042 E:15046 ||| IN
the  ||| S:15046 E:15050 ||| DT
developmental  ||| S:15050 E:15064 ||| JJ
delay  ||| S:15064 E:15070 ||| NN
of  ||| S:15070 E:15073 ||| IN
the  ||| S:15073 E:15077 ||| DT
Ing2-depleted  ||| S:15077 E:15091 ||| JJ
embryos ||| S:15091 E:15098 ||| NN
,  ||| S:15098 E:15100 ||| ,
we  ||| S:15100 E:15103 ||| PRP
assayed  ||| S:15103 E:15111 ||| JJ
expression  ||| S:15111 E:15122 ||| NN
of  ||| S:15122 E:15125 ||| IN
p21 ||| S:15125 E:15128 ||| NNP
,  ||| S:15128 E:15130 ||| ,
Bax ||| S:15130 E:15133 ||| NNP
,  ||| S:15133 E:15135 ||| ,
and  ||| S:15135 E:15139 ||| CC
HDAC1  ||| S:15139 E:15145 ||| CD
in  ||| S:15145 E:15148 ||| IN
these  ||| S:15148 E:15154 ||| DT
embryos  ||| S:15154 E:15162 ||| NN
by  ||| S:15162 E:15165 ||| IN
real-time  ||| S:15165 E:15175 ||| JJ
PCR ||| S:15175 E:15178 ||| NNP
.  ||| S:15178 E:15180 ||| .
The  ||| S:15180 E:15184 ||| DT
rationale  ||| S:15184 E:15194 ||| NN
for  ||| S:15194 E:15198 ||| IN
doing  ||| S:15198 E:15204 ||| VBG
so  ||| S:15204 E:15207 ||| RB
is  ||| S:15207 E:15210 ||| VBZ
that  ||| S:15210 E:15215 ||| IN
ING2  ||| S:15215 E:15220 ||| CD
activation  ||| S:15220 E:15231 ||| NN
leads  ||| S:15231 E:15237 ||| VBZ
to  ||| S:15237 E:15240 ||| TO
up-regulation  ||| S:15240 E:15254 ||| JJ
of  ||| S:15254 E:15257 ||| IN
p21  ||| S:15257 E:15261 ||| NNP
and  ||| S:15261 E:15265 ||| CC
Bax  ||| S:15265 E:15269 ||| NNP
in  ||| S:15269 E:15272 ||| IN
a  ||| S:15272 E:15274 ||| DT
number  ||| S:15274 E:15281 ||| NN
of  ||| S:15281 E:15284 ||| IN
cancer  ||| S:15284 E:15291 ||| NN
cell  ||| S:15291 E:15296 ||| NN
lines  ||| S:15296 E:15302 ||| NNS
( ||| S:15302 E:15303 ||| -LRB-
Nagashima  ||| S:15303 E:15313 ||| FW
et  ||| S:15313 E:15316 ||| FW
al. ||| S:15316 E:15319 ||| FW
,  ||| S:15319 E:15321 ||| ,
2001 ||| S:15321 E:15325 ||| CD
) ||| S:15325 E:15326 ||| -RRB-
.  ||| S:15326 E:15328 ||| .
Additionally ||| S:15328 E:15340 ||| RB
,  ||| S:15340 E:15342 ||| ,
HDAC  ||| S:15342 E:15347 ||| NNP
inhibitors  ||| S:15347 E:15358 ||| NNS
have  ||| S:15358 E:15363 ||| VBP
been  ||| S:15363 E:15368 ||| VBN
shown  ||| S:15368 E:15374 ||| VBN
to  ||| S:15374 E:15377 ||| TO
induce  ||| S:15377 E:15384 ||| VB
expression  ||| S:15384 E:15395 ||| NN
of  ||| S:15395 E:15398 ||| IN
p21  ||| S:15398 E:15402 ||| CD
in  ||| S:15402 E:15405 ||| IN
many  ||| S:15405 E:15410 ||| JJ
cell  ||| S:15410 E:15415 ||| NN
types  ||| S:15415 E:15421 ||| NNS
and  ||| S:15421 E:15425 ||| CC
tumors ||| S:15425 E:15431 ||| NNS
,  ||| S:15431 E:15433 ||| ,
leading  ||| S:15433 E:15441 ||| VBG
to  ||| S:15441 E:15444 ||| TO
cell  ||| S:15444 E:15449 ||| NN
cycle  ||| S:15449 E:15455 ||| NN
arrest  ||| S:15455 E:15462 ||| NN
( ||| S:15462 E:15463 ||| -LRB-
Zhu  ||| S:15463 E:15467 ||| FW
et  ||| S:15467 E:15470 ||| FW
al. ||| S:15470 E:15473 ||| FW
,  ||| S:15473 E:15475 ||| ,
2004 ||| S:15475 E:15479 ||| CD
) ||| S:15479 E:15480 ||| -RRB-
.  ||| S:15480 E:15482 ||| .
Induction  ||| S:15482 E:15492 ||| NNP
of  ||| S:15492 E:15495 ||| IN
p21  ||| S:15495 E:15499 ||| NNP
was  ||| S:15499 E:15503 ||| VBD
also  ||| S:15503 E:15508 ||| RB
observed  ||| S:15508 E:15517 ||| VBN
in  ||| S:15517 E:15520 ||| IN
Hdac1-deficient  ||| S:15520 E:15536 ||| CD
embryonic  ||| S:15536 E:15546 ||| NNS
stem  ||| S:15546 E:15551 ||| VBP
cells  ||| S:15551 E:15557 ||| NNS
( ||| S:15557 E:15558 ||| -LRB-
Lagger  ||| S:15558 E:15565 ||| FW
et  ||| S:15565 E:15568 ||| FW
al. ||| S:15568 E:15571 ||| FW
,  ||| S:15571 E:15573 ||| ,
2002 ||| S:15573 E:15577 ||| CD
) ||| S:15577 E:15578 ||| -RRB-
.  ||| S:15578 E:15580 ||| .
In  ||| S:15580 E:15583 ||| IN
this  ||| S:15583 E:15588 ||| DT
study ||| S:15588 E:15593 ||| NN
,  ||| S:15593 E:15595 ||| ,
we  ||| S:15595 E:15598 ||| PRP
observed  ||| S:15598 E:15607 ||| VBD
a  ||| S:15607 E:15609 ||| DT
2.3-fold  ||| S:15609 E:15618 ||| JJ
increase  ||| S:15618 E:15627 ||| NN
in  ||| S:15627 E:15630 ||| IN
p21  ||| S:15630 E:15634 ||| CD
mRNA  ||| S:15634 E:15639 ||| JJ
expression  ||| S:15639 E:15650 ||| NN
level  ||| S:15650 E:15656 ||| NN
at  ||| S:15656 E:15659 ||| IN
the  ||| S:15659 E:15663 ||| DT
early  ||| S:15663 E:15669 ||| JJ
blastocyst  ||| S:15669 E:15680 ||| JJ
stage  ||| S:15680 E:15686 ||| NN
( ||| S:15686 E:15687 ||| -LRB-
96  ||| S:15687 E:15690 ||| CD
h  ||| S:15690 E:15692 ||| CD
post-hCG  ||| S:15692 E:15701 ||| JJ
injection ||| S:15701 E:15710 ||| NN
) ||| S:15710 E:15711 ||| -RRB-
,  ||| S:15711 E:15713 ||| ,
while  ||| S:15713 E:15719 ||| IN
there  ||| S:15719 E:15725 ||| EX
was  ||| S:15725 E:15729 ||| VBD
a  ||| S:15729 E:15731 ||| DT
corresponding  ||| S:15731 E:15745 ||| JJ
85 ||| S:15745 E:15747 ||| CD
%  ||| S:15747 E:15749 ||| NN
decrease  ||| S:15749 E:15758 ||| NN
in  ||| S:15758 E:15761 ||| IN
HDAC1  ||| S:15761 E:15767 ||| CD
mRNA  ||| S:15767 E:15772 ||| JJ
level  ||| S:15772 E:15778 ||| NN
at  ||| S:15778 E:15781 ||| IN
the  ||| S:15781 E:15785 ||| DT
same  ||| S:15785 E:15790 ||| JJ
time  ||| S:15790 E:15795 ||| NN
point  ||| S:15795 E:15801 ||| NN
in  ||| S:15801 E:15804 ||| IN
Ing2-depleted  ||| S:15804 E:15818 ||| CD
embryos  ||| S:15818 E:15826 ||| NNS
( ||| S:15826 E:15827 ||| -LRB-
Fig.  ||| S:15827 E:15832 ||| CD
4 ||| S:15832 E:15833 ||| CD
) ||| S:15833 E:15834 ||| -RRB-
.  ||| S:15834 E:15836 ||| .
It  ||| S:15836 E:15839 ||| PRP
is  ||| S:15839 E:15842 ||| VBZ
hypothesized  ||| S:15842 E:15855 ||| VBN
that  ||| S:15855 E:15860 ||| IN
the  ||| S:15860 E:15864 ||| DT
ING2-induced  ||| S:15864 E:15877 ||| JJ
developmental  ||| S:15877 E:15891 ||| JJ
delay  ||| S:15891 E:15897 ||| NN
could  ||| S:15897 E:15903 ||| MD
be  ||| S:15903 E:15906 ||| VB
due  ||| S:15906 E:15910 ||| JJ
to  ||| S:15910 E:15913 ||| TO
decreased  ||| S:15913 E:15923 ||| VB
expression  ||| S:15923 E:15934 ||| NN
of  ||| S:15934 E:15937 ||| IN
HDAC1  ||| S:15937 E:15943 ||| NNP
and  ||| S:15943 E:15947 ||| CC
concomitant  ||| S:15947 E:15959 ||| JJ
increased  ||| S:15959 E:15969 ||| JJ
expression  ||| S:15969 E:15980 ||| NN
of  ||| S:15980 E:15983 ||| IN
p21 ||| S:15983 E:15986 ||| NNP
,  ||| S:15986 E:15988 ||| ,
and  ||| S:15988 E:15992 ||| CC
may  ||| S:15992 E:15996 ||| MD
not  ||| S:15996 E:16000 ||| RB
be  ||| S:16000 E:16003 ||| VB
associated  ||| S:16003 E:16014 ||| VBN
with  ||| S:16014 E:16019 ||| IN
apoptosis  ||| S:16019 E:16029 ||| NN
because  ||| S:16029 E:16037 ||| IN
there  ||| S:16037 E:16043 ||| EX
was  ||| S:16043 E:16047 ||| VBD
no  ||| S:16047 E:16050 ||| DT
increase  ||| S:16050 E:16059 ||| NN
in  ||| S:16059 E:16062 ||| IN
the  ||| S:16062 E:16066 ||| DT
expression  ||| S:16066 E:16077 ||| NN
of  ||| S:16077 E:16080 ||| IN
the  ||| S:16080 E:16084 ||| DT
pro-apoptotic  ||| S:16084 E:16098 ||| JJ
Bax  ||| S:16098 E:16102 ||| JJ
transcripts  ||| S:16102 E:16114 ||| NNS
( ||| S:16114 E:16115 ||| -LRB-
Fig.  ||| S:16115 E:16120 ||| CD
4 ||| S:16120 E:16121 ||| CD
) ||| S:16121 E:16122 ||| -RRB-
.  ||| S:16122 E:16125 ||| .
Figure  ||| S:16125 E:16132 ||| NN
4  ||| S:16132 E:16135 ||| CD
Real-time  ||| S:16135 E:16145 ||| JJ
PCR  ||| S:16145 E:16149 ||| NNP
analysis  ||| S:16149 E:16158 ||| NN
of  ||| S:16158 E:16161 ||| IN
expression  ||| S:16161 E:16172 ||| NN
of  ||| S:16172 E:16175 ||| IN
Ing2-associated  ||| S:16175 E:16191 ||| CD
genes  ||| S:16191 E:16197 ||| NNS
in  ||| S:16197 E:16200 ||| IN
early  ||| S:16200 E:16206 ||| JJ
blastocyst  ||| S:16206 E:16217 ||| JJ
stage  ||| S:16217 E:16223 ||| NN
embryos  ||| S:16223 E:16231 ||| NN
after  ||| S:16231 E:16237 ||| IN
microinjection  ||| S:16237 E:16252 ||| NN
with  ||| S:16252 E:16257 ||| IN
ING2  ||| S:16257 E:16262 ||| CD
specific  ||| S:16262 E:16271 ||| JJ
esiRNA ||| S:16271 E:16277 ||| NN
.  ||| S:16277 E:16279 ||| .
The  ||| S:16279 E:16283 ||| DT
control  ||| S:16283 E:16291 ||| NN
and  ||| S:16291 E:16295 ||| CC
calibration  ||| S:16295 E:16307 ||| JJ
sample  ||| S:16307 E:16314 ||| NN
was  ||| S:16314 E:16318 ||| VBD
untreated  ||| S:16318 E:16328 ||| JJ
embryos  ||| S:16328 E:16336 ||| NN
at  ||| S:16336 E:16339 ||| IN
the  ||| S:16339 E:16343 ||| DT
same  ||| S:16343 E:16348 ||| JJ
developmental  ||| S:16348 E:16362 ||| JJ
stage  ||| S:16362 E:16368 ||| NN
( ||| S:16368 E:16369 ||| -LRB-
early  ||| S:16369 E:16375 ||| JJ
blastocyst ||| S:16375 E:16385 ||| NN
) ||| S:16385 E:16386 ||| -RRB-
.  ||| S:16386 E:16388 ||| .
Data  ||| S:16388 E:16393 ||| NNS
are  ||| S:16393 E:16397 ||| VBP
presented  ||| S:16397 E:16407 ||| VBN
as  ||| S:16407 E:16410 ||| IN
the  ||| S:16410 E:16414 ||| DT
mean  ||| S:16414 E:16419 ||| NN
of  ||| S:16419 E:16422 ||| IN
at  ||| S:16422 E:16425 ||| IN
least  ||| S:16425 E:16431 ||| JJS
three  ||| S:16431 E:16437 ||| CD
biological  ||| S:16437 E:16448 ||| JJ
replicates ||| S:16448 E:16458 ||| NN
.  ||| S:16458 E:16460 ||| .
Bar  ||| S:16460 E:16464 ||| NN
graphs  ||| S:16464 E:16471 ||| NNS
indicate  ||| S:16471 E:16480 ||| VBP
mean  ||| S:16480 E:16487 ||| JJ
standard  ||| S:16487 E:16496 ||| JJ
deviation  ||| S:16496 E:16506 ||| NN
( ||| S:16506 E:16507 ||| -LRB-
SD ||| S:16507 E:16509 ||| NNP
) ||| S:16509 E:16510 ||| -RRB-
;  ||| S:16510 E:16512 ||| :
*P  ||| S:16512 E:16517 ||| CD
0.05  ||| S:16517 E:16522 ||| CD
vs.  ||| S:16522 E:16526 ||| IN
control ||| S:16526 E:16533 ||| NN
.  ||| S:16533 E:16537 ||| .
Discussion  ||| S:16537 E:16548 ||| UH
In  ||| S:16548 E:16551 ||| IN
this  ||| S:16551 E:16556 ||| DT
study ||| S:16556 E:16561 ||| NN
,  ||| S:16561 E:16563 ||| ,
we  ||| S:16563 E:16566 ||| PRP
investigated  ||| S:16566 E:16579 ||| VBD
the  ||| S:16579 E:16583 ||| DT
expression  ||| S:16583 E:16594 ||| NN
and  ||| S:16594 E:16598 ||| CC
localization  ||| S:16598 E:16611 ||| NN
of  ||| S:16611 E:16614 ||| IN
ING2  ||| S:16614 E:16619 ||| CD
during  ||| S:16619 E:16626 ||| IN
mouse  ||| S:16626 E:16632 ||| JJ
preimplantation  ||| S:16632 E:16648 ||| JJ
development ||| S:16648 E:16659 ||| NN
.  ||| S:16659 E:16661 ||| .
We  ||| S:16661 E:16664 ||| PRP
also  ||| S:16664 E:16669 ||| RB
demonstrated  ||| S:16669 E:16682 ||| VBD
its  ||| S:16682 E:16686 ||| PRP$
physiological  ||| S:16686 E:16700 ||| JJ
function  ||| S:16700 E:16709 ||| NN
in  ||| S:16709 E:16712 ||| IN
embryonic  ||| S:16712 E:16722 ||| JJ
development  ||| S:16722 E:16734 ||| NN
and  ||| S:16734 E:16738 ||| CC
made  ||| S:16738 E:16743 ||| VBD
preliminary  ||| S:16743 E:16755 ||| JJ
investigations  ||| S:16755 E:16770 ||| NNS
on  ||| S:16770 E:16773 ||| IN
its  ||| S:16773 E:16777 ||| PRP$
mechanism  ||| S:16777 E:16787 ||| NN
of  ||| S:16787 E:16790 ||| IN
action ||| S:16790 E:16796 ||| NN
.  ||| S:16796 E:16798 ||| .
RT-PCR  ||| S:16798 E:16805 ||| JJ
analysis  ||| S:16805 E:16814 ||| NN
revealed  ||| S:16814 E:16823 ||| VBD
that  ||| S:16823 E:16828 ||| IN
there  ||| S:16828 E:16834 ||| EX
was  ||| S:16834 E:16838 ||| VBD
a  ||| S:16838 E:16840 ||| DT
marked  ||| S:16840 E:16847 ||| JJ
increase  ||| S:16847 E:16856 ||| NN
in  ||| S:16856 E:16859 ||| IN
Ing2  ||| S:16859 E:16864 ||| CD
expression  ||| S:16864 E:16875 ||| NN
from  ||| S:16875 E:16880 ||| IN
the  ||| S:16880 E:16884 ||| DT
2-cell  ||| S:16884 E:16891 ||| NN
to  ||| S:16891 E:16894 ||| TO
4-cell  ||| S:16894 E:16901 ||| CD
embryo  ||| S:16901 E:16908 ||| NN
stage ||| S:16908 E:16913 ||| NN
.  ||| S:16913 E:16915 ||| .
This  ||| S:16915 E:16920 ||| DT
is  ||| S:16920 E:16923 ||| VBZ
consistent  ||| S:16923 E:16934 ||| JJ
with  ||| S:16934 E:16939 ||| IN
the  ||| S:16939 E:16943 ||| DT
immunostaining  ||| S:16943 E:16958 ||| JJ
results ||| S:16958 E:16965 ||| NNS
,  ||| S:16965 E:16967 ||| ,
which  ||| S:16967 E:16973 ||| WDT
showed  ||| S:16973 E:16980 ||| VBD
an  ||| S:16980 E:16983 ||| DT
increase  ||| S:16983 E:16992 ||| NN
in  ||| S:16992 E:16995 ||| IN
expression  ||| S:16995 E:17006 ||| NN
of  ||| S:17006 E:17009 ||| IN
ING2  ||| S:17009 E:17014 ||| CD
at  ||| S:17014 E:17017 ||| IN
the  ||| S:17017 E:17021 ||| DT
protein  ||| S:17021 E:17029 ||| NN
level  ||| S:17029 E:17035 ||| NN
from  ||| S:17035 E:17040 ||| IN
the  ||| S:17040 E:17044 ||| DT
2-cell  ||| S:17044 E:17051 ||| JJ
embryo  ||| S:17051 E:17058 ||| NN
stage ||| S:17058 E:17063 ||| NN
,  ||| S:17063 E:17065 ||| ,
together  ||| S:17065 E:17074 ||| RB
with  ||| S:17074 E:17079 ||| IN
increasing  ||| S:17079 E:17090 ||| VBG
localization  ||| S:17090 E:17103 ||| NN
within  ||| S:17103 E:17110 ||| IN
the  ||| S:17110 E:17114 ||| DT
nucleus  ||| S:17114 E:17122 ||| NN
of  ||| S:17122 E:17125 ||| IN
4-cell  ||| S:17125 E:17132 ||| CD
blastomeres ||| S:17132 E:17143 ||| NNS
.  ||| S:17143 E:17145 ||| .
In  ||| S:17145 E:17148 ||| IN
mouse ||| S:17148 E:17153 ||| NN
,  ||| S:17153 E:17155 ||| ,
the  ||| S:17155 E:17159 ||| DT
first  ||| S:17159 E:17165 ||| JJ
upsurge  ||| S:17165 E:17173 ||| NN
of  ||| S:17173 E:17176 ||| IN
gene  ||| S:17176 E:17181 ||| NN
expression  ||| S:17181 E:17192 ||| NN
occurs  ||| S:17192 E:17199 ||| VBZ
at  ||| S:17199 E:17202 ||| IN
the  ||| S:17202 E:17206 ||| DT
2-cell  ||| S:17206 E:17213 ||| JJ
embryo  ||| S:17213 E:17220 ||| NN
stage ||| S:17220 E:17225 ||| NN
,  ||| S:17225 E:17227 ||| ,
and  ||| S:17227 E:17231 ||| CC
is  ||| S:17231 E:17234 ||| VBZ
known  ||| S:17234 E:17240 ||| VBN
as  ||| S:17240 E:17243 ||| IN
zygotic  ||| S:17243 E:17251 ||| FW
genome  ||| S:17251 E:17258 ||| FW
activation  ||| S:17258 E:17269 ||| FW
( ||| S:17269 E:17270 ||| -LRB-
ZGA ||| S:17270 E:17273 ||| NNP
)  ||| S:17273 E:17275 ||| -RRB-
( ||| S:17275 E:17276 ||| -LRB-
Flach  ||| S:17276 E:17282 ||| FW
et  ||| S:17282 E:17285 ||| FW
al. ||| S:17285 E:17288 ||| FW
,  ||| S:17288 E:17290 ||| ,
1982 ||| S:17290 E:17294 ||| CD
;  ||| S:17294 E:17296 ||| :
Latham  ||| S:17296 E:17303 ||| NNP
et  ||| S:17303 E:17306 ||| NNP
al. ||| S:17306 E:17309 ||| NNP
,  ||| S:17309 E:17311 ||| ,
1992 ||| S:17311 E:17315 ||| CD
;  ||| S:17315 E:17317 ||| :
Nothias  ||| S:17317 E:17325 ||| FW
et  ||| S:17325 E:17328 ||| FW
al. ||| S:17328 E:17331 ||| FW
,  ||| S:17331 E:17333 ||| ,
1995 ||| S:17333 E:17337 ||| CD
) ||| S:17337 E:17338 ||| -RRB-
.  ||| S:17338 E:17340 ||| .
From  ||| S:17340 E:17345 ||| IN
then  ||| S:17345 E:17350 ||| RB
onwards ||| S:17350 E:17357 ||| JJ
,  ||| S:17357 E:17359 ||| ,
the  ||| S:17359 E:17363 ||| DT
embryo  ||| S:17363 E:17370 ||| NN
will  ||| S:17370 E:17375 ||| MD
exploit  ||| S:17375 E:17383 ||| VB
its  ||| S:17383 E:17387 ||| PRP$
own  ||| S:17387 E:17391 ||| JJ
transcriptional  ||| S:17391 E:17407 ||| NN
and  ||| S:17407 E:17411 ||| CC
translational  ||| S:17411 E:17425 ||| JJ
machinery  ||| S:17425 E:17435 ||| NN
to  ||| S:17435 E:17438 ||| TO
carry  ||| S:17438 E:17444 ||| VB
out  ||| S:17444 E:17448 ||| RP
its  ||| S:17448 E:17452 ||| PRP$
developmental  ||| S:17452 E:17466 ||| JJ
program ||| S:17466 E:17473 ||| NN
.  ||| S:17473 E:17475 ||| .
This  ||| S:17475 E:17480 ||| DT
enables  ||| S:17480 E:17488 ||| JJ
reprogramming  ||| S:17488 E:17502 ||| NN
of  ||| S:17502 E:17505 ||| IN
the  ||| S:17505 E:17509 ||| DT
newly  ||| S:17509 E:17515 ||| RB
formed  ||| S:17515 E:17522 ||| VBN
embryonic  ||| S:17522 E:17532 ||| JJ
genome  ||| S:17532 E:17539 ||| NN
to  ||| S:17539 E:17542 ||| TO
a  ||| S:17542 E:17544 ||| DT
totipotent  ||| S:17544 E:17555 ||| JJ
state ||| S:17555 E:17560 ||| NN
,  ||| S:17560 E:17562 ||| ,
which  ||| S:17562 E:17568 ||| WDT
is  ||| S:17568 E:17571 ||| VBZ
subsequently  ||| S:17571 E:17584 ||| RB
lost  ||| S:17584 E:17589 ||| VBN
at  ||| S:17589 E:17592 ||| IN
the  ||| S:17592 E:17596 ||| DT
blastocyst  ||| S:17596 E:17607 ||| JJ
stage  ||| S:17607 E:17613 ||| NN
( ||| S:17613 E:17614 ||| -LRB-
Duranthon  ||| S:17614 E:17624 ||| FW
et  ||| S:17624 E:17627 ||| FW
al. ||| S:17627 E:17630 ||| FW
,  ||| S:17630 E:17632 ||| ,
2008 ||| S:17632 E:17636 ||| CD
;  ||| S:17636 E:17638 ||| :
Calle  ||| S:17638 E:17644 ||| FW
et  ||| S:17644 E:17647 ||| FW
al. ||| S:17647 E:17650 ||| FW
,  ||| S:17650 E:17652 ||| ,
2012 ||| S:17652 E:17656 ||| CD
) ||| S:17656 E:17657 ||| -RRB-
.  ||| S:17657 E:17659 ||| .
Previous  ||| S:17659 E:17668 ||| JJ
research  ||| S:17668 E:17677 ||| NN
suggested  ||| S:17677 E:17687 ||| VBD
that  ||| S:17687 E:17692 ||| IN
genes  ||| S:17692 E:17698 ||| NNS
activated  ||| S:17698 E:17708 ||| VBN
from  ||| S:17708 E:17713 ||| IN
the  ||| S:17713 E:17717 ||| DT
transition  ||| S:17717 E:17728 ||| NN
of  ||| S:17728 E:17731 ||| IN
fertilized  ||| S:17731 E:17742 ||| JJ
eggs  ||| S:17742 E:17747 ||| NNS
to  ||| S:17747 E:17750 ||| TO
4-cell  ||| S:17750 E:17757 ||| CD
embryos  ||| S:17757 E:17765 ||| NNS
contribute  ||| S:17765 E:17776 ||| VBP
mainly  ||| S:17776 E:17783 ||| RB
to  ||| S:17783 E:17786 ||| TO
the  ||| S:17786 E:17790 ||| DT
regulation  ||| S:17790 E:17801 ||| NN
of  ||| S:17801 E:17804 ||| IN
basic  ||| S:17804 E:17810 ||| JJ
cellular  ||| S:17810 E:17819 ||| JJ
machinery ||| S:17819 E:17828 ||| NN
,  ||| S:17828 E:17830 ||| ,
while  ||| S:17830 E:17836 ||| IN
genes  ||| S:17836 E:17842 ||| NNS
activated  ||| S:17842 E:17852 ||| VBN
from  ||| S:17852 E:17857 ||| IN
transition  ||| S:17857 E:17868 ||| NN
of  ||| S:17868 E:17871 ||| IN
8-cell  ||| S:17871 E:17878 ||| CD
embryos  ||| S:17878 E:17886 ||| NN
to  ||| S:17886 E:17889 ||| TO
the  ||| S:17889 E:17893 ||| DT
morula  ||| S:17893 E:17900 ||| NN
and  ||| S:17900 E:17904 ||| CC
blastocyst  ||| S:17904 E:17915 ||| JJ
stages  ||| S:17915 E:17922 ||| NNS
are  ||| S:17922 E:17926 ||| VBP
mainly  ||| S:17926 E:17933 ||| RB
associated  ||| S:17933 E:17944 ||| VBN
with  ||| S:17944 E:17949 ||| IN
dramatic  ||| S:17949 E:17958 ||| JJ
biological  ||| S:17958 E:17969 ||| NN
and  ||| S:17969 E:17973 ||| CC
morphological  ||| S:17973 E:17987 ||| JJ
events  ||| S:17987 E:17994 ||| NNS
( ||| S:17994 E:17995 ||| -LRB-
Hamatani  ||| S:17995 E:18004 ||| FW
et  ||| S:18004 E:18007 ||| FW
al. ||| S:18007 E:18010 ||| FW
,  ||| S:18010 E:18012 ||| ,
2004 ||| S:18012 E:18016 ||| CD
) ||| S:18016 E:18017 ||| -RRB-
.  ||| S:18017 E:18019 ||| .
The  ||| S:18019 E:18023 ||| DT
spatio-temporal  ||| S:18023 E:18039 ||| JJ
expression  ||| S:18039 E:18050 ||| NN
pattern  ||| S:18050 E:18058 ||| NN
of  ||| S:18058 E:18061 ||| IN
ING2 ||| S:18061 E:18065 ||| NNP
,  ||| S:18065 E:18067 ||| ,
may  ||| S:18067 E:18071 ||| MD
give  ||| S:18071 E:18076 ||| VB
some  ||| S:18076 E:18081 ||| DT
cues  ||| S:18081 E:18086 ||| NN
on  ||| S:18086 E:18089 ||| IN
how  ||| S:18089 E:18093 ||| WRB
it  ||| S:18093 E:18096 ||| PRP
may  ||| S:18096 E:18100 ||| MD
contribute  ||| S:18100 E:18111 ||| VB
to  ||| S:18111 E:18114 ||| TO
mouse  ||| S:18114 E:18120 ||| VB
preimplantation  ||| S:18120 E:18136 ||| JJ
development ||| S:18136 E:18147 ||| NN
.  ||| S:18147 E:18149 ||| .
Further  ||| S:18149 E:18157 ||| JJ
investigation  ||| S:18157 E:18171 ||| NN
showed  ||| S:18171 E:18178 ||| VBD
that  ||| S:18178 E:18183 ||| DT
down-regulation  ||| S:18183 E:18199 ||| JJ
of  ||| S:18199 E:18202 ||| IN
ING2  ||| S:18202 E:18207 ||| CD
by  ||| S:18207 E:18210 ||| IN
RNAi  ||| S:18210 E:18215 ||| NNP
led  ||| S:18215 E:18219 ||| VBD
to  ||| S:18219 E:18222 ||| TO
a  ||| S:18222 E:18224 ||| DT
decreased  ||| S:18224 E:18234 ||| JJ
blastocyst  ||| S:18234 E:18245 ||| JJ
formation  ||| S:18245 E:18255 ||| NN
rate  ||| S:18255 E:18260 ||| NN
compared  ||| S:18260 E:18269 ||| VBN
with  ||| S:18269 E:18274 ||| IN
the  ||| S:18274 E:18278 ||| DT
negative  ||| S:18278 E:18287 ||| JJ
control  ||| S:18287 E:18295 ||| NN
group ||| S:18295 E:18300 ||| NN
,  ||| S:18300 E:18302 ||| ,
which  ||| S:18302 E:18308 ||| WDT
means  ||| S:18308 E:18314 ||| VBZ
that  ||| S:18314 E:18319 ||| IN
ING2  ||| S:18319 E:18324 ||| NNP
does  ||| S:18324 E:18329 ||| VBZ
play  ||| S:18329 E:18334 ||| VB
a  ||| S:18334 E:18336 ||| DT
crucial  ||| S:18336 E:18344 ||| JJ
role  ||| S:18344 E:18349 ||| NN
in  ||| S:18349 E:18352 ||| IN
preimplantation  ||| S:18352 E:18368 ||| JJ
development ||| S:18368 E:18379 ||| NN
.  ||| S:18379 E:18381 ||| .
As  ||| S:18381 E:18384 ||| IN
a  ||| S:18384 E:18386 ||| DT
growth  ||| S:18386 E:18393 ||| NN
inhibition  ||| S:18393 E:18404 ||| NN
factor ||| S:18404 E:18410 ||| NN
,  ||| S:18410 E:18412 ||| ,
ING2  ||| S:18412 E:18417 ||| NNP
has  ||| S:18417 E:18421 ||| VBZ
a  ||| S:18421 E:18423 ||| DT
PHD  ||| S:18423 E:18427 ||| NNP
domain  ||| S:18427 E:18434 ||| NN
that  ||| S:18434 E:18439 ||| WDT
enables  ||| S:18439 E:18447 ||| VBZ
its  ||| S:18447 E:18451 ||| PRP$
interaction  ||| S:18451 E:18463 ||| NN
with  ||| S:18463 E:18468 ||| IN
H3K4Me3  ||| S:18468 E:18476 ||| CD
to  ||| S:18476 E:18479 ||| TO
regulate  ||| S:18479 E:18488 ||| VB
gene  ||| S:18488 E:18493 ||| NN
repression  ||| S:18493 E:18504 ||| NN
( ||| S:18504 E:18505 ||| -LRB-
Gozani  ||| S:18505 E:18512 ||| FW
et  ||| S:18512 E:18515 ||| FW
al. ||| S:18515 E:18518 ||| FW
,  ||| S:18518 E:18520 ||| ,
2003 ||| S:18520 E:18524 ||| CD
;  ||| S:18524 E:18526 ||| :
Shi  ||| S:18526 E:18530 ||| FW
et  ||| S:18530 E:18533 ||| FW
al. ||| S:18533 E:18536 ||| FW
,  ||| S:18536 E:18538 ||| ,
2006 ||| S:18538 E:18542 ||| CD
) ||| S:18542 E:18543 ||| -RRB-
.  ||| S:18543 E:18545 ||| .
ING2  ||| S:18545 E:18550 ||| NNP
is  ||| S:18550 E:18553 ||| VBZ
a  ||| S:18553 E:18555 ||| DT
stable  ||| S:18555 E:18562 ||| JJ
component  ||| S:18562 E:18572 ||| NN
of  ||| S:18572 E:18575 ||| IN
the  ||| S:18575 E:18579 ||| DT
Sin3  ||| S:18579 E:18584 ||| NNP
HDAC  ||| S:18584 E:18589 ||| NNP
complex ||| S:18589 E:18596 ||| NN
.  ||| S:18596 E:18598 ||| .
It  ||| S:18598 E:18601 ||| PRP
has  ||| S:18601 E:18605 ||| VBZ
been  ||| S:18605 E:18610 ||| VBN
shown  ||| S:18610 E:18616 ||| VBN
that  ||| S:18616 E:18621 ||| IN
ING2  ||| S:18621 E:18626 ||| NNP
negatively  ||| S:18626 E:18637 ||| RB
regulates  ||| S:18637 E:18647 ||| JJ
cell  ||| S:18647 E:18652 ||| NN
proliferation ||| S:18652 E:18665 ||| NN
,  ||| S:18665 E:18667 ||| ,
chromatin  ||| S:18667 E:18677 ||| JJ
remodeling ||| S:18677 E:18687 ||| NN
,  ||| S:18687 E:18689 ||| ,
apoptosis  ||| S:18689 E:18699 ||| NN
and  ||| S:18699 E:18703 ||| CC
DNA  ||| S:18703 E:18707 ||| NNP
repair  ||| S:18707 E:18714 ||| NN
through  ||| S:18714 E:18722 ||| IN
modulation  ||| S:18722 E:18733 ||| NN
of  ||| S:18733 E:18736 ||| IN
the  ||| S:18736 E:18740 ||| DT
p53  ||| S:18740 E:18744 ||| NN
acetylation  ||| S:18744 E:18756 ||| NN
pathway ||| S:18756 E:18763 ||| NN
,  ||| S:18763 E:18765 ||| ,
which  ||| S:18765 E:18771 ||| WDT
incidentally  ||| S:18771 E:18784 ||| RB
enhance  ||| S:18784 E:18792 ||| VB
its  ||| S:18792 E:18796 ||| PRP$
own  ||| S:18796 E:18800 ||| JJ
transcription  ||| S:18800 E:18814 ||| NNS
( ||| S:18814 E:18815 ||| -LRB-
Wang  ||| S:18815 E:18820 ||| NNP
et  ||| S:18820 E:18823 ||| NNP
al. ||| S:18823 E:18826 ||| NNP
,  ||| S:18826 E:18828 ||| ,
2006 ||| S:18828 E:18832 ||| CD
;  ||| S:18832 E:18834 ||| :
Unoki  ||| S:18834 E:18840 ||| FW
et  ||| S:18840 E:18843 ||| FW
al. ||| S:18843 E:18846 ||| FW
,  ||| S:18846 E:18848 ||| ,
2008 ||| S:18848 E:18852 ||| CD
) ||| S:18852 E:18853 ||| -RRB-
.  ||| S:18853 E:18855 ||| .
Additionally ||| S:18855 E:18867 ||| RB
,  ||| S:18867 E:18869 ||| ,
ING2  ||| S:18869 E:18874 ||| NNP
has  ||| S:18874 E:18878 ||| VBZ
also  ||| S:18878 E:18883 ||| RB
been  ||| S:18883 E:18888 ||| VBN
implicated  ||| S:18888 E:18899 ||| VBN
in  ||| S:18899 E:18902 ||| IN
muscle  ||| S:18902 E:18909 ||| NN
differentiation  ||| S:18909 E:18925 ||| NN
through  ||| S:18925 E:18933 ||| IN
regulation  ||| S:18933 E:18944 ||| NN
of  ||| S:18944 E:18947 ||| IN
myogenin  ||| S:18947 E:18956 ||| JJ
transcription  ||| S:18956 E:18970 ||| NNS
( ||| S:18970 E:18971 ||| -LRB-
Eapen  ||| S:18971 E:18977 ||| FW
et  ||| S:18977 E:18980 ||| FW
al. ||| S:18980 E:18983 ||| FW
,  ||| S:18983 E:18985 ||| ,
2012 ||| S:18985 E:18989 ||| CD
) ||| S:18989 E:18990 ||| -RRB-
.  ||| S:18990 E:18992 ||| .
The  ||| S:18992 E:18996 ||| DT
tri-methylated  ||| S:18996 E:19011 ||| JJ
histone  ||| S:19011 E:19019 ||| JJ
mark  ||| S:19019 E:19024 ||| NN
is  ||| S:19024 E:19027 ||| VBZ
found  ||| S:19027 E:19033 ||| VBN
mainly  ||| S:19033 E:19040 ||| RB
in  ||| S:19040 E:19043 ||| IN
transcriptionally  ||| S:19043 E:19061 ||| JJ
active  ||| S:19061 E:19068 ||| JJ
regions  ||| S:19068 E:19076 ||| NNS
( ||| S:19076 E:19077 ||| -LRB-
Bannister  ||| S:19077 E:19087 ||| NNP
&  ||| S:19087 E:19089 ||| CC
Kouzarides ||| S:19089 E:19099 ||| NNP
,  ||| S:19099 E:19101 ||| ,
2004 ||| S:19101 E:19105 ||| CD
) ||| S:19105 E:19106 ||| -RRB-
.  ||| S:19106 E:19108 ||| .
ING2 ||| S:19108 E:19112 ||| NNP
,  ||| S:19112 E:19114 ||| ,
being  ||| S:19114 E:19120 ||| VBG
a  ||| S:19120 E:19122 ||| DT
stable  ||| S:19122 E:19129 ||| JJ
component  ||| S:19129 E:19139 ||| NN
of  ||| S:19139 E:19142 ||| IN
the  ||| S:19142 E:19146 ||| DT
Sin3  ||| S:19146 E:19151 ||| NNP
HDAC  ||| S:19151 E:19156 ||| NNP
complex ||| S:19156 E:19163 ||| NN
,  ||| S:19163 E:19165 ||| ,
recruits  ||| S:19165 E:19174 ||| NNS
and  ||| S:19174 E:19178 ||| CC
stabilizes  ||| S:19178 E:19189 ||| VBZ
the  ||| S:19189 E:19193 ||| DT
Sin3  ||| S:19193 E:19198 ||| NNP
HDAC  ||| S:19198 E:19203 ||| NNP
complex  ||| S:19203 E:19211 ||| NN
on  ||| S:19211 E:19214 ||| IN
gene  ||| S:19214 E:19219 ||| NN
promoters ||| S:19219 E:19228 ||| NNS
,  ||| S:19228 E:19230 ||| ,
leading  ||| S:19230 E:19238 ||| VBG
to  ||| S:19238 E:19241 ||| TO
histone  ||| S:19241 E:19249 ||| VB
deacetylation  ||| S:19249 E:19263 ||| NNS
and  ||| S:19263 E:19267 ||| CC
gene  ||| S:19267 E:19272 ||| NN
repression  ||| S:19272 E:19283 ||| NN
( ||| S:19283 E:19284 ||| -LRB-
Doyon  ||| S:19284 E:19290 ||| FW
et  ||| S:19290 E:19293 ||| FW
al. ||| S:19293 E:19296 ||| FW
,  ||| S:19296 E:19298 ||| ,
2006 ||| S:19298 E:19302 ||| CD
;  ||| S:19302 E:19304 ||| :
Pena  ||| S:19304 E:19309 ||| FW
et  ||| S:19309 E:19312 ||| FW
al. ||| S:19312 E:19315 ||| FW
,  ||| S:19315 E:19317 ||| ,
2006 ||| S:19317 E:19321 ||| CD
;  ||| S:19321 E:19323 ||| :
Shi  ||| S:19323 E:19327 ||| FW
et  ||| S:19327 E:19330 ||| FW
al. ||| S:19330 E:19333 ||| FW
,  ||| S:19333 E:19335 ||| ,
2006 ||| S:19335 E:19339 ||| CD
) ||| S:19339 E:19340 ||| -RRB-
.  ||| S:19340 E:19342 ||| .
Histone  ||| S:19342 E:19350 ||| JJ
deacetylase  ||| S:19350 E:19362 ||| NNS
( ||| S:19362 E:19363 ||| -LRB-
HDAC ||| S:19363 E:19367 ||| NNP
)  ||| S:19367 E:19369 ||| -RRB-
inhibitors  ||| S:19369 E:19380 ||| RB
cause  ||| S:19380 E:19386 ||| VB
the  ||| S:19386 E:19390 ||| DT
dissociation  ||| S:19390 E:19403 ||| NN
of  ||| S:19403 E:19406 ||| IN
the  ||| S:19406 E:19410 ||| DT
PHD  ||| S:19410 E:19414 ||| NNP
domain  ||| S:19414 E:19421 ||| NN
containing  ||| S:19421 E:19432 ||| VBG
ING2  ||| S:19432 E:19437 ||| CD
subunit  ||| S:19437 E:19445 ||| NN
from  ||| S:19445 E:19450 ||| IN
the  ||| S:19450 E:19454 ||| DT
Sin3  ||| S:19454 E:19459 ||| JJ
deacetylase  ||| S:19459 E:19471 ||| JJ
complex ||| S:19471 E:19478 ||| NN
.  ||| S:19478 E:19480 ||| .
The  ||| S:19480 E:19484 ||| DT
loss  ||| S:19484 E:19489 ||| NN
of  ||| S:19489 E:19492 ||| IN
ING2  ||| S:19492 E:19497 ||| NNP
subsequently  ||| S:19497 E:19510 ||| RB
disrupts  ||| S:19510 E:19519 ||| VB
the  ||| S:19519 E:19523 ||| DT
in  ||| S:19523 E:19526 ||| IN
vivo  ||| S:19526 E:19531 ||| JJ
binding  ||| S:19531 E:19539 ||| NN
of  ||| S:19539 E:19542 ||| IN
the  ||| S:19542 E:19546 ||| DT
Sin3  ||| S:19546 E:19551 ||| JJ
complex  ||| S:19551 E:19559 ||| NN
to  ||| S:19559 E:19562 ||| TO
the  ||| S:19562 E:19566 ||| DT
p21  ||| S:19566 E:19570 ||| JJ
promoter  ||| S:19570 E:19579 ||| NN
( ||| S:19579 E:19580 ||| -LRB-
Smith  ||| S:19580 E:19586 ||| NNP
et  ||| S:19586 E:19589 ||| NNP
al. ||| S:19589 E:19592 ||| NNP
,  ||| S:19592 E:19594 ||| ,
2010 ||| S:19594 E:19598 ||| CD
) ||| S:19598 E:19599 ||| -RRB-
.  ||| S:19599 E:19601 ||| .
In  ||| S:19601 E:19604 ||| IN
this  ||| S:19604 E:19609 ||| DT
study ||| S:19609 E:19614 ||| NN
,  ||| S:19614 E:19616 ||| ,
we  ||| S:19616 E:19619 ||| PRP
found  ||| S:19619 E:19625 ||| VBD
that  ||| S:19625 E:19630 ||| IN
p21  ||| S:19630 E:19634 ||| CD
expression  ||| S:19634 E:19645 ||| NN
was  ||| S:19645 E:19649 ||| VBD
significantly  ||| S:19649 E:19663 ||| RB
increased  ||| S:19663 E:19673 ||| VBN
in  ||| S:19673 E:19676 ||| IN
ING2  ||| S:19676 E:19681 ||| CD
knockdown  ||| S:19681 E:19691 ||| CD
embryos ||| S:19691 E:19698 ||| NNS
.  ||| S:19698 E:19700 ||| .
Additionally ||| S:19700 E:19712 ||| RB
,  ||| S:19712 E:19714 ||| ,
there  ||| S:19714 E:19720 ||| EX
was  ||| S:19720 E:19724 ||| VBD
dramatically  ||| S:19724 E:19737 ||| RB
decreased  ||| S:19737 E:19747 ||| VBN
expression  ||| S:19747 E:19758 ||| NN
of  ||| S:19758 E:19761 ||| IN
HDAC1  ||| S:19761 E:19767 ||| CD
in  ||| S:19767 E:19770 ||| IN
these  ||| S:19770 E:19776 ||| DT
ING2  ||| S:19776 E:19781 ||| FW
knockdown  ||| S:19781 E:19791 ||| FW
embryos ||| S:19791 E:19798 ||| FW
.  ||| S:19798 E:19800 ||| .
These  ||| S:19800 E:19806 ||| DT
results  ||| S:19806 E:19814 ||| NNS
thus  ||| S:19814 E:19819 ||| RB
suggest  ||| S:19819 E:19827 ||| VB
that  ||| S:19827 E:19832 ||| IN
p21  ||| S:19832 E:19836 ||| CD
as  ||| S:19836 E:19839 ||| IN
well  ||| S:19839 E:19844 ||| RB
as  ||| S:19844 E:19847 ||| IN
HDAC1  ||| S:19847 E:19853 ||| NNP
may  ||| S:19853 E:19857 ||| MD
contribute  ||| S:19857 E:19868 ||| VB
to  ||| S:19868 E:19871 ||| TO
the  ||| S:19871 E:19875 ||| DT
regulation  ||| S:19875 E:19886 ||| NN
of  ||| S:19886 E:19889 ||| IN
preimplantation  ||| S:19889 E:19905 ||| JJ
embryonic  ||| S:19905 E:19915 ||| JJ
development ||| S:19915 E:19926 ||| NN
.  ||| S:19926 E:19928 ||| .
Previous  ||| S:19928 E:19937 ||| JJ
studies  ||| S:19937 E:19945 ||| NNS
show  ||| S:19945 E:19950 ||| VBP
that  ||| S:19950 E:19955 ||| IN
down-regulation  ||| S:19955 E:19971 ||| JJ
of  ||| S:19971 E:19974 ||| IN
HDAC1  ||| S:19974 E:19980 ||| NNP
leads  ||| S:19980 E:19986 ||| VBZ
to  ||| S:19986 E:19989 ||| TO
hyperacetylation  ||| S:19989 E:20006 ||| VB
of  ||| S:20006 E:20009 ||| IN
histone  ||| S:20009 E:20017 ||| CD
H4 ||| S:20017 E:20019 ||| CD
,  ||| S:20019 E:20021 ||| ,
which  ||| S:20021 E:20027 ||| WDT
in  ||| S:20027 E:20030 ||| IN
turn  ||| S:20030 E:20035 ||| NN
results  ||| S:20035 E:20043 ||| NNS
in  ||| S:20043 E:20046 ||| IN
developmental  ||| S:20046 E:20060 ||| JJ
delay ||| S:20060 E:20065 ||| NN
.  ||| S:20065 E:20067 ||| .
The  ||| S:20067 E:20071 ||| DT
underlying  ||| S:20071 E:20082 ||| JJ
molecular  ||| S:20082 E:20092 ||| JJ
mechanism  ||| S:20092 E:20102 ||| NN
involves  ||| S:20102 E:20111 ||| VBZ
increased  ||| S:20111 E:20121 ||| VBN
expression  ||| S:20121 E:20132 ||| NN
of  ||| S:20132 E:20135 ||| IN
p21 ||| S:20135 E:20138 ||| NNP
,  ||| S:20138 E:20140 ||| ,
without  ||| S:20140 E:20148 ||| IN
any  ||| S:20148 E:20152 ||| DT
increase  ||| S:20152 E:20161 ||| NN
in  ||| S:20161 E:20164 ||| IN
expression  ||| S:20164 E:20175 ||| NN
of  ||| S:20175 E:20178 ||| IN
either  ||| S:20178 E:20185 ||| RB
the  ||| S:20185 E:20189 ||| DT
pro-apoptotic  ||| S:20189 E:20203 ||| JJ
Bax  ||| S:20203 E:20207 ||| NNP
or  ||| S:20207 E:20210 ||| CC
Bcl2  ||| S:20210 E:20215 ||| CD
transcripts  ||| S:20215 E:20227 ||| NNS
within  ||| S:20227 E:20234 ||| IN
the  ||| S:20234 E:20238 ||| DT
HDAC1-depleted  ||| S:20238 E:20253 ||| CD
embryos  ||| S:20253 E:20261 ||| NNS
( ||| S:20261 E:20262 ||| -LRB-
Ma  ||| S:20262 E:20265 ||| NNP
&  ||| S:20265 E:20267 ||| CC
Schultz ||| S:20267 E:20274 ||| NNP
,  ||| S:20274 E:20276 ||| ,
2008 ||| S:20276 E:20280 ||| CD
) ||| S:20280 E:20281 ||| -RRB-
.  ||| S:20281 E:20283 ||| .
Additionally ||| S:20283 E:20295 ||| RB
,  ||| S:20295 E:20297 ||| ,
induction  ||| S:20297 E:20307 ||| VBG
of  ||| S:20307 E:20310 ||| IN
p21  ||| S:20310 E:20314 ||| NNP
was  ||| S:20314 E:20318 ||| VBD
also  ||| S:20318 E:20323 ||| RB
observed  ||| S:20323 E:20332 ||| VBN
in  ||| S:20332 E:20335 ||| IN
Hdac1-deficient  ||| S:20335 E:20351 ||| CD
embryonic  ||| S:20351 E:20361 ||| NNS
stem  ||| S:20361 E:20366 ||| VBP
cells  ||| S:20366 E:20372 ||| NNS
( ||| S:20372 E:20373 ||| -LRB-
Lagger  ||| S:20373 E:20380 ||| FW
et  ||| S:20380 E:20383 ||| FW
al. ||| S:20383 E:20386 ||| FW
,  ||| S:20386 E:20388 ||| ,
2002 ||| S:20388 E:20392 ||| CD
) ||| S:20392 E:20393 ||| -RRB-
.  ||| S:20393 E:20395 ||| .
In  ||| S:20395 E:20398 ||| IN
summary ||| S:20398 E:20405 ||| NN
,  ||| S:20405 E:20407 ||| ,
this  ||| S:20407 E:20412 ||| DT
study  ||| S:20412 E:20418 ||| NN
has  ||| S:20418 E:20422 ||| VBZ
demonstrated  ||| S:20422 E:20435 ||| VBN
that  ||| S:20435 E:20440 ||| IN
ING2  ||| S:20440 E:20445 ||| NNP
plays  ||| S:20445 E:20451 ||| VBZ
important  ||| S:20451 E:20461 ||| JJ
roles  ||| S:20461 E:20467 ||| NNS
in  ||| S:20467 E:20470 ||| IN
mouse  ||| S:20470 E:20476 ||| JJ
preimplantation  ||| S:20476 E:20492 ||| JJ
development  ||| S:20492 E:20504 ||| NN
which  ||| S:20504 E:20510 ||| WDT
may  ||| S:20510 E:20514 ||| MD
be  ||| S:20514 E:20517 ||| VB
associated  ||| S:20517 E:20528 ||| VBN
with  ||| S:20528 E:20533 ||| IN
complex  ||| S:20533 E:20541 ||| JJ
epigenetic  ||| S:20541 E:20552 ||| JJ
mechanisms ||| S:20552 E:20562 ||| NNS
.  ||| S:20562 E:20564 ||| .
Nevertheless ||| S:20564 E:20576 ||| RB
,  ||| S:20576 E:20578 ||| ,
it  ||| S:20578 E:20581 ||| PRP
must  ||| S:20581 E:20586 ||| MD
be  ||| S:20586 E:20589 ||| VB
noted  ||| S:20589 E:20595 ||| VBN
that  ||| S:20595 E:20600 ||| IN
although  ||| S:20600 E:20609 ||| IN
our  ||| S:20609 E:20613 ||| PRP$
results  ||| S:20613 E:20621 ||| NNS
do  ||| S:20621 E:20624 ||| VBP
show  ||| S:20624 E:20629 ||| NN
that  ||| S:20629 E:20634 ||| IN
ING2  ||| S:20634 E:20639 ||| NNP
plays  ||| S:20639 E:20645 ||| VBZ
a  ||| S:20645 E:20647 ||| DT
crucial  ||| S:20647 E:20655 ||| JJ
role  ||| S:20655 E:20660 ||| NN
in  ||| S:20660 E:20663 ||| IN
preimplantation  ||| S:20663 E:20679 ||| JJ
development ||| S:20679 E:20690 ||| NN
,  ||| S:20690 E:20692 ||| ,
it  ||| S:20692 E:20695 ||| PRP
is  ||| S:20695 E:20698 ||| VBZ
unlikely  ||| S:20698 E:20707 ||| JJ
to  ||| S:20707 E:20710 ||| TO
be  ||| S:20710 E:20713 ||| VB
the  ||| S:20713 E:20717 ||| DT
unique  ||| S:20717 E:20724 ||| JJ
modulator  ||| S:20724 E:20734 ||| NN
of  ||| S:20734 E:20737 ||| IN
this  ||| S:20737 E:20742 ||| DT
process ||| S:20742 E:20749 ||| NN
.  ||| S:20749 E:20751 ||| .
As  ||| S:20751 E:20754 ||| RB
seen  ||| S:20754 E:20759 ||| VBN
in  ||| S:20759 E:20762 ||| IN
Fig.  ||| S:20762 E:20767 ||| NNP
3C  ||| S:20767 E:20770 ||| NNP
and  ||| S:20770 E:20774 ||| CC
Table  ||| S:20774 E:20780 ||| NNP
1 ||| S:20780 E:20781 ||| CD
,  ||| S:20781 E:20783 ||| ,
only  ||| S:20783 E:20788 ||| RB
a  ||| S:20788 E:20790 ||| DT
certain  ||| S:20790 E:20798 ||| JJ
percentage  ||| S:20798 E:20809 ||| NN
of  ||| S:20809 E:20812 ||| IN
embryos  ||| S:20812 E:20820 ||| NNS
are  ||| S:20820 E:20824 ||| VBP
affected  ||| S:20824 E:20833 ||| VBN
by  ||| S:20833 E:20836 ||| IN
microinjection  ||| S:20836 E:20851 ||| NN
of  ||| S:20851 E:20854 ||| IN
ING2-specific  ||| S:20854 E:20868 ||| NNP
esiRNA ||| S:20868 E:20874 ||| NNP
.  ||| S:20874 E:20876 ||| .
This  ||| S:20876 E:20881 ||| DT
could  ||| S:20881 E:20887 ||| MD
suggest  ||| S:20887 E:20895 ||| VB
the  ||| S:20895 E:20899 ||| DT
existence  ||| S:20899 E:20909 ||| NN
of  ||| S:20909 E:20912 ||| IN
multiple  ||| S:20912 E:20921 ||| JJ
redundant  ||| S:20921 E:20931 ||| JJ
signalling  ||| S:20931 E:20942 ||| JJ
pathways  ||| S:20942 E:20951 ||| NN
in  ||| S:20951 E:20954 ||| IN
preimplantation  ||| S:20954 E:20970 ||| JJ
development ||| S:20970 E:20981 ||| NN
.  ||| S:20981 E:20983 ||| .
Indeed ||| S:20983 E:20989 ||| RB
,  ||| S:20989 E:20991 ||| ,
it  ||| S:20991 E:20994 ||| PRP
has  ||| S:20994 E:20998 ||| VBZ
been  ||| S:20998 E:21003 ||| VBN
hypothesized  ||| S:21003 E:21016 ||| VBN
that  ||| S:21016 E:21021 ||| IN
this  ||| S:21021 E:21026 ||| DT
redundancy  ||| S:21026 E:21037 ||| NN
may  ||| S:21037 E:21041 ||| MD
provide  ||| S:21041 E:21049 ||| VB
a  ||| S:21049 E:21051 ||| DT
fail-safe  ||| S:21051 E:21061 ||| JJ
protection  ||| S:21061 E:21072 ||| NN
to  ||| S:21072 E:21075 ||| TO
the  ||| S:21075 E:21079 ||| DT
preimplantation  ||| S:21079 E:21095 ||| JJ
development  ||| S:21095 E:21107 ||| NN
programme  ||| S:21107 E:21117 ||| NNS
( ||| S:21117 E:21118 ||| -LRB-
Kaye ||| S:21118 E:21122 ||| NNP
,  ||| S:21122 E:21124 ||| ,
1997 ||| S:21124 E:21128 ||| CD
) ||| S:21128 E:21129 ||| -RRB-
.  ||| S:21129 E:21131 ||| .
As  ||| S:21131 E:21134 ||| IN
a  ||| S:21134 E:21136 ||| DT
basic  ||| S:21136 E:21142 ||| JJ
subunit  ||| S:21142 E:21150 ||| NN
of  ||| S:21150 E:21153 ||| IN
the  ||| S:21153 E:21157 ||| DT
Sin3  ||| S:21157 E:21162 ||| NNP
HDAC  ||| S:21162 E:21167 ||| NNP
complex ||| S:21167 E:21174 ||| NN
,  ||| S:21174 E:21176 ||| ,
ING2  ||| S:21176 E:21181 ||| CD
displays  ||| S:21181 E:21190 ||| NNS
a  ||| S:21190 E:21192 ||| DT
high  ||| S:21192 E:21197 ||| JJ
degree  ||| S:21197 E:21204 ||| NN
of  ||| S:21204 E:21207 ||| IN
interspecies  ||| S:21207 E:21220 ||| JJ
homology  ||| S:21220 E:21229 ||| NN
between  ||| S:21229 E:21237 ||| IN
human  ||| S:21237 E:21243 ||| JJ
and  ||| S:21243 E:21247 ||| CC
mouse  ||| S:21247 E:21253 ||| NN
( ||| S:21253 E:21254 ||| -LRB-
Guerillon  ||| S:21254 E:21264 ||| FW
et  ||| S:21264 E:21267 ||| FW
al. ||| S:21267 E:21270 ||| FW
,  ||| S:21270 E:21272 ||| ,
2013 ||| S:21272 E:21276 ||| CD
) ||| S:21276 E:21277 ||| -RRB-
.  ||| S:21277 E:21279 ||| .
Hence ||| S:21279 E:21284 ||| RB
,  ||| S:21284 E:21286 ||| ,
we  ||| S:21286 E:21289 ||| PRP
hypothesize  ||| S:21289 E:21301 ||| VBD
that  ||| S:21301 E:21306 ||| IN
ING2  ||| S:21306 E:21311 ||| NNP
may  ||| S:21311 E:21315 ||| MD
also  ||| S:21315 E:21320 ||| RB
play  ||| S:21320 E:21325 ||| VB
a  ||| S:21325 E:21327 ||| DT
similar  ||| S:21327 E:21335 ||| JJ
key  ||| S:21335 E:21339 ||| JJ
role  ||| S:21339 E:21344 ||| NN
in  ||| S:21344 E:21347 ||| IN
human  ||| S:21347 E:21353 ||| JJ
preimplantation  ||| S:21353 E:21369 ||| JJ
embryonic  ||| S:21369 E:21379 ||| JJ
development ||| S:21379 E:21390 ||| NN
.  ||| S:21390 E:21392 ||| .
In  ||| S:21392 E:21395 ||| IN
clinical  ||| S:21395 E:21404 ||| JJ
assisted  ||| S:21404 E:21413 ||| JJ
reproduction ||| S:21413 E:21425 ||| NN
,  ||| S:21425 E:21427 ||| ,
obtaining  ||| S:21427 E:21437 ||| VBG
high-quality  ||| S:21437 E:21450 ||| JJ
embryos  ||| S:21450 E:21458 ||| NN
is  ||| S:21458 E:21461 ||| VBZ
critical  ||| S:21461 E:21470 ||| JJ
for  ||| S:21470 E:21474 ||| IN
improving  ||| S:21474 E:21484 ||| VBG
the  ||| S:21484 E:21488 ||| DT
pregnancy  ||| S:21488 E:21498 ||| NN
rate ||| S:21498 E:21502 ||| NN
.  ||| S:21502 E:21504 ||| .
Additionally ||| S:21504 E:21516 ||| RB
,  ||| S:21516 E:21518 ||| ,
extended  ||| S:21518 E:21527 ||| JJ
culture  ||| S:21527 E:21535 ||| NN
and  ||| S:21535 E:21539 ||| CC
transfer  ||| S:21539 E:21548 ||| NN
of  ||| S:21548 E:21551 ||| IN
embryos  ||| S:21551 E:21559 ||| NN
at  ||| S:21559 E:21562 ||| IN
the  ||| S:21562 E:21566 ||| DT
blastocyst  ||| S:21566 E:21577 ||| JJ
stage  ||| S:21577 E:21583 ||| NN
for  ||| S:21583 E:21587 ||| IN
assisted  ||| S:21587 E:21596 ||| JJ
reproduction  ||| S:21596 E:21609 ||| NN
offers  ||| S:21609 E:21616 ||| VBZ
some  ||| S:21616 E:21621 ||| DT
theoretical  ||| S:21621 E:21633 ||| JJ
advantages  ||| S:21633 E:21644 ||| NNS
over  ||| S:21644 E:21649 ||| IN
the  ||| S:21649 E:21653 ||| DT
transfer  ||| S:21653 E:21662 ||| NN
of  ||| S:21662 E:21665 ||| IN
cleavage-stage  ||| S:21665 E:21680 ||| JJ
embryos ||| S:21680 E:21687 ||| NN
.  ||| S:21687 E:21689 ||| .
For  ||| S:21689 E:21693 ||| IN
example ||| S:21693 E:21700 ||| NN
,  ||| S:21700 E:21702 ||| ,
higher  ||| S:21702 E:21709 ||| JJR
implantation  ||| S:21709 E:21722 ||| NN
rates ||| S:21722 E:21727 ||| NNS
,  ||| S:21727 E:21729 ||| ,
single  ||| S:21729 E:21736 ||| JJ
embryo  ||| S:21736 E:21743 ||| NN
transfer  ||| S:21743 E:21752 ||| NN
and  ||| S:21752 E:21756 ||| CC
better  ||| S:21756 E:21763 ||| RBR
temporal  ||| S:21763 E:21772 ||| JJ
synchronization  ||| S:21772 E:21788 ||| NN
between  ||| S:21788 E:21796 ||| IN
embryo  ||| S:21796 E:21803 ||| NN
and  ||| S:21803 E:21807 ||| CC
endometrium  ||| S:21807 E:21819 ||| NNS
can  ||| S:21819 E:21823 ||| MD
be  ||| S:21823 E:21826 ||| VB
achieved  ||| S:21826 E:21835 ||| VBN
by  ||| S:21835 E:21838 ||| IN
transfer  ||| S:21838 E:21847 ||| NN
of  ||| S:21847 E:21850 ||| IN
embryos  ||| S:21850 E:21858 ||| NN
at  ||| S:21858 E:21861 ||| IN
the  ||| S:21861 E:21865 ||| DT
blastocyst  ||| S:21865 E:21876 ||| JJ
stage  ||| S:21876 E:21882 ||| NN
( ||| S:21882 E:21883 ||| -LRB-
Jones  ||| S:21883 E:21889 ||| NNP
et  ||| S:21889 E:21892 ||| NNP
al. ||| S:21892 E:21895 ||| NNP
,  ||| S:21895 E:21897 ||| ,
1998 ||| S:21897 E:21901 ||| CD
;  ||| S:21901 E:21903 ||| :
Tsirigotis ||| S:21903 E:21913 ||| NNP
,  ||| S:21913 E:21915 ||| ,
1998 ||| S:21915 E:21919 ||| CD
;  ||| S:21919 E:21921 ||| :
Hambiliki  ||| S:21921 E:21931 ||| FW
et  ||| S:21931 E:21934 ||| FW
al. ||| S:21934 E:21937 ||| FW
,  ||| S:21937 E:21939 ||| ,
2013 ||| S:21939 E:21943 ||| CD
) ||| S:21943 E:21944 ||| -RRB-
.  ||| S:21944 E:21946 ||| .
However ||| S:21946 E:21953 ||| RB
,  ||| S:21953 E:21955 ||| ,
the  ||| S:21955 E:21959 ||| DT
extended  ||| S:21959 E:21968 ||| JJ
duration  ||| S:21968 E:21977 ||| NN
of  ||| S:21977 E:21980 ||| IN
in  ||| S:21980 E:21983 ||| IN
vitro  ||| S:21983 E:21989 ||| JJ
culture  ||| S:21989 E:21997 ||| NN
involves  ||| S:21997 E:22006 ||| VBZ
high  ||| S:22006 E:22011 ||| JJ
risk  ||| S:22011 E:22016 ||| NN
of  ||| S:22016 E:22019 ||| IN
reduction  ||| S:22019 E:22029 ||| NN
in  ||| S:22029 E:22032 ||| IN
the  ||| S:22032 E:22036 ||| DT
number  ||| S:22036 E:22043 ||| NN
of  ||| S:22043 E:22046 ||| IN
embryos  ||| S:22046 E:22054 ||| JJ
available  ||| S:22054 E:22064 ||| JJ
for  ||| S:22064 E:22068 ||| IN
transfer ||| S:22068 E:22076 ||| NN
,  ||| S:22076 E:22078 ||| ,
because  ||| S:22078 E:22086 ||| IN
the  ||| S:22086 E:22090 ||| DT
in  ||| S:22090 E:22093 ||| IN
vitro  ||| S:22093 E:22099 ||| JJ
culture  ||| S:22099 E:22107 ||| NN
environment  ||| S:22107 E:22119 ||| NN
may  ||| S:22119 E:22123 ||| MD
exert  ||| S:22123 E:22129 ||| VB
detrimental  ||| S:22129 E:22141 ||| JJ
effects  ||| S:22141 E:22149 ||| NNS
on  ||| S:22149 E:22152 ||| IN
embryonic  ||| S:22152 E:22162 ||| JJ
development  ||| S:22162 E:22174 ||| NN
( ||| S:22174 E:22175 ||| -LRB-
Jones  ||| S:22175 E:22181 ||| NNP
et  ||| S:22181 E:22184 ||| NNP
al. ||| S:22184 E:22187 ||| NNP
,  ||| S:22187 E:22189 ||| ,
1998 ||| S:22189 E:22193 ||| CD
;  ||| S:22193 E:22195 ||| :
Kawamura  ||| S:22195 E:22204 ||| FW
et  ||| S:22204 E:22207 ||| FW
al. ||| S:22207 E:22210 ||| FW
,  ||| S:22210 E:22212 ||| ,
2012 ||| S:22212 E:22216 ||| CD
;  ||| S:22216 E:22218 ||| :
Calzi  ||| S:22218 E:22224 ||| FW
et  ||| S:22224 E:22227 ||| FW
al. ||| S:22227 E:22230 ||| FW
,  ||| S:22230 E:22232 ||| ,
2012 ||| S:22232 E:22236 ||| CD
) ||| S:22236 E:22237 ||| -RRB-
.  ||| S:22237 E:22239 ||| .
Hence  ||| S:22239 E:22245 ||| RB
rigorous  ||| S:22245 E:22254 ||| JJ
characterization  ||| S:22254 E:22271 ||| NN
of  ||| S:22271 E:22274 ||| IN
the  ||| S:22274 E:22278 ||| DT
regulatory  ||| S:22278 E:22289 ||| JJ
mechanisms  ||| S:22289 E:22300 ||| NNS
in  ||| S:22300 E:22303 ||| IN
embryonic  ||| S:22303 E:22313 ||| JJ
development  ||| S:22313 E:22325 ||| NN
is  ||| S:22325 E:22328 ||| VBZ
of  ||| S:22328 E:22331 ||| IN
great  ||| S:22331 E:22337 ||| JJ
significance  ||| S:22337 E:22350 ||| NN
to  ||| S:22350 E:22353 ||| TO
clinical  ||| S:22353 E:22362 ||| VB
assisted  ||| S:22362 E:22371 ||| VBN
reproduction ||| S:22371 E:22383 ||| NN
.  ||| S:22383 E:22385 ||| .
This  ||| S:22385 E:22390 ||| DT
study  ||| S:22390 E:22396 ||| NN
sheds  ||| S:22396 E:22402 ||| VBD
some  ||| S:22402 E:22407 ||| DT
light  ||| S:22407 E:22413 ||| NN
on  ||| S:22413 E:22416 ||| IN
the  ||| S:22416 E:22420 ||| DT
crucial  ||| S:22420 E:22428 ||| JJ
role  ||| S:22428 E:22433 ||| NN
of  ||| S:22433 E:22436 ||| IN
ING2  ||| S:22436 E:22441 ||| CD
in  ||| S:22441 E:22444 ||| IN
mouse  ||| S:22444 E:22450 ||| JJ
preimplantation  ||| S:22450 E:22466 ||| JJ
development  ||| S:22466 E:22478 ||| NN
which  ||| S:22478 E:22484 ||| WDT
gives  ||| S:22484 E:22490 ||| VBZ
an  ||| S:22490 E:22493 ||| DT
inkling  ||| S:22493 E:22501 ||| NN
on  ||| S:22501 E:22504 ||| IN
the  ||| S:22504 E:22508 ||| DT
function  ||| S:22508 E:22517 ||| NN
of  ||| S:22517 E:22520 ||| IN
ING2  ||| S:22520 E:22525 ||| CD
in  ||| S:22525 E:22528 ||| IN
human  ||| S:22528 E:22534 ||| JJ
in  ||| S:22534 E:22537 ||| IN
vitro  ||| S:22537 E:22543 ||| JJ
cultured  ||| S:22543 E:22552 ||| JJ
embryos ||| S:22552 E:22559 ||| NN
.  ||| S:22559 E:22562 ||| .
Competing  ||| S:22562 E:22572 ||| VBG
interests  ||| S:22572 E:22583 ||| NNS
The  ||| S:22583 E:22587 ||| DT
authors  ||| S:22587 E:22595 ||| NNS
hereby  ||| S:22595 E:22602 ||| VBP
declare  ||| S:22602 E:22610 ||| VBN
that  ||| S:22610 E:22615 ||| IN
there  ||| S:22615 E:22621 ||| EX
are  ||| S:22621 E:22625 ||| VBP
no  ||| S:22625 E:22628 ||| DT
conflicting  ||| S:22628 E:22640 ||| JJ
interests ||| S:22640 E:22649 ||| NNS
.  ||| S:22649 E:22653 ||| .
Acknowledgements  ||| S:22653 E:22671 ||| VBG
This  ||| S:22671 E:22676 ||| DT
work  ||| S:22676 E:22681 ||| NN
was  ||| S:22681 E:22685 ||| VBD
financially  ||| S:22685 E:22697 ||| RB
supported  ||| S:22697 E:22707 ||| VBN
by  ||| S:22707 E:22710 ||| IN
the  ||| S:22710 E:22714 ||| DT
National  ||| S:22714 E:22723 ||| NNP
Natural  ||| S:22723 E:22731 ||| NNP
Science  ||| S:22731 E:22739 ||| NNP
Foundation  ||| S:22739 E:22750 ||| NNP
of  ||| S:22750 E:22753 ||| IN
China  ||| S:22753 E:22759 ||| NNP
( ||| S:22759 E:22760 ||| -LRB-
81100420 ||| S:22760 E:22768 ||| CD
,  ||| S:22768 E:22770 ||| ,
81270701 ||| S:22770 E:22778 ||| LS
) ||| S:22778 E:22779 ||| -RRB-
.  ||| S:22779 E:22783 ||| .
